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About the Academy
The Academy of Science of South Africa (ASSAf) was inaugurated in 
May 1996 in the presence of then President Nelson Mandela, the patron 
of the launch of the Academy. It was formed in response to the need 
for an Academy of Science consonant with the dawn of democracy 
in South Africa: activist in its mission of using science for the benefit of 
society, with a mandate encompassing all fields of scientific enquiry in a 
seamless way, and including in its ranks the full diversity of South Africa’s 
distinguished scientists.
The Parliament of South Africa passed the Academy of Science of South 
Africa Act, Act 67 of 2001, and the Act came into force on 15 May 
2002. This has made ASSAf the official Academy of Science of South 
Africa, recognised by government and representing South Africa in the 
international community of science academies.
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Foreword
This proceedings report is the product of a two-day workshop 
hosted by the Academy of Science of South Africa (ASSAf) 
from 17-18 September 2009. ASSAf, in partnership with the 
Union of the German Academies of Sciences and Humanities, 
the Network of African Science Academies (NASAC) and 
the Uganda National Academy of Sciences (UNAS) received 
funding from the InterAcademy Panel (IAP) to conduct a study 
on “Genetically Modified Organisms (GMOs): Opportunities 
and Challenges in Africa”. 
A planning committee comprising Dr Hennie Groenewald 
(Chair), Dr Antonio Llobell and Prof. Ed Rybicki from South Africa 
and Prof. Patrick Rubaihayo from Uganda was established. 
The committee held its first meeting in June 2009 and decided 
to focus on agricultural crops within the context of the African 
continent. The proposed structure for the follow-up scientific 
workshop was also formulated at this meeting.
viii
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The two-day September 2009 scientific workshop was titled “GMOs for African Agriculture: 
Opportunities and Challenges”. Invited experts from seven different African countries 
(South Africa, Uganda, Kenya, Senegal, Cameroon, Zimbabwe and Mauritius), as well as 
an expert from the Union of the German Academies of Sciences and Humanities, attended 
the meeting to address issues concerning GMOs in agriculture. 
Papers presented at the workshop included accounts of research being undertaken in 
Africa on GM technology, and highlighted the opportunities created by GM technology 
and the many challenges faced in applying this technology to African agriculture. It was 
noted that the capacity to develop GM technology and to evaluate risks was available. 
Scientists in African countries were ready to engage in scientific and funding partnerships 
to develop GM technology, and the basis on which regulatory systems can be developed 
already exists. However, it was recognised that there are numerous challenges that lie 
ahead, chief of which are those relating to the commercialisation of GM products and the 
applications of GM technology in the market place. 
It was agreed unanimously by participants at the workshop that the conclusions of the 
workshop should be brought to the attention of policy-makers across Africa and that this 
should be done through the production of a concise, colourful and digestible policy-
makers’ document. The production of the workshop proceedings is the first step in this 
direction. 
This study on GMOs was conducted by ASSAf as a forum study, in which invited experts were 
assembled to exchange views on a particular topic, and through the presentations and 
debates were able to draw some conclusions. This particular study was conducted under 
the umbrella of the ASSAf Committee on Science for Poverty Alleviation, underscoring the 
potential role of GMOs in food security on the African continent. It is sincerely hoped that 
this study will assist in the alleviation of poverty in Africa.
I would like to thank the IAP for funding this study and particularly wish to express my thanks 
to those who assisted in the planning of the workshop and all those who contributed the 
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FOREWORD
papers that comprise this proceedings report. Finally, I wish to thank all the staff of ASSAf, 
particularly Ms Phakamile Mngadi, for the support given to the committee to enable them 
to complete this task. 
Prof. Robin Crewe
President: Academy of Science of South Africa
xWORKSHOP PROCEEDINGS REPORT
GMOs FOR AFRICAN AGRICULTURE: CHALLENGES AND OPPORTUNITIES
Acknowledgements
The Committee on Science for Poverty Alleviation of the Academy of Science of South 
Africa (ASSAf) wishes to express its appreciation to all the presenters, as well as all the 
individuals who gave their valuable input. The workshop programme giving the names of 
all presenters is included as Appendix 2.
The valuable leadership and guidance provided by Dr Hennie Groenewald, Chair of the 
Committee, is gratefully acknowledged.
Prof. Roseanne Diab, Executive Officer, is thanked for her support. 
Beverlie Davies (editor) and Profit Creative are also acknowledged for producing this 
publication.
The following ASSAf staff are also acknowledged: Mr Takalani Rambau, Liaison Manager, 
for proposing the project to the InterAcademy Panel (IAP) and securing the funding; Ms 
Phakamile Mngadi, Projects Officer/Study Director of this Forum and Dr Nthabiseng Taole, 
Projects Manager for their much-valued contributions during the course of the Forum 
process and the production of these proceedings.
The support offered by all ASSAf staff and others who contributed to the success of this 
Forum and the ASSAf publication team for the production of this report are also greatly 
appreciated.
Finally, the Committee acknowledges the financial support provided by the IAP, as well 
as that provided by the South African National Department of Science and Technology 
(DST).
xi
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
Executive Summary
The production of genetically modified organisms (GMOs) in Africa has the potential to 
alleviate many problems on the continent – at present, millions of Africans are vulnerable to 
food insecurity and malnourishment. This is particularly evident in rural areas, where people 
depend primarily on agriculture for food and income. This report focuses on the potential 
of biotechnology, through GMOs, to provide solutions to such problems.
Biotechnology is defined as “any technique that uses living organisms or substances from 
these organisms, to make or modify a product, to improve plants or animals, or to develop 
microorganisms for specific uses” (Office of Technology Assessment of the United States 
Congress). 
Modern biotechnology has been associated with genetic engineering or genetic modifi- 
cation (GM). Recombinant DNA, or genetic engineering, is a more precise form of 
biotechnology, allowing a breeder to transfer known, desirable genes into crops, instead of 
moving large groups of mostly unknown genes into crops, as in most traditional breeding. 
“genetically modified crops”, often known by the acronym “GM crops”, are usually 
received with varying emotions worldwide. Nonetheless, GM application, a component 
of biotechnology, is gradually finding its niche across the globe. Indeed, plant and crop 
breeders have been using biotechnology to modify the genetic make-up of crops for 
thousands of years.
African agriculture has for decades been faced by multiple challenges, ranging from low 
productivity to poor or non-existent markets and infrastructure. There has been a decline 
in the production of cereals over the past four years, which has been attributed to low-
input (i.e. farming based on a reduction of fertilisers, herbicides and insecticides) usage, 
declining soil fertility, erratic climatic conditions and low government commitment to fund 
development efforts in the sector. Biotechnology offers a mechanism to increase crop 
productivity, and as such to contribute towards food security and poverty eradication in 
Africa. 
xii
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A decade after GM crops were introduced into the world, their production has grown to 
about 125 million ha globally. Biotechnology first found its way into Africa through Bt maize, 
which was introduced into South Africa in 2003. Since its introduction, the technology has 
been found to reduce losses of maize incurred through damage by stem borers. However, 
there is still a large untapped potential in biotechnology that can be embraced to address 
Africa’s challenges. 
Although biotechnology is gradually being embraced across the globe, it nonetheless 
faces much opposition. Challenges to its adoption include: 
perceptions and attitudes • 
access to and use of proprietary technology• 
biotechnology policy• 
the cost of biotechnology research.• 
In order to tap into the potential that biotechnology offers to agricultural productivity and 
food security, there is a need for greater dedication by African governments towards 
biotechnology development. This can be done by developing their capacity to negotiate 
access to intellectual property (IP) rights, and to enact and operationalise IP rights and 
biosafety policies and guidelines that foster technological innovations, delivery and 
trade.
In Chapter 1, the situation with respect to GM crop plants in Germany is investigated. 
German companies invest large sums of money in plant biotechnology, but much of the 
research and production is conducted outside Germany due to the hostility of the German 
public towards GM plants. 
The licensing of GM crops for all 27 member states of the European Union (EU) is carried 
out by the European Council. To date, relatively few products from GM crops have been 
admitted in the EU for human consumption or fodder and all have to be labelled as GM. It is 
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noted that in Europe a large proportion of the public is opposed to plant gene technology 
and that politicians have been influenced by this sentiment. 
The activities of the German science academies in conjunction with the InterAcademy 
Panel (IAP) to counteract the misleading campaigns by GM opponent organisations are 
explored in this chapter. 
The ecological and economic aspects of the cultivation of GM insect-resistant varieties of 
maize, rice and cotton are summarised, and it is concluded that the growth of these crops 
by small-scale farmers in developing countries can be beneficial. 
Chapter 2 focuses on the role of GMOs in food and nutrition security in Africa. In 2000, the 
UN adopted the Millennium Development Goals (MDGs), many of which have a direct 
connection with food security. By definition, food security is achieved when all people at 
all times have physical and economic access to sufficient, safe and nutritious food to meet 
their dietary needs and food preferences for an active and healthy life. Clearly, in the light 
of this definition, food security poses a major problem for the developing countries of sub-
Saharan Africa, where problems of food supply, hunger, under-nutrition and malnutrition 
exist. 
GM technology presents an exciting opportunity to contribute towards the resolution 
of the African food and nutrition security problem, provided it is carried out within a 
framework of appropriate biotechnology policy with sufficient financing for human capital 
development, the construction and equipping of the necessary laboratories and the 
conducting of rigorously planned, results-oriented GM food research. Research results 
have shown the possibility of increasing crop yields, improving the storage potential of 
harvested crops, improving the protein content of starchy foods, biofortification of local 
foods, and improving the functional potential of local foods. 
In Chapter 3, some of the opportunities and challenges in the use of GM technology are 
explored. The use of GM technology and its products is still in its infancy in Africa. South 
EXECUTIVE SUMMARY
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Africa, which has biosafety regulations in place, is one of the three countries [with Egypt 
and Burkina Faso] on the continent that are producing commercial GM crops. The GM 
crops that are produced on a commercial basis have been limited to maize (Zea mays 
L.), cotton (Gossypium hirsutum L.), soybean (Glycine max L.) and oilseed rape (Brassica 
napus L.). These four crops have been transformed for the two traits of insect resistance 
and herbicide tolerance. There is a need in Africa also to develop GM crops with other 
important traits.
One of the very few transgenic crops with virus resistance that has been commercialised is 
papaya (Carica papaya L.). Papaya with resistance to papaya ringspot virus (PRSV) is now 
grown on a commercial basis by farmers on the Hawaiian islands, where GM technology 
was used to save the local papaya industry from total collapse due to infection by PRSV. 
The Hawaiian papaya experience can be used as a model to address the many virus 
problems that have affected African farming communities for a long time.
Various laboratories across the continent are using GM technology to develop transgenic 
crops with virus resistance. The first all-African-produced modified plant in the form of 
transgenic maize with resistance to the maize streak virus (MSV) has been developed. This 
maize is at present being evaluated under containment. Other projects underway on the 
continent are also discussed.
As the number of scientists with training in molecular biology, tissue culture and virology 
increases, there is likely to be a concomitant increase in the number of projects aimed at 
developing transgenic crops with virus resistance. Against this background, it is concluded 
that the future for the development of GMOs in Africa looks promising. GM technology in 
the form of GMO plants with virus resistance could be the key to unlocking the potential 
of African agriculture by, among other things, addressing and solving the numerous viral 
disease problems that have hampered the economic production of Africa’s major food 
and commercial crops. 
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Chapter 4 provides an evidence-based evaluation of the environmental effects of GM 
crops. Most concerns about GM crops can be categorised as follows: food safety and 
animal/human health concerns, environmental concerns, agricultural concerns and socio-
economic issues. 
Some of the studies that have been conducted on potential impacts of insect-resistant and 
herbicide-tolerant GM crops are highlighted. In order to effectively evaluate GM crops, an 
acknowledgment of their potential benefits must be made in addition to an evaluation of 
the potential damage to the environment and human and animal health. 
With a large number of GM crops currently under development in Africa it is evident that 
regulatory authorities in the continent will continue receiving applications for GM trials and/
or environmental releases. In order to be able to effectively evaluate these applications, it 
is imperative that they have access to relevant information and appropriate training. 
The application of a multidisciplinary systems biology approach to the evaluation of GM 
crops is described in Chapter 5. The concept of “substantial equivalence” is used to 
compare GM plants and their non-GM counterparts in terms of changes in gene expression 
and associated protein and metabolite derivatives as a result of genetic modification. 
These key compounds have been determined by international standards to form the 
basis of substantial equivalence. The substantial equivalence approach was adopted by 
regulatory bodies to ensure that GM plants and foods are as safe and nutritious as their 
conventional counterparts.
A case study involving the genetic modification of a Bt maize cultivar grown in one location 
over three years (seasons) with its non-GM maize counterpart is presented. 
Chapter 6 documents the lessons learned from the commercialisation of a GM potato in 
South Africa. It is concluded that only larger multi-institutional and multidisciplinary groups 
stand any chance of success in the commercialisation process and it is noted that the 
South African authorities appear to be becoming more conservative and less willing to 
EXECUTIVE SUMMARY
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grant permits. If this is the trend, it may make it more difficult for other African countries to 
embrace this potentially beneficial technology.
GMOs are produced by one of three methods: recombinant DNA technology, chemical 
methods, or through nuclear techniques. Chapter 7 focuses on the use of nuclear tech-
niques in GMO production, noting that they are highly competitive in comparison with non-
nuclear technologies, and that huge economic benefits have accrued in other regions 
through the use of radiation-induced mutations. 
An opinion paper on sustainable GMO technologies for African agriculture is presented 
in Chapter 8. Agricultural sustainability usually refers to agronomic sustainability, including 
aspects such as agronomic practices, productivity and ecological diversity – all factors 
that should be considered during the risk assessment of a GM crop before it is released 
commercially. Most GM crops that have been commercialised to date were developed 
primarily for large-scale farming systems and would, arguably, not impart the same scale 
of benefits to small-scale and subsistence farmers, typical of developing countries. 
Therefore, to allow developing countries to derive the full potential benefits of biotechnology 
crops, it is proposed that, in addition to the traditional biosafety aspects mentioned above, 
technology developers should also more carefully consider factors such as the relevance 
and accessibility of a particular technology to ensure sustainability. Risk assessment and 
risk management play a critical role in the successful commercialisation of GM crops and 
should therefore be considered as an integral part of any GM research and development 
programme. This chapter develops these concepts and presents a risk analysis framework 
which can be used in an R&D programme to identify, assess and mitigate potential 
biosafety and other deployment risks. 
The sustainability of GMOs usually revolves around their sustainable use in agricultural 
systems, focusing predominantly on food/feed and environmental safety. Sustainability 
is therefore often equated with the post-release safety of the GMO, an aspect that is 
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regulated in all systems and is therefore carefully considered during the development and 
risk assessment processes. Potential socioeconomic impacts, by contrast, are currently 
either not regulated in many countries or are considered only at a very late stage of 
product development. The fact that most of the current commercial GM crops were 
designed around the needs of specific markets which differ considerably from those in 
the developing world, and that they were not developed based on locally established 
priorities and competencies, has resulted in GM products that are unable to deliver positive 
socioeconomic impacts to many farmers in developing countries. 
The sustainable adoption and use of GM technology is also subject to many socioeconomic 
and practical constraints, which should be considered proactively in ex ante sustainability 
analyses. By integrating sustainability analyses, including biosafety and socioeconomic 
assessments, into a GMO research and development pipeline, the development of both 
safe and economically sustainable products could be ensured. Such an approach should 
also improve the overall efficiency of the innovation system because it will help to ensure 
the development of safe, relevant and accessible products that are truly sustainable. 
The penultimate chapter, Chapter 9, recognises that Africa, home to over 900 million 
people and representing 14% of the world’s population, is the only continent where food 
production per capita is decreasing and where hunger and malnutrition afflict at least one 
in three people. It is the continent that represents by far the biggest challenge in terms 
of adoption and acceptance of new technologies, and the chapter questions whether 
agricultural biotechnology can work in Africa. 
It is noted that despite the Green Revolution, crop yields in sub-Saharan Africa have hardly 
changed over the past 40 years and cereal production per capita is steadily declining. 
It is estimated that with current yields, the projected shortfall of cereals will be 88.7 million 
tons by 2025. 
EXECUTIVE SUMMARY
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Biotechnology offers considerable opportunity for addressing many of Africa’s pressing 
challenges. Ongoing biotechnology research in Africa focuses largely on attempting to 
solve local problems associated with food production, health and the environment.
Biotechnology can play a role in increased global crop productivity to improve food, feed 
and fibre security in sustainable crop production systems that also conserve biodiversity. 
It can contribute to the alleviation of poverty and hunger, and the augmentation of 
traditional plant breeding, and can reduce the environmental footprint of agriculture, 
mitigate climate change, reduce greenhouse gas emissions and contribute to the cost-
effective production of biofuel. Agricultural biotechnology is vital for addressing the 
chronic food shortages in sub-Saharan Africa.
GM technology is employed in only a few African countries, namely South Africa, 
Zimbabwe, Egypt, Kenya, Burkina Faso, Uganda and Malawi, and to a lesser extent in 
Mauritius. Of all these countries, only South Africa, Egypt and Burkina Faso have reached 
the commercialisation stage.
Most countries in Africa have ratified the Cartagena Protocol on Biosafety (CPB) and have 
received United Nations Environment Programme – Global Environment Facility (UNEP-
GEF) assistance to formulate their biosafety frameworks, yet only a few have functioning 
biosafety legislation that allows field trials of GM products (South Africa, Zimbabwe, 
Malawi, Kenya, Uganda, Tanzania, Burkina Faso, Ghana, Nigeria, Egypt, Tunisia, Morocco 
and Mauritania). 
With the commercialisation of biotechnology products in other parts of Africa, South 
Africa is no longer the sole producer of biotechnology products in Africa. However, the 
country remains the pioneer of the technology and is a role model for the rest of Africa. 
South Africa is seen as the hub of agricultural biotechnology for Africa as it is one of the 
few countries in Africa that has a well-developed regulatory system and the expertise 
to manage the technology. However, South Africa seems to be moving towards stricter 
legislation, contrary to available scientific evidence. 
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There is therefore a need in South Africa to ensure that decision-makers who develop 
policies and amend and enforce the existing legislation and regulations are continually 
educated and informed on biosafety and biotechnology.
Chapter 10 presents the experience of a technology developer in the regulation of GMO 
activities in South Africa and concludes with some recommendations. 
Challenges are experienced at various levels: in the design of the legislative framework, 
in the operational procedures and in the authorisations granted. It is recommended that 
legislative frameworks should be functional, practical and operational, while providing 
protection of the developer’s investment in terms of IP. Application forms should be activity-
specific, easily accessible and science-based. Assessment of applications by regulators 
should be timely, transparent and focused on information that will assist in determining 
the safety of the proposed activity and product. Concerns, decisions and reasons for 
decisions should be communicated in a timely fashion and be clearly stated. Conditions 
should be activity-specific, based on agricultural practice and remain consistent to enable 
implementation, unless supported by scientific evidence that would necessitate any 
amendment to the conditions. Applications should be processed within the time periods 
described in legislative frameworks.
EXECUTIVE SUMMARY
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INTRODUCTION AND PROBLEM STATEMENT  
DR GOSPEL OMANYA
African Agricultural Technology Foundation (AATF), Kenya
Introduction 
Biotechnology: A Historical Perspective 
Biotechnology is “any technique that uses living organisms or substances from these 
organisms, to make or modify a product, to improve plants or animals, or to develop 
microorganisms for specific uses” (Office of Technology Assessment of the United States 
Congress). In this broad sense, plant and crop breeders have been using biotechnology 
to modify the genetic make-up of crops for thousands of years (McHughen, 2008). In fact, 
no currently grown crop varieties are “natural”, in that all arose from human intervention 
in moving genes around to create new genetic combinations. A new variety, whether 
developed using traditional or modern breeding methods, must carry a new combination 
of genes not present in nature. Modern biotechnology has been associated with genetic 
engineering or genetic modification (GM). Recombinant DNA, or genetic engineering, is 
a more precise form of biotechnology, allowing the breeder to transfer known, desirable 
genes into crops, instead of moving large groups of mostly unknown genes as in most 
traditional breeding. But the words “genetically modified crops”, often known by the 
acronym “GM crops”, are usually received with varying emotions worldwide. Nonetheless, 
GM application, a component of biotechnology, is gradually finding its niche across the 
globe. 
Incidentally, biotechnology has been with us throughout history, since the domestication 
of plants around 8000 BC. For instance, brewing, fermentation, bread- and cheese- 
making and the production of dairy products were some of the earliest forms of applying 
biotechnology. Groundbreaking work by Mendel in the 1860s laid the foundation for 
classical plant breeding. This took advantage of natural genetic recombination within 
3A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
species, an aspect that has been exploited by farmers over the centuries, resulting 
in superior harvests in successive generations. Later in 1901, it was discovered that the 
bacterium Bacillus thuringiensis (Bt) was able to produce toxins that are lethal to insects 
but harmless to humans. Furthermore, the discovery of Agrobacterium tumefaciens in 
1907 offered a unique tool for transfer of the Bt genes to crops, ushering in a new era 
of gene transfer across plant species, a process that became clearer following Watson 
and Crick’s unravelling of the DNA structure in the 1950s. Biotechnology thus provides a 
complementary approach to conventional breeding methods. 
African agriculture and biotechnologies 
African Agriculture: Challenges and Future Prospects 
Millions of Africans are vulnerable to food insecurity and malnourishment. This is particularly 
evident in rural areas, where people primarily depend on agriculture for food and income. 
However, the agricultural sector on the continent has for decades been faced by myriad 
challenges, ranging from low productivity to poor or non-existent markets and infrastructure. 
As shown in Figure 0.1, the yields of cereals in sub-Saharan Africa have stagnated over the 
last four decades, despite the tremendous growth recorded in other regions of the world. 
This decline in productivity has been attributed to low-input usage, declining soil fertility, 
erratic climatic conditions and low government commitment to fund development efforts 
in the sector. 
INTRODUCTION AND PROBLEM STATEMENT 
Dr Gospel Omanya
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Figure 0.1: Global trends in the yield of cereals (1961–2003) 
As a result of the incidence of poverty among small-scale farmers in Africa, it has been 
difficult for them to purchase adequate inputs, a predicament that further fuels the vicious 
cycle of poverty. Indeed, Chambers (1983) elaborates that poverty contributes to physical 
weakness through the lack of food, small physiques, malnutrition leading to a low immune 
response to infections, and the inability to reach or pay for health services. Furthermore, 
the climate change predicament is predicted to aggravate the situation considering that 
only 4% of crop land on the continent has access to irrigation and that 33% of the land is 
subject to moderate drought. The rise in global food prices has caused a dilemma since 
government has to spend huge sums of foreign exchange for food imports. 
However, as noted by the World Bank (2008), agriculture can work in concert with other 
sectors to produce faster growth, reduce poverty and sustain the environment. This is 
because agriculture contributes to development as an economic activity, as a livelihood 
and as a provider of environmental services, making the sector a unique instrument for 
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development. However, to achieve this, there is a dire need for renewed efforts towards 
revitalising agriculture at local and global levels since agricultural productivity growth is 
synonymous with poverty alleviation. Agriculture can be a main pathway leading out 
of poverty by making small-scale farming more productive, profitable and sustainable 
through the establishment of policy instruments that embrace innovation and technology, 
market reforms and improved linkages between farmers and research. 
Biotechnology and Agricultural Development
The debate on the linkage between rural development and biotechnology has been 
going on for some time. However, the important question has been: “What role can 
biotechnology play in solving the farm problem and make agriculture work for the poor?” 
As noted by USAID (2007), agricultural biotechnology offers an additional tool for increasing 
crop productivity, especially when conventional methods cannot deliver on breeding 
targets. This offers a great breakthrough in Africa towards advancing even faster towards 
food security and poverty eradication. A number of studies have been done to assess the 
impact of GM crops on farm productivity in developing countries (e.g. Huang et al., 2005; 
Zilberman et al., 2007). There is unanimous agreement that biotechnology is indeed an 
important tool for increasing farm productivity for the smallholder farm sector. A study by 
Subramanian and Qaim (2009) provides empirical evidence that production of Bt cotton 
has direct and spill-over positive socioeconomic effects on all types of rural households 
through improved yields and increased employment. These important findings point to the 
role that GM crops can play in solving poverty and development issues. 
Status of Biotechnology in the Developing World 
A decade after genetically modified crops were introduced into the world, their pro-
duction has grown to about 125 million ha globally (GMO Compass, 2009). According 
to the annual report of the International Service for the Acquisition of Agri-Biotech 
Applications (ISAAA, 2008; Karembu et al., 2009) on the global crop situation, a world total 
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of 13.3 million farmers used GM crops in 2008, 1.3 million more than in 2007. However, over 
90% of these farmers are in developing countries, mainly China, India and the Philippines. 
Although the developed countries are leading in the production of GM crops, with the US 
alone accounting for close to 50% (62.5 million ha) of the global area under GM crops, 
production in the developing countries has also been growing gradually. In 2008, China, 
Paraguay and South Africa cultivated GM crops on an area of over one million ha, and 
in the same year, Bolivia, Egypt and Burkina Faso cultivated GM crops for the first time. So 
far, the Philippines has approved 21 transgenic varieties for food, feeds and processing. 
These include Bt maize, herbicide-tolerant maize, rice, soybean, canola, potato, cotton, 
sugar beet and alfalfa. India has also approved GM cotton which is at present being 
cultivated on about 1.5 million ha, with other crops (eggplant, rice, cauliflower, tomato, 
okra, potato and mustard) under trial for potential release. China has about 3.3 million 
ha under GM crop production – the Chinese government has committed vast resources 
(US$1.4 billion) for development of agricultural biotechnology, and has established more 
than 100 biotechnology laboratories, signifying intent and commitment by the country to 
use biotechnology to address its food security challenge. Two Latin American countries, 
Argentina and Brazil, are following the global giant in GM crop production with 21.0 and 
18.5 million ha respectively, mainly Bt maize and Roundup Ready soybean. Other countries 
producing GM crops (Bt cotton, Bt maize and Roundup Ready soybean) in the region are 
Paraguay, Bolivia and Uruguay. 
However, despite the fact that Africa is the only continent whose per capita food production 
has been declining, biotechnology has been adopted on a very cautious basis. By 2007, 
only the Republic of South Africa had benefited from the commercialisation of GM crops. 
However, in 2008, two more countries, Egypt and Burkina Faso, joined South Africa. As 
Africa gradually embraces innovative techniques, the development and implementation 
of biosafety policies and laws will be key in guiding the commercialisation and use of 
biotech products. 
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Current Biotechnology Solutions in Africa 
Biotechnology found its way into Africa through Bt maize introduced into South Africa 
in 2003. Since its introduction, the technology has been found to reduce losses of maize 
incurred through damage by stem borers (Wanyama et al., 2004). James (2008) reports that 
GM maize in South Africa offers a grain yield advantage of 11% and increased revenue 
of US$35 per ha. In Burkina Faso, Bt cotton was commercialised in 2008, making this the 
third African country to commercialise GM crops after South Africa and Egypt (Kerumbu 
et al., 2009). It was reported that the technology has produced 15% higher yields and that 
insecticide sprays have been reduced by two thirds, hence reducing labour costs and 
environmental pollution. Vitale et al. (2008) further reports that 15 102 ha were planted for 
cotton seed production in 2008 and this could result in 163 265 ha of Bt cotton in 2009 in 
Burkina Faso. In North Africa, Egypt has several GM crops under field trials, including maize, 
melon, potato, wheat and sugar cane (Mansul, 2005). However, the country is yet to enact 
a biosafety law even though some of the tested crops (potato, squash, maize and cotton) 
are approaching commercialisation. 
Potential Biotechnology Solutions in Africa 
As mentioned earlier, a number of biotechnological successes such as Bt maize in South 
Africa and Bt cotton in Burkina Faso are beginning to benefit farmers in Africa. However, 
there is still a large untapped potential in biotechnology that can be embraced to address 
Africa’s challenges. In recognition of these potentials, the African Agricultural Technology 
Foundation (AATF), an international not-for-profit organisation, is leading several public-
private partnerships to access, develop and deliver various technologies and products to 
resource-poor farmers in Africa. These include herbicide-tolerant maize varieties for Striga 
weed control, cowpea varieties with resistance to Maruca pod borers, drought-tolerant 
maize varieties, banana varieties resistant to bacterial wilt, rice varieties with better 
productivity under saline and low soil nitrogen, and reduction of aflatoxin contamination 
in maize grains. 
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Challenges and future perspectives 
Challenges to the Use of GM Crops in Africa 
While biotechnology is gradually being embraced across continents, it nonetheless faces 
challenges to its adoption. Such challenges may be founded on perceptions and attitudes 
which vary depending on the level of information and knowledge of stakeholders. 
Perceptions and attitudes 
A number of perception and attitude issues have been raised about GM crops by several 
stakeholders, including environmental activists. These groups have raised concerns over 
the potential effects of GM crops on human health. Human health concerns have been 
raised over food safety aspects associated with allergenicity, toxicity, horizontal transfer, 
antibiotic resistance and changed nutrient levels. Concerns have also been raised over 
the effect of GM crop production on the environment, especially their impacts on non-
targets, crop-to-weed gene flow and pest resistance build-up. It is important to note that 
biotech products actually undergo intense safety tests to minimise any negative effects, 
if any. 
Access and use of proprietary technology 
New technologies, particularly biotechnology, are increasingly coming with intellectual 
property protection. This may promote private sector research and development, but it 
may also impose higher royalty fees that could spill over into product prices that outpace 
the particularly resource-poor farmers in Africa. Fortunately, institutions such as the AATF 
have the prime mission of negotiating for royalty-free access to proprietary technology 
such that end-products are affordable to small-scale farmers in Africa. In delivering its 
products, the AATF facilitates stewardship to ensure responsible and sustainable use for 
long-term benefits. 
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Biotechnology policy 
Although there have been success stories about biosafety legislation in Africa, progress 
has been a bit slow, with only seven countries (Burkina Faso, Mali, Mauritius, South Africa, 
Sudan, Zimbabwe, Kenya) having developed functional national biosafety frameworks. 
A further 13 countries (Ethiopia, Ghana, Madagascar, Malawi, Mozambique, Namibia, 
Nigeria, Rwanda, Senegal, Uganda, Tanzania, Zambia, and Egypt) are at various stages 
in the development of biosafety policies and laws. Apparently the raging debate on 
GM crops has sent mixed signals, hence influencing decision-making at policy level and 
slowing progress. 
The cost of biotechnology research 
The cost of biotechnology research has been prohibitive and this has been a major 
challenge in African countries, considering that most of them have minimal budget 
allocations for agricultural research and development. According to Kalaitzandonakes 
et al. (2007), the cost of regulatory compliance for Bt maize ranges between US$7 million 
and US$15 million over and above the development cost. Therefore this requirement for 
huge investments has been a key drawback in the progress towards breakthroughs in 
biotechnology research and development. 
Policy implications and future perspectives 
From the foregoing discussion, it is apparent that the adoption of new agricultural 
technologies, including biotechnologies, will play an important role in closing the current 
harvest gap in African agriculture and in helping African farmers to cope with the impact of 
climate change. GM also offers an opportunity to move faster in addressing food security 
and poverty challenges among Africa’s households. Meanwhile, the increasing trend of 
Intellectual Property Rights (IPRs) in agricultural research will most likely continue.
To tap into the potential that biotechnology offers to agricultural productivity and 
food security, there is a need for renewed dedication by African governments towards 
10
WORKSHOP PROCEEDINGS REPORT
GMOs FOR AFRICAN AGRICULTURE: CHALLENGES AND OPPORTUNITIES
biotechnology development. This can be done by developing their capacity to negotiate 
access to IP, enact and operationalise IP and biosafety policies and guidelines that foster 
technological innovations, delivery and trade. It is essential for African countries to 
understand the importance of minimising the cost of regulations in order to maximise the 
benefits from biotechnology because positions taken by other regions may not necessarily 
be suited to Africa. Furthermore, there is need for sound stewardship that will ensure 
responsible and sustainable use of biotechnologies while minimising any risks. 
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IN GERMANY PROF. HANS-WALTER HELDT
Union of the German Academies of Sciences and Humanities, Germany
1 Plant research in Germany
In Germany, experimental plant research has a long tradition. The first publication on a 
transgenic plant was by Jeff Schell’s group at the Max Planck Institute for Plant Breeding 
Research in Cologne together with the group of Marc van Montagu in Gent, Belgium (De 
Block et al., 1984). At present, a large number of institutions in Germany are engaged 
in experimental plant research, examples of which are given below. This list, which is far 
from complete, includes large research institutes with up to several hundred staff members 
and research groups at universities. The research institutes, as well as universities, carry out 
primarily basic research, which is in many cases related to biotechnical applications.
1.1 The Max Planck Society
The Max Planck Society for the Advancement of Science is an independent, non-profit 
organisation that promotes basic research. With about 80 institutes, it supports promising 
research activities in life sciences, natural sciences and humanities that require personnel 
and equipment expenditures that universities cannot afford.
(a) Max Planck Institute for Molecular Plant Physiology, Potsdam-Golm (Prof. Ralph Bock, 
Prof. Mark Stitt, Prof. Lothar Willmitzer). From genome structure to genome function, 
network analyses, genetic diversity, phenotyping, data mining and biomodelling 
and biotechnology.
(b) Max Planck Institute for Plant Breeding Research, Cologne (Prof. George Coupland, 
Prof. Maarten Koorneef, Prof. Paul Schulze-Leffert). Plant developmental biology, 
plant breeding and genetics, plant microbe interactions.
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(c) Max Planck Institute for Chemical Ecology, Jena (Prof. Ian T. Baldwin, Prof. Wilhelm 
Boland, Prof. Jonathan Gershenzon). Molecular ecology, plant defense mechanisms, 
metabolism of secondary plant compounds.
1.2 The Leibniz Association
The Leibniz Association is the umbrella organisation for 86 institutions conducting research 
or providing scientific infrastructure. They conduct strategic theme-based research with an 
interdisciplinary approach.
(a) Leibniz-Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben (Prof. 
Andreas Graner, Dr Winfried Weschke, Dr Helmut Baeumlein, Dr Udo Conrad, Dr 
Lothar Altschmied, Prof. Falk Schreiber, Dr Mario Gils, Prof. Nicolaus van Wiren, Dr 
Michael Melzer).
 Gene bank with 148 000 accessions from 3 049 plant species and 801 genera, 
and herbarium with 390 000 samples. Seed development, gene regulation, phyto-
antibodies, expression mapping, plant bioinformatics, hybrid wheat, molecular 
engineering, molecular farming, elucidation of genes regulated by biotic and 
abiotic stress, structural cell biology.
(b)  Leibniz-Institute of Plant Biochemistry, Halle (Prof. Steffen Abel, Prof. Dierk Scheel, 
Prof. Ludger Wesjohann). Molecular signal processing, stress and developmental 
biology, bioorganic chemistry of natural products from plants and fungi.
(c) Institute for Biosafety of Genetically Modified Plants, Quedlinburg and Brunswick 
(Prof. Joachim Schiemann). Risk assessment and monitoring of GM organisms and 
co-existence of cultivation systems with and without GM plants, investigation of 
possible effects of GM plants on nature and sustainable agriculture. The institute 
gives advice to the government on the safety aspects of gene technology.
THE SITUATION CONCERNING GM CROP PLANTS IN GERMANY 
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1.3 University of Bielefeld 
(a) Department of Genetics (Prof. Alfred Puehler). Research to indentify genes from 
plants and microorganisms responsible for relevant biological phenomena, e.g. 
symbiotic nitrogen fixation. Biological safety research analyses of the potential and 
probabilities of a putative horizontal gene transfer in natural habitats. 
(b)  Department of Biochemistry and Physiology of Plants (Prof. Karl-Josef Dietz). Analysis 
of protein structure and function (peroxiredoxins, V-ATPase), salt adaption and 
tolerance, heavy metal tolerance.
1.4 University of Cologne
 Botanical Institute II (Prof. Ulf Ingo Flügge). Molecular plant physiology (chloroplast 
translocators). Plant membrane database, improved antioxidant content for food 
applications, European Arabidopsis stock centre (Tamara).
1.5 University of Düsseldorf
(a) Department of Developmental and Molecular Biology of Plants (Prof. Peter Westhoff). 
Genetic analysis of chloroplast differentiation, molecular basis and evolution of C4 
photosynthesis.
(b) Department of Plant Biochemistry (Prof. Andreas Paul Weber, Prof. Peter Jahns). 
Systems biology and biochemistry of intracellular transport processes in plants, 
photo-oxidative stress in plants.
1.6 University of Erlangen
(a) Department of Molecular Plant Physiology (Prof. Norbert Sauer). Multiple aspects 
of transport through plasmodesmata, long-distance assimilate allocation between 
tissues and organs, and cell-to-cell signalling in plants.
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(b) Department of Biochemistry (Prof. Uwe Sonnewald). Molecular plant biochemistry 
and physiology (photosynthetic carbon fixation and its use for primary and secondary 
metabolites). Plant biotechnology (plant-made vaccines and antibodies, improved 
food and feed sources with reduced allergenic potential and increased nutritional 
value).
1.7 University of Freiburg
 Department of Plant Biotechnology (Prof. Ralf Reski). Production of pharmaceutically 
relevant proteins by transgenic Physcomitrella grown in bioreactors.
1.8 University of Göttingen
(a) Department of International Food Economics and Rural Development (Prof. Matin 
Qaim). Role of agricultural biotechnology for rural development, e.g. poverty and 
welfare in India, socioeconomic impacts of banana tissue cultures in East Africa.
(b) Department of Tropical Plant Cultivation (Prof. H. Thiessen). Biogeochemical 
determinants of land-cover change and land use in savanna cultivation grazing 
systems.
(c) Department of Molecular Phytopathology and Mycotoxin Research (Prof. Ptr. 
Karlovsky). Role of secondary metabolites in biotic interactions between plants and 
fungi.
(d) Department of Biochemistry (Prof. Ivo Feussner). Role of oxilipins in plant development 
and stress response, production of unusual fatty acids in crop plants for industrial 
purposes.
(e) Department of Plant Molecular Biology and Physiology (Prof. Christiane Gatz). 
Regulation of gene expression in response to xenobiotic stress.
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1.9 University of Heidelberg
(a) Department of Plant Cell Biology (Prof. David G. Robinson). Intracellular protein 
transfer in plant cells (e.g. vesicle-mediated).
(b) Department of Plant Molecular Physiology (Prof. Thomas Rausch). Molecular 
mechanisms by which crop plants counter the effects of abiotic and biotic stress 
exposure, development of genetic markers for breeding stress-resistant crop plants.
1.10 University Hohenheim
 Department of Plant Production and Agro Ecology in the Tropics and Subtropics 
(Prof. Joachim Sauerborn, Prof. Folkard Asch, Prof. Georg Cadisch). Plant production 
in the tropics and subtropics, crop water stress management, development of 
sustainable agricultural production systems, generation of fungal disease-resistant 
crops.
1.11 University of Potsdam
(a) Department of Molecular Biology (Prof. Bernd Mueller-Roeber). Plant genome 
research, biomolecular technologies.
(b) Department of Plant Physiology (Prof. Martin Steup). Various aspects of starch 
metabolism.
1.12 University of Rostock
(a)  Department of Biochemistry (Prof. Birgit Piechulla). Floral scent synthesis and emission, 
molecular basis of chronobiology of plants.
(b)  Department of Plant Physiology (Prof. Hermann Bauwe). Investigation of the process 
of photorespiration at the molecular level.
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 German companies invest large sums in plant biotechnology. BASF Plant, among 
other projects, carries out research on the development of drought-tolerant 
crops, protection of plants against the fungus Phytophtera, generation of canola 
traits with healthy long-chain omega-3 fatty acids and starch for industrial use in 
potato (AMFLORA). Bayer Crop Science is working on the generation of genetically 
modified rice, cotton, maize, canola and soybean. KWS Saat AG has developed 
herbicide-resistant sugar beet, and is involved in the generation of large-size maize 
plants for biogas production. Unfortunately much of the research and production 
of the above companies is being done outside Germany due to the hostility of the 
public in Germany towards GM plants.
2 Licensing of GM crops in Europe for human consumption 
and fodder and for cultivation
The licensing for all countries of the European Union is carried out by the European Council. 
After an assessment of the safety of the environment and consumption by the European 
Food Safety Authority, the assessment has to be approved by a qualified majority vote of 
the European Council for Agriculture and Fisheries. The different European Councils each 
represent 27 member countries. The bigger the country’s population, the more votes it has, 
but the number is weighted in favour of the less populous countries. A qualified majority 
is reached if a majority of member states approves, and there is a minimum of 74% of 
the votes and the votes in favour represent at least 62% of the total population of the 
European Union.
Obviously, the hurdle for any agreement is very high. This explains how until now only 
relatively few products from GM crops have been admitted in the European Union for 
human consumption or fodder as listed below. It should be noted that this licensing does 
not include cultivation in Europe.
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3 GM crop products admitted in Europe
Maize: • 11 traits, herbicide and insect resistance (Syngenta, Monsanto, Pioneer)
Canola: • 4 traits, herbicide resistance, male sterility (Bayer Crop Science, Monsanto)
Soybeans:•  2 traits, herbicide resistance (Bayer Crop Science, Monsanto)
Sugar beet:•  1 trait, herbicide resistance (KWS Saat, Monsanto)
Cotton:•  6 traits, herbicide and insect resistance (Monsanto, Bayer Crop Science)
Carnation flowers: • 4 traits, altered colour of flowers, durability (Florigene Ltd)
In Europe the rule is that products from GM crops have to be labelled. If food or fodder 
contains more than 0.9% of a GM product, or if 0.9% of a product derived from GM 
material was involved in producing it, then the label must say so. This applies to food in the 
supermarket as well as food served in restaurants. It has the effect that GM products are 
not used in restaurants as they would have to be marked on the menu card. The products 
are practically unsaleable in supermarkets. If labelled products were to appear on the 
shelves, activists from Greenpeace and other GM opponents would turn up and make 
such a fuss that the shopkeepers would not put up with it. Thus, in reality the consumer has 
no choice. 
When licensed GM products are used as fodder, the resulting animal products do not 
have to be labelled according to the European rules. Since animal farmers are largely 
dependent on imported soybean and maize as fodder, GM products are frequently fed 
to the animals. This has raised protests of GM opponents in Germany with the result that 
in Germany the label “Without Gene Technology” has been recently created for animal 
products not containing GM fodder. It remains to be seen to what extent this label will 
actually appear on products on the shelves of supermarkets. 
In several European countries, due to misinformation campaigns of GM opponents such 
as Greenpeace, large parts of the public are against plant gene technology, and as 
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the leading politicians of these countries follow this sentiment, it is often very difficult to 
obtain a qualified majority for the admission of a GM trait in the European Council. To 
give an example: the safety of maize MON 88017 as food or fodder was approved by 
the European Food Safety Authority, but it failed a qualified majority for its licensing in the 
European Council of Agriculture. This had severe consequences: shiploads of shredded 
soybean had to be returned since they contained traces far below 0.1% of the maize Mon 
88017 as contaminant. Since the Council has until now not agreed on threshold values for 
permissible contaminations, due to the sensitivities of modern analysis techniques, even 
traces of dust from unlicensed GM traits are enough for a rejection. This creates great 
difficulties in the fodder industry. 
Licensing for the cultivation of GM crops is extremely difficult. In 2003, BASF generated, 
in cooperation with the Max Planck Institute in Potsdam, a potato with uniform starch 
(amylopectin) for industrial use (AMFLORA). Numerous studies gave convincing evidence 
that growing of AMFLORA was safe for the environment and it was approved by the 
European Food Safety Authority as safe for human consumption in case these potatoes 
were eaten by mistake. The commercial cultivation of the potato was planned for 2007. 
Until now the European Commission has still not given its approval. So far only a single 
GM trait, namely the maize MON 810 containing a Bt protein for protection against 
the corn borer, has been admitted in Europe, and for about ten years has been grown 
successfully in Spain and also in a very few places in Germany. There is a provision that 
member governments are allowed to ban the cultivation of a GM crop licensed in Europe 
if there is an immediate danger. For the sake of popularity, governments of some member 
states, including Germany, used this provision to ban the cultivation of MON 810 based on 
dubious publications which have been debunked by experts.
In a country such as Germany, the problem with GM products is that the consumer 
derives no benefit from consuming them, since food prices are low anyway. Also there 
is no pressing need for the large majority of German farmers to cultivate the insect- and 
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herbicide-resistant crop plants currently available. On the other hand, people are very 
conscious about the quality of their food, and many are willing to pay much higher prices 
for food if it is labelled “organic” despite the fact that it has never been proved that 
“organic” food is healthier than conventional food. Organisations of GM opponents 
exploit this sentiment to seek donations by worrying the public with unfounded allegations 
that the consumption of GM food is a health hazard. Professionally organised campaigns, 
in particular by Greenpeace, have been very successful in convincing the majority of the 
public of this, and the politicians, when making decisions, just follow this sentiment.
4 Activities of German Academies in conjunction with the 
InterAcademy Panel (IAP) to counteract the misleading 
campaigns by GM opponent organisations
The Union of German Academies of Sciences and Humanities adopted a programme 
funded by the IAP on the prospects of GM crops for sustaining the food supply for the 
growing populations of developing countries (IAP GMO Initiative on Genetically Modified 
Plants). The programme aimed at counteracting the false arguments of environmental 
activists against Green Biotechnology by forming a panel of experts to collect scientifically 
based arguments. Texts were to be produced and presented in a simple manner in order 
to attract the attention of decision-makers and the media. A Commission of Green 
Biotechnology of the Union of German Academies produced two draft reports and a 
statement which were the basis for extensive discussions at an International Workshop on 
GM Crops held in Berlin in May 2006. The panel of international experts at this workshop 
(the participant from South Africa was Prof. Jocelyn Webster from AfricaBIO) passed, by 
subsequent correspondence, the reports Are there hazards for the consumer from eating 
GM food?  and  GM insect-resistant crops with regard to developing countries, which were 
both adopted as official documents of the IAP. Moreover, a statement on GM crops in 
developing countries was passed. A summary of the findings of these documents, being 
relevant to the present workshop, is therefore given below.
21
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
THE SITUATION CONCERNING GM CROP PLANTS IN GERMANY 
Prof. Hans-Walter Heldt
4.1 Commission of Green Biotechnology of the Union of German 
Academies and an International Workshop on GM Crops held in 
Berlin in May 2006
(a) Are there health hazards for the consumer from eating genetically modified food?
 Based on the published scientific literature, this report examines the potential 
hazards and risks of consuming genetically modified (GM) plant products. Toxicity, 
carcinogenicity and food allergenicity, and the possible effects of consuming 
foreign DNA (including antibiotic-resistant genes) are all taken into account. The 
report concludes that food derived from GM plants approved by the EU and the 
US poses no risks greater than those from the corresponding “conventional” food. 
On the contrary, in some cases food from GM plants appears to be superior with 
respect to health.
 Probably no discovery in plant sciences has had, in so short a time, such far-
reaching consequences on agriculture as the method reported in 1983 for the 
genetic modification of plants using gene technology. In 2005, such genetically 
modified varieties comprised 60% of global soybean cultivation, 14% of maize, 28% 
of cotton and 18% of rape seed; between 2003 and 2005 the overall increase of 
the area worldwide given over to GM crops was 33%. This clearly demonstrates 
that the application of gene technology in agriculture has been economically very 
successful. 
 Genetic modifications to crop plants have so far focused primarily on the production 
of herbicide-tolerant varieties for minimising harvest losses due to weeds, and the 
generation of insect-resistant varieties to decrease losses from insect damage. More 
recent developments are directed at protection against viral and fungal infections, 
the enhancement of tolerance towards drought and salinity, the formation of male 
sterile plants for the generation of productive hybrids, and the improvement of the 
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nutritional quality of crop plants, for example by modifying the fatty acid composition 
in oil seeds.
 The campaigns of opponents of agricultural biotechnology have deliberately pro-
voked widespread public anxiety by asserting that food from GMOs is a health 
hazard. “Organic” products are advertised as free from GMOs, thus claiming that 
they are especially healthy. The slightest trace of GMOs in “organic” products as 
a result of cross-pollination is termed “genetic pollution”; in some countries it may 
justify a claim for damages.
(b) Does the consumption of food from GM plants really involve a health hazard for the 
consumer? 
 This report bases its findings on reliable and attributed data. Thus, in marked contrast 
to the claims made by opponents of these foods, all the information used is derived 
from publications in peer-reviewed scientific journals in which contributions are 
reviewed anonymously by experts in the field. The interests of the consumer are 
protected by very rigorous licensing procedures based on scientifically robust 
protocols as laid down by national and international organisations, including the 
Food and Agricultural Organisation of the United Nations (FAO), the Organisation for 
Economic Co-operation and Development (OECD) and the EU. These regulations 
are much stricter than those required for conventionally grown food which normally 
receive no formal testing whatsoever from a health perspective. Moreover, in the EU 
it is now obligatory that all food ingredients from GM plants are so labelled if they 
exceed a threshold content of 0.9% for each ingredient.
 In principle, no absolute guarantee can ever be offered for the safety of any food, 
whether produced conventionally or from GM plants. It is common knowledge 
that conventionally produced food can be the cause of allergies in predisposed 
persons; nuts (and particularly peanuts), strawberries, shellfish and wheat are 
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all familiar examples. Foods of plant origin often contain toxic or carcinogenic 
substances; nature has provided plants with a large arsenal of defensive substances 
as protection against damage from feeding insects or from bacterial and fungal 
infections. Moreover, plant products may be contaminated by fungal toxins, a 
number of which are strongly carcinogenic; Fusaria toxins, which often pollute wheat 
and maize (even when grown “organically”), are examples. It has been estimated 
that in industrial countries most of the carcinogenic substances ingested derive from 
“natural” plant food.
 Since absolute safety is never possible, the basis for approving GM food products is 
the failure – after extensive prescribed testing – to find any adverse indicators. Such 
tests show that these foods are at least as safe and nutritious as the corresponding 
products from conventionally produced crops.
 This paper addresses in more detail some conceivable risks of consuming GMOs or 
products containing them. Note has been taken in particular of the very detailed 
GM Science Review of the Royal Society (First Report 2003, Second Report 2004), 
compiled by a panel of 28 distinguished scientists from various disciplines, a report 
from the Food Standard Agency (UK) and the Symposium of Green Biotechnology 
of the Union of the German Academies (2002). 
(c) Is it possible that some or all GM foods are more toxic or carcinogenic than 
conventionally grown food, either directly because of the new gene product itself 
or from unexpected effects of the new inserted gene(s) causing damage to one or 
more existing genes?
 It must be stressed that in conventional breeding seeds have for long been treated 
with mutagenic chemicals or high-energy radiation (Y-rays from a cobalt radiation 
source) to promote random mutations in the hope that some of them may be 
beneficial. The potential dangers from such mutations, as well as from the natural 
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mutations which occur continually in all living organisms, are very much higher than 
those from transgenic plants. Yet no formal testing of their safety as human and 
animal food is required.
 The situation is very different for GM products. It takes at least ten years to develop a 
new GM trait, during which time a very detailed investigation is undertaken in both 
laboratory and field trials of the equivalence of the GM plant to its conventional 
counterpart: they are compared with respect to phenotype, growth and nutritional 
properties, and chemical composition. Toxicity and carcinogenicity are tested in 
feeding trials with livestock and rats before the product can be approved for the 
market. Trials with thousands of animals have shown GM products to be harmless: no 
scientifically substantiated reports have suggested that the health or productivity of 
animals is impaired after being fed GM fodder in comparison with the conventional 
equivalent. Moreover, for some ten years GM food products have been part of 
the human diet in the US and some other countries. It is estimated that 60–70% of 
processed foods on US supermarket shelves contain GM components – and they 
are not labelled. Accordingly, trillions of GM meals have been eaten without any 
scientifically based report indicating a single health hazard – not one. Furthermore, 
in spite of a number attempts to do so, there has been no successful consumer 
claim in any court anywhere for compensation for damage supposedly incurred 
from the consumption of GM products. This constitutes yet more evidence for the 
efficacy of the testing procedures and for the safety of the products themselves.
 On the other hand, the well-known health risk to consumers from the presence in 
maize of contaminating fungal toxins is decreased in GM insect-resistant varieties. 
Conventional maize cobs are often infected with the fungus Fusarium moniliforme, 
resulting in production of the fungal toxin fumonisin. For more than a century, 
“mouldy corn disease” has been recognised as a hazard for horses, pigs and 
other livestock, with entire herds dying after being fed corn infected with Fusaria. 
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Sixteen years ago, fumonisin was identified as the cause of the disease. It is known 
to induce liver cancer in rats. Fumonisin is thus a serious problem; it is so stable 
that it survives processing and can sometimes be found in cornflakes. In the UK in 
September 2003, the analysis of 30 samples of maize products in supermarkets led to 
the removal of ten of them because of excessively high levels of fumonisin content. 
The contaminated samples with the highest fumonisin contents were those labelled 
“organic”. 
 Several studies have found contamination with fumonisin to be greatly decreased 
in insect-resistant (Bt) GM maize, whereas in conventional maize plants the fungi 
proliferate in cobs injured by insects. In GM maize there is much less insect damage 
and hence less fumonisin. These findings indicate that food from GM maize is more 
healthy for humans than that from conventionally grown maize.
(d) Is there a higher risk of food allergy from eating food derived from GM plants than 
from conventional food?
 Estimates suggest that 5–8% of children and of 1–2% adults are allergic to certain 
conventionally produced foods. Peanuts, for instance, are known to contain 12 
allergenic proteins. 
 While there is no legal requirement for the testing of foods from conventional 
varieties, strict allergy tests are mandatory for GMO products. The World Health 
Organisation (WHO) has introduced a protocol for detailed GMO allergenicity tests, 
both for the plant products concerned and also for their pollen. This protocol is 
being constantly improved. Tests of this sort on one occasion alerted scientists to the 
fact that the introduction of a gene from Brazil nut into soybean, in the hope that 
it would improve quality, would be allergenic for certain people. As a result, further 
development of that GMO was abandoned by the company involved prior to any 
commercialisation, demonstrating that the safety regulation system functions well. 
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 Our collective experience to date shows the strict allergenicity tests of GM products 
to have been very successful: not one allergenic GM product has been introduced 
onto the market. In conventional breeding, in which genes are altered at random 
by experimentally-caused mutations or unexpected gene combinations generated 
by crossings, such tests are not legally required. For this reason the risk of GM plants 
causing allergies can be regarded as substantially lower than that of products from 
conventional breeding. Furthermore, intensive gene technology research is already 
underway with a view to removing allergens from peanuts, wheat and rice. 
(e) Has the consumption of transgenic DNA adverse effects on health? Might transgenic 
DNA survive the digestive tract and become incorporated into human cells, thus 
altering their genetic information? Does transgenic DNA affect the intestinal 
microflora and might this constitute a health risk?
 Every day, people on average consume 0.1–1 g DNA in their food. In food from GM 
plants, transgenic DNA would amount to about 1/100 000–1/1 000 000 parts of this. 
Scientists are in agreement that digestion of transgenic DNA in no way differs from 
that of DNA from conventional food. The “new” genes in GM plants derive mostly 
from other organisms already present in conventional food: viruses and soil bacteria 
are present in vegetables. 
 All DNA, transgenic or not, is degraded in the digestive tract although this process 
may not always be complete. Experiments with animals have shown that very limited 
quantities of DNA fragments from food may be taken up into blood and body cells, 
which probably applies equally to humans. Nevertheless, this would have no effect 
on the genetic composition of human cells: the stable integration of plant DNA into 
animal genomes has never been observed, with natural barriers apparently in place 
to prevent any such horizontal gene transfer. 
 To provide a promoter (gene switch) for the synthesis of the foreign protein in GM 
plants, a promoter from the cauliflower mosaic virus (CMV) is often used. There 
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has been speculation that the DNA sequence of this virus promoter might be 
incorporated from undigested plant material into the genome of human cells, there 
to provoke the development of tumours. No evidence has been provided for this 
theory which ignores the fact that the viral promoter has the properties of a plant 
DNA with its uptake into the human genome prevented by the natural barriers 
mentioned above. 
 However, there is another significant detail negating this speculation: for centuries, 
cabbage and cauliflower have been part of the human diet. Half of all cauliflower 
and 10% of cabbage are infected with the virus, so people have been eating 
cauliflower mosaic virus for centuries or perhaps for millennia. There have never been 
adverse health reports from the consumption of these naturally “contaminated” 
vegetables.
 Experimental research has demonstrated that natural barriers make the horizontal 
gene transfer of plant DNA extremely unlikely, whether from the roots of plants into 
soil bacteria or from an animal digestive tract into intestinal bacteria. This argues 
strongly against unsupported assertions that recombinant DNA from a transgenic 
plant might be spread by bacteria. 
 The situation is different in the case of recombinant DNA originally derived from 
a bacterial source. Those DNA sequences can indeed be inserted into bacterial 
genomes by homologous recombination. A number of approved GM plants do 
contain bacterial genes conferring resistance to antibiotics; they are used as 
selection markers in the procedure of gene transfer. The possibility exists of these 
resistance genes being transferred to intestinal bacteria. In most cases, the gene 
employed confers resistance to the antibiotics kanamycin and neomycin. Because 
of their high toxicity, these antibiotics are very seldom used in human medicine, 
and then exclusively for external applications only. Moreover, the resistance genes 
to these two antibiotics are already present in large amounts in an average soil 
sample. 
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 Occasionally, bacterial ampicillin-resistant genes have been used as selection 
markers for the generation of GM plants. Since ampicillin is used medically for severe 
infections such as meningitis, there has been speculation that the consumption 
of products from the corresponding GM plants may lead to a loss of therapeutic 
effectiveness due to the spread of ampicillin resistance via intestinal bacteria. 
Plausible though this scenario at first sight appears to be, in normal healthy persons 
up to 27% of the Escherichia coli bacteria in the intestine already contain this 
ampicillin-resistant gene. The practice of adding antibiotics to cattle fodder means 
that the droppings of 75% of cattle and pigs in Germany were found to contain 
Escherichia coli bearing the ampicillin resistance gene. In New Zealand, some 20% 
of soil bacteria were found to contain the ampicillin marker even though GM plants 
had never been grown there. This clearly shows that the presence of these antibiotic 
resistance markers in GM plants, even if they were able to survive passage through 
the digestive tract, represent no risk to human health. However, since it seems to 
be impossible to convey to the general public the difference between various 
antibiotics and the corresponding resistance genes, they are no longer used as 
selection markers or are later excised and so not present in GM plants.
 In summary, the evidence suggests it to be most unlikely that the consumption of 
the well-characterised transgenic DNA from approved GMO food presents any 
recognisable health risk.
5 Conclusion
This paper noted at the outset that the consumption of any foodstuff present various 
degrees of risks to health. Estimating the importance of risks specifically related to GM 
food products can be made only by comparison with the corresponding conventional 
products. The former offer the advantage of having been exceptionally thoroughly tested 
with respect to health risks, but the latter have not been tested at all. In estimating the 
health risks, it is also relevant to remember that, since 1996, hundreds of millions of people in 
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the Americas and elsewhere have regularly been consuming GM products as part of their 
normal diets without any proven evidence of adverse health effects. It might be argued 
that this is only evidence for the absence of strong and easily observed adverse effects, 
and that milder or long-term damage cannot be excluded. While long-term effects are 
not expected, which is equally true for all food; how many of our ailments in later life derive 
from decades of eating particular foods? For the most part, we do not know. 
The present regulations for the approval of GM plants and their product have established 
a framework which: 
affords an effective safety evaluation on the basis of scientific data before market-• 
ing
requires GM products to be labelled by law, so offering the consumer informed • 
choice
specifies monitoring procedures which will reveal unexpected effects after the • 
introduction of GM products onto the market
permits the regulatory authorities to evaluate these data at any time.• 
This report shows that, because of the rigour with which they must be tested and the 
controls to which they are subject, it is extremely unlikely that GMO products approved 
for market in the European Union and other countries present a greater health risk than the 
corresponding products from conventional sources.
6 Genetically modified insect-resistant crops with regard 
to developing countries
Using existing literature, this report summarises ecological and economical aspects of the 
cultivation of genetically modified insect-resistant varieties of maize, rice and cotton. It 
shows that the growth of these crops by smallholder farmers in developing countries can 
be beneficial for their earnings, their health and also for the ecosystem.
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Agriculture in general leads to ecological disturbances as wild plant communities are 
replaced by monocultures of crop plants. In order to obtain sufficiently high yields, fertilisers 
are used and weeds combated by herbicides and tilling. Insect attack and fungal infections 
have to be minimised. These are both achieved conventionally by the application of 
pesticides which have adverse effects on the agricultural ecosystems. An alternative 
approach is to use genetically modified (GM) crops resistant to pests. It is just over ten 
years since the first GM crops were introduced, yet they are very popular with farmers. 
In 2005 it was estimated that approved GM crops were grown globally on 90 million ha, 
about 5% of all arable land; the increase between 2003 and 2005 alone was 33%. Some 
90% of those benefiting were resource-poor farmers from developing countries whose 
increased incomes from biotech crops contributed to the alleviation of their poverty. The 
Nuffield Council of Bioethics stated in 1999 that “GM crops had a considerable potential to 
improve food security and the effectiveness for the agriculture in developing countries”.
Whether the growth of GM crops is more economically rewarding and less damaging to 
the environment than the cultivation of their conventional counterparts with conventional 
protection by agrochemicals needs to be considered on a case-by-case basis. The present 
report deals with three important crops grown in developing countries: maize, rice and 
cotton, all with genetically engineered resistance against feeding insects. This has been 
achieved by the expression within the crop plants of proteins (Bt proteins) derived from 
the bacterium Bacillus thuringensis. Over 200 different Bt proteins toxic to selected insects 
have been identified in various strains of this bacterium. For 40 years Bt proteins have had 
a safe history as biopesticide preparations and are approved for organic farming. Rats fed 
with very high doses of Bt proteins showed no detectable toxic effects, whereas synthetic 
pesticides, such as organophosphates and chlorinated biphenyls, are toxic. The high price 
of Bt preparations, however, makes them expensive for use on commodity crops and they 
represent less than 2% of pesticides sold worldwide. Synthetic pesticides kill a very broad 
spectrum of insects, i.e. the target pests, as well as beneficial insects, whereas Bt crops kill 
primarily those insects attacking the crops.
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Seeds incorporating Bt technology are particularly suitable for smallholder farmers, because 
they do not require the equipment and knowledge necessary for pesticide applications, 
and reduce farmers’ exposure to insecticides, particularly for those using hand sprayers.
6.1 Maize
Worldwide, maize is the leading staple in terms of tonnage, with two-thirds of the global 
hectarage grown in developing countries. It is noteworthy that the yields of maize harvested 
per hectare in the Corn Belt of the US can be 20-fold higher than that of resource-poor 
subsistence farmers in developing countries. Although most maize is used as animal feed, 
it is a staple food in many countries, particularly in sub-Saharan Africa and South Asia. For 
example, the consumption of maize in Kenya has been reported to be 400 g per person 
per day. In such countries it is imperative for food security that maize harvest yields are 
improved. Decreasing the harvest losses caused by insect pests is a major factor in yield 
improvement and stability. 
On a global basis, the most important insect pests of maize are the larvae of various moths 
(corn borers). In temperate areas of America, and also more recently in Europe, rootworm 
larvae which damage roots have emerged as serious maize pests, with the yield losses 
in fields infested with rootworms as high as 50%. While rootworms can be combated by 
spraying organophosphates onto the soil, stem borers are difficult to control by pesticide 
spraying as the caterpillars penetrate into the plant. The application of pesticides must 
thus target the caterpillars during the very short time between their emerging from the egg 
and entering the maize plant. Bt maize, by contrast, has the advantage of the caterpillars 
being targeted when they feed on the plant and are so prevented from entering the 
stem. Although combating some pests will increase the population of others, the global 
deployment of Bt genes to control maize pests has been estimated to have the potential 
of eliminating 40–50% of the insecticides currently in use.
During the past ten years, hundreds of million people have consumed products from GM 
maize and it has been widely used as animal feed. Yet, as discussed in an earlier report 
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of our commission (“Are there health hazards for the consumer from eating genetically 
modified food?”), there is no evidence of the consumption of GM maize or its products 
being harmful to health. Moreover, there is clear evidence that GM maize offers the 
advantage of being much less subject to contamination by mycotoxins such as fumonisin 
and aflatoxin, toxins produced by fungi that infest maize cobs and cause serious illnesses 
in man and animals. The invading fungi are opportunistic, primarily infecting kernels 
damaged by caterpillars. Contamination by these powerful toxins can be so high that 
harvest products have to be withdrawn from the market. For subsistence farmers, e.g. 
in parts of Africa, the toxins cause serious health problems, particularly for children. The 
significantly lower mycotoxin contamination of GM maize is due to the fact that the cobs 
have fewer injuries. Thus, Bt maize offers a critically important advantage for consumers 
concerned about food safety.
So far, Bt maize seeds have been distributed as hybrid varieties giving high yields, but the 
harvested grains cannot be used as farmer-saved seed. Critics of biotechnology often 
offer this as a reason why, in developing countries, Bt seeds are not suitable for smallholder 
farmers who mostly use farmer-saved seeds. However, hybrids are the predominant seed 
types in many developing countries. In China, the largest producer of maize after the US, 
where maize is grown by 105 million farmers with an average holding of 0.23 ha per farm, 
84% have adopted hybrid seeds since they offer a higher return. For areas such as Central 
America and West Central Africa, where most of the maize is grown by subsistence farmers 
with farmer-saved seeds, non-profit organisations are called upon to introduce Bt genes 
into local varieties so that these farmers may also profit from Bt technology. 
6.2 Rice
Worldwide, rice is the principal food for nearly two billion people, with the main producers 
being China, India and Indonesia. In these countries, rice is mostly grown by about 250 
million smallholder farmers. Again, major insect pests are caterpillars such as stem borers 
and leaf-folders. At present, the productivity of rice plantations depends heavily on 
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chemical inputs. The introduction of conventional pesticides about 30 years ago had a 
devastating impact on insect diversity, drastically reducing the populations of fish and 
crabs in the rice fields. Many companies and institutions in the world, e.g. in Iran and China, 
are developing genetically modified insect-resistant rice. Bt rice cultivars have already 
been field-tested in Iran, China and Costa Rica, to be fully commercialised in due course. 
Field studies indicate that the introduction of Bt rice has the potential for decreasing the 
amount of pesticides sprayed on the fields by more than 50% together with considerable 
increases in harvest yield.
6.3 Cotton
Cotton is grown in developing countries, mainly by smallholder farmers. The harvest is 
particularly threatened by insect pests such as the cotton bollworm and caterpillars 
feeding within the fruit where the cotton fibres are produced. Without treatment, these 
pests can destroy most of the harvest. Conventionally, they are combated by spraying 
organophosphate or pyrethroid pesticides. More pesticides are applied per hectare of 
cotton than to any other crop with the number of sprayings necessary per season varying 
from 2 to 12, but sometimes as high as 30. Despite major expenditure on pesticides, cotton 
cultivation has totally collapsed in various regions of the world because of extremely high 
infestation levels. 
For the past nine years, genetically modified cultivars containing a Bt protein toxic to 
the cotton bollworm have been available. Their commercial introduction has been very 
successful: by 2005, Bt cotton was grown on 28% of the global hectarage of cotton, 
with an increase of 33% in the last year. Whereas the Bt cotton technology was originally 
commercialised by a single company in the US, it is now also distributed by a range of 
companies and institutions in China, India and elsewhere. In China in 2005, about 65% of 
the cotton was Bt cultivars, and in South Africa as much as 85%.
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7 Ecological aspects
Experience with traditional crops shows that, through hybridisation, they can give rise to 
weeds requiring special agricultural practices for their elimination. It is well established that 
gene flow occurs between both GM cultivars and non-GM crops and their wild relatives. 
Cultivars of maize, rice and cotton sown as crops do not have sufficient biological fitness 
to survive in natural habitats; in most cases the incorporation of a few additional genes is 
unlikely to alter the fitness of a cultivar in a natural ecosystem. Maize has wild relatives only 
in Mexico and Central America, whereas the wild relatives of cotton and rice are more 
widespread. So far, no transgenes have been observed to escape from maize or cotton 
to a wild relative, there permanently to initiate a selective advantage. In the wild, insect 
resistance could offer such a selective advantage, but insect resistance mediated by a 
single gene is unlikely to persist. In the case of Bt rice, particularly with modern rice cultivars 
designed for dry-land agriculture, special attention must be paid to the question of the 
possibility of gene flow to weedy wild rice relatives. It is surely relevant for such scenarios 
that, for more than 30 years, a very large number of rice cultivars have been grown into 
which single genes conferring resistance to certain insects have been introduced by 
conventional breeding. There are no known cases in which wild or weedy rice populations 
have become more competitive as a result of hybridisation with these cultivars. 
Some years ago it was reported in a laboratory experiment that feeding pollen to Bt maize 
caused considerable toxicity to Monarch butterflies and that survival of the species was 
threatened by this GM crop. The report provoked so much public anxiety that the EU 
placed a moratorium lasting several years on the approval of GM crops. Extensive field 
studies, subsequently carried out by numerous investigators, clearly demonstrated that the 
cultivation of Bt maize has no measurable impact on Monarch butterflies. A large number 
of studies on Bt maize, rice and cotton, performed in several countries, have all shown 
that the populations of many non-target insects are higher in fields of Bt cultivars than in 
fields of conventional crops regularly receiving applications of broad-spectrum pesticide.
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There has been concern that Bt proteins from the litter of plants and root exudates persist 
in the soil and have an impact on its fauna. Taking into account that agricultural soils are 
in any case highly modified by conventional cultivation, and particularly by tilling and the 
application of fertilisers and pesticides, the impact of Bt crops on the fauna in the soil has 
been shown in extensive studies, including bioassays, to be negligible.
As mentioned earlier, Bt proteins are toxic only to selective insect pests. Combating those 
pests that are insensitive to the Bt toxin means that in many cases the cultivation of Bt 
cultivars still requires the application of pesticides, although the number of pesticide sprays 
required is mostly much lower than with conventional cultivars. Decreases in pesticide 
applications are beneficial not only to the environment but also to farm labourers. Spraying 
chemical pesticides is a considerable health hazard, especially if hand sprayers are used. 
A survey in China revealed there were formerly on average 54 000 poisoning incidents 
annually, including 490 deaths due to the use of pesticides, and that the introduction of 
Bt cotton cultivars reduced this health risk substantially. These facts provide overwhelming 
support for the beneficial effect of Bt crop cultivation, both for the environment and for the 
health of farm labourers.
8 Economic aspects
Since the seeds of Bt cultivars are more expensive than their conventional counterparts, 
a farmer will have to decide whether infestation by pests is high enough to make the 
purchase of GM seeds profitable. Although the returns for using Bt technology can result 
in reduced labour and pesticide costs, as well as increased harvest yields, there remain 
situations in which the cost of Bt seeds is not justified.
The fact that in 2003 30% of maize and 46% of cotton in the US were planted as Bt cultivars 
clearly demonstrates that Bt technology can indeed be profitable for farmers. The fact 
also that only 30% and 46% was planted suggests that there are circumstances in which 
the additional cost of the seeds is not justified. The decision of whether or not to use such 
seeds was made by individual American farmers on commercial grounds.
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This also applies to many developing countries. In China, where cotton is grown by about 
11 million farmers with an average holding of 0.4 ha, about two-thirds of these farmers have 
already adopted Bt cotton. Bt technology is reported as being profitable because it leads 
in many cases both to a substantial decrease in pesticide use and to a yield increase. 
In India, where cotton contributes 30% of the national agricultural gross domestic pro-
duction and is grown mainly by smallholder farmers, the infestation of cotton fields by 
insect pests is very high and the average yield per area is only about half of the world 
average. In India, only three years after the commercial release of Bt cotton, about one 
million farmers have decided to grow it. As reported, most, although not all of the farmers, 
made substantial profits as a result. Future success depends on the introduction of locally 
adapted varieties. In both China and India the distribution of Bt technology is no longer 
restricted to multinational companies but increasingly involves national companies and 
institutions, resulting in more competitive pricing.
These examples show clearly that Bt technology can indeed be valuable in economic 
terms to smallholder farmers with relatively small fields in developing countries, as well as 
to the large farms in developed countries. 
There is, however, the possibility that pests may become resistant to Bt toxins as has happened 
in the past with the extensive use of organophosphates and pyrethroids. Although the 
evolution of resistant pests will not cause major ecological problems, it might seriously 
affect the economy of farmers and seed companies. In order to prevent such resistance, 
countries, such as the US, have adopted insect-resistant management programmes which 
include providing refuges of non-GM crops or other hosts. This ensures that susceptible 
insects are available in sufficient numbers to mate with any resistant survivors from Bt fields, 
so preventing the build-up of resistant insect populations. Thus far this system has worked 
well; almost all farmers obey the rules and several recent studies have failed to find any 
resistance. Smallholder farmers do not have such problems, because they usually have 
several small fields with diverse crops.
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World agriculture must continue to fulfil the food and fibre needs of the growing human 
population, as well as rectify the existing widespread malnutrition. To achieve this aim, pest 
control will have to rely on integrated pest-management practices which include crop 
rotation, biological control, Bt technology and the sparing use of pesticides. Bt technology 
has shown itself to be a valuable contribution to knowledge-based agriculture.
9 Statement on genetically modified crops 
Molecular engineering of crops has brought revolutionary advances in agriculture. In 
2005, just ten years from their introduction, many GM crop varieties have been grown on 
about 5% of all global arable crop land in 21 countries by 8.5 million farmers, 90% of whom 
are resource poor. Some developing countries have used GM varieties and benefited 
from them for several years and are now in a position to affirm their need and their will to 
develop more GM farming. We of the academies of sciences worldwide wish to state the 
following:
Foods from GM crops are more extensively tested than any other. They have been shown 
to be as safe as, or even sometimes safer, than foods derived from the corresponding 
conventional plants. Ten years of human consumption and extensive nutritional testing 
amply support this conclusion (see the report of the IAP GMO initiative: Are there health 
hazards for the consumer from eating genetically modified food?).
Any food, GM or not, may certainly involve some risk – known or not, indexed or not – for 
human health. There is at present not the least scientific or medical evidence that possible 
risks posed by GM food are higher than risks posed by non-GM food. 
The environmental impact of GM crops is no greater than that of traditional crops. In some 
cases GM crops have decreased the negative effects of current agricultural practices: for 
example, insect-resistant cotton requires mostly substantially decreased applications of 
chemical pesticides, and herbicide-tolerant crops allow no-till practices, cutting energy 
use and promoting healthy soils. Seed-incorporated technology is particularly suitable for 
small farmers in developing countries. GM crops resistant to insects, viruses or fungi reduce 
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farmers’ exposure to chemical pesticides, particularly when pesticides are applied with 
hand sprays. The successful cultivation of GM cotton in China and South Africa shows how 
former subsistence farmers have significantly increased their income and dramatically 
improved their quality of life.
In both developed and some developing countries, organic farmers already operate 
in an environment in which they are subject to influences from neighbouring activities. 
With proper separation safeguards the presence of genes encoding GM traits in organic 
products is negligible. Nothing in GM agriculture prevents organic farmers from pursuing 
their normal practices. Although the rules of organic farming currently exclude the use of 
GM crops, there is no evidence-based justification for that position. 
GM crops can make a major global contribution to the quantity and quality of food. In 
developing countries, farmers suffer major crop losses caused by insects and diseases. 
GM technology has already shown that such losses can be significantly reduced, leading 
directly to improvements in food quality and safety (e.g. insect-resistant maize has 
appreciably lower levels of highly carcinogenic fungal toxins).
Just as each consumer ought to have the right to accept or reject GM food, so farmers 
in developing countries and elsewhere should be able to decide for themselves whether 
to plant conventional, organic or GM crops. They should have the freedom to decide 
whether it is profitable for them to use the more costly GM seeds instead of conventional 
seeds. For there to be choice, appropriate regulations including labelling of GM products 
must be in place, regulations that are proportionate and not excessive. For developing 
countries to have access to crop biotechnology for their own agriculture, international 
and non-profit organisations must help governments to formulate appropriate regulations 
and assist with the training of personnel to administer them. 
We wish to debunk the unsupported arguments against genetically modified (GM) crops. 
On the basis of a wealth of experimental evidence on GM crops – evidence that has 
accumulated in the past decade from many studies – we affirm that:
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Foods from legally approved GM crops are no less safe for humans and animals as • 
conventional crops.
In the country concerned, legally approved GM crops do not pose greater environ-• 
mental hazards than conventional crops.
Small-scale farmers, not just large farms and multinational corporations, can profit • 
from the adoption of GM crops, which in turn could contribute to the alleviation of 
poverty and hunger in the developing world.
GM crops pose no unresolvable conflict with either non-GM crops or organic • 
farming.
GM crops can make major contributions to the quantity and quality of food • 
worldwide.
Freedom of choice should apply to all farmers and consumers, not just to some of • 
them.
Decisions about the cultivation of GM crops and the consumption of GM foods • 
must be based on the best available scientific evidence, not on ideological or 
political beliefs. We should be able to call on governments and non-government 
environmental organisations to end any unjustified campaigns against GM crops.
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THE ROLE OF GMOS IN AFRICA: FOOD AND 
NUTRITION SECURITY PROF. CARL M.F. MBOFUNG
Department of Food Science and Nutrition (ENSAIC), University of Ngaoundere, 
Cameroon 
Developing countries, especially those in sub-Saharan Africa, have for decades been faced 
with numerous problems which impede their overall growth process. As a consequence, 
the human development index of these countries has, in most cases, remained at quite a 
disappointingly low level. Within the community of multilateral organisations and the United 
Nations, this situation and others have for long been a matter of concern and debate on 
how to ameliorate these countries’ development processes. It was in the course of one 
of their meetings that the UN, at the end of the 1990s (2001), adopted the Millennium 
Development Goals (MDG) consisting of eight points that were to serve as indicators of the 
progress being made towards development in these countries by 2015. Halfway through 
September 2007, the MDG African Steering Group, consisting of the Secretary-General of 
the UN, the top executives of the African Development Bank, the European Union (EU), the 
International Monetary Fund (IMF), the African Union and of the World Bank, met to identify 
the practical steps needed to achieve the MDG in Africa. At the end of the meeting the 
following recommendations, aimed at spurring on progress for the attainment of the MDG 
in African countries by 2015, were adopted: 
(a) The doubling of agricultural production with the objective of reducing poverty, 
hunger and malnutrition.
(b) The progressive introduction of commercial farming aimed at accelerating eco-
nomic growth.
(c) The improvement of child nutrition and the systematic introduction of school meal 
programmes.
43
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
(d) Micronutrient supplementation to vulnerable groups, especially to children under 
the age of two, accompanied by systematic deparasitation programmes.
These recommendations all have a direct connection with the issue of food security. 
By definition, food security is achieved when all people at all times have physical and 
economic access to sufficient, safe and nutritious food to meet their dietary needs and 
food preferences for an active and healthy life. In the light of this definition food security 
is a major problem for the developing countries of sub-Saharan Africa. This is more so 
when one considers the factors that influence food production. In almost all cases low 
food production has constantly been ascribed to such factors as climate (drought or 
inadequate rainfall), soil fertility, soil erosion and desertification; poor farming practices; 
crop losses due to weed and insect attack; inappropriate post-harvest technology; poor 
farm inputs and natural disasters. In addition to these factors, the situation is increasingly 
being made worse by the global warming phenomenon, the decrease in farm labour 
due to rapid rural urban migration, widespread poverty and conflicts. The recent world 
food crises, together with the HIV/AIDS pandemic, only aggravate the situation, and the 
attainment of the MDG related to food and nutrition by 2015 is looking more like a myth 
for most African countries. 
In situations of food insecurity, problems of food supply, hunger, undernutrition and 
eventually malnutrition tend to exist in varying proportions. Available statistics on hunger, 
undernutrition and malnutrition in developing countries in general and in Africa in 
particular, are not only alarming but are disturbing indicators of the poor state of the food 
and nutrition situation. These indicators reveal the magnitude of the challenges that the 
governments of these countries have to overcome to improve human life. 
Food supply situation: Per capita food consumption figures for sub-Saharan Africa (Figure 
2.1) have not only been the lowest in the world but have remained relatively stagnant 
for more than four decades (1961–2003), suggesting a very poor food security situation. 
Based on the International Model for Policy Analysis of Agricultural Commodities and Trade 
THE ROLE OF GMOS IN AFRICA: FOOD AND NUTRITION SECURITY 
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(IMPACT) for food supply, demand, net trade and malnutrition under the Business as Usual 
(BAU) scenario, projected crop production data indicate that annual cereal production 
rates in sub-Saharan Africa will decrease from the average rate of 3.6% achieved between 
1982–1997 to 2.7% between 1997–2025 (Rosegrant et al., 2004). Equally, a decrease from 
4.3% to 2.7% for the same periods will be experienced in the case of root and tuber 
production. 
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Source: FAO (2007) 
Figure 2.1:  Per capita food consumption between 1961 and 2003
In this scenario, the incidence of hunger and the high prevalence of undernutrition and 
malnutrition are bound to be common. At the global level, estimates for the 1999–2001 
period put hunger and malnutrition as affecting 842 million people, with 798 million living in 
developing countries. Sub-Saharan Africa alone accounted for 198 million. 
Recent global statistics for malnutrition show that 60% of the almost 11 million deaths 
occurring in children under the age of five in developing countries are associated with 
nutritional problems (UNICEF, 2007). In Africa, the prevalence of malnutrition varies from 
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5% to 34%. About one in every three children under the age of five experiences chronic 
growth retardation with the attendant consequences of poor brain development and 
poor health. These figures, which reflect the degree of food insecurity on the continent, 
are in some cases exacerbated by widespread poverty and the occurrence of HIV/AIDS. 
Also common is the occurrence of micronutrient deficiencies. Of particular concern in this 
case is the high incidence of iron deficiency anaemia (30–50% in pregnant and lactating 
women; 20–30% in children under the age of five) and vitamin A and iodine deficiency 
with their attendant effects on metabolism and growth. At country level, to use Cameroon 
as an example, the prevalence of these micronutrient deficiencies show that:
(a) Pregnant and lactating women and children under the age of five are the main 
groups at risk of vitamin A deficiency. Earlier studies have shown the prevalence of 
this avitaminosis to be around 40% for under-five-year-olds, with the northern parts of 
the country registering the highest (62.5%) rates.
(b) Anaemia due to iron and other vitamin deficiencies is equally very widespread 
among the vulnerable groups, and the prevalence, which varies according to 
ecological zones, is as high as 53% for pregnant women and 75% for children.
(c) Iodine deficiency is also common although relatively low in intensity. The prevalence 
ranges from 5.3% for children to 7% for women. Over 424 000 new-born babies 
suffer from mental retardation because of iodine deficiency during the intrauterine 
period.
This malnutrition is projected to worsen in time if deliberate and appropriate action is 
not taken. According to the International Food Policy Research Institute (IFPRI, 2004), the 
malnutrition figures of 37 million African children will increase by 13.5% to a whopping 42 
million by 2020 (Figure 2.2). If current efforts are not improved upon, the figures will even 
be as high as 58 million. These trends equally predict that sub-Saharan Africa will be far 
from attaining the MDG for undernutrition in 2015 (21.1% as against 17.9%) as shown in 
Table 2.1.
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Figure 2.2:  Malnutrition trends for African children between 1995 and 2002
Table 2.1:  Projected undernutrition figures 
Region
Undernourished population
(millions)
Prevalence of undernutrition
(% of population)
1990-
1992 2015
WFS 
Objec-
tives
1990–
1992 2015
MDG
Objec-
tives
Developing 
countries
823 582 412 20.3 10.1 10.2
Sub-Saharan 
Africa
170 179 85 35.7 21.1 17.9
Middle East 
and N. Africa
24 36 12 7.6 7.0 3.9
Latin America 
& Caribbean
60 41 30 13.4 6.6 6.7
South Asia 291 203 146 25.9 12.1 13.0
East Asia 277 123 139 16.5 5.8 8.3
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The seriousness of this problem lies in the fact that, if unattended to, its consequences will 
be carried over from parent to offspring in a vicious cycle (Figure 2.3) with the magnitude 
of the problem growing with each passing cycle. The overall impact will be a reduction in 
the biological potential of children and in the development process of the country.
OLDER PEOPLE
Malnourished
BABY 
Low
birthweight
CHILD
Stunted
ADOLESCENT
Stunted
WOMEN
Malnourished
PREGNANCY
Low weight 
gain
Inadequate
infant 
nutrition Inadequate
fetal 
nutrition
Inadequate
catch-up 
growth
Higher
mortality rate
Impaired mental 
development
Increased risk of 
adult chronic 
disease
Untimely / inadequate feeding
Frequent infections
Inadequate food, health & 
care
Reduced 
mental 
capacity
Inadequate food, 
health & care
Reduced physical labor capacity, lower 
educational attainment
Inadequate food, 
health & care
Higher maternal 
mortality
Reduced 
physical 
labor 
capacity, 
lower 
educational 
attainment,
restricted 
economic 
potential, 
shortened 
life 
expectancy
Inadequate 
food, health & 
care
Reduced capacity to 
care for child
Figure 2.3:  Vicious cycle of the burden of malnutrition
Source: Benson, 2004. 
The food and nutrition picture of sub-Saharan Africa in Figure 2.3 calls for reflections on and 
suggestions for a way forward to contribute to the solution to these problems. Generally, 
although nutritional status is attributed not only to food security (Figure 2.4), it does play a 
predominant role. Given the several constraining factors that are known to influence food 
production in Africa, the present paper takes a look at the role that recent genetically 
modified organism (GMO) technology can play in contributing to the enhancement of 
the food and nutritional status of African countries.
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Figure 2.4:  Factors influencing nutritional status
Possible role of GMO: For the past 20 years the science of biotechnology has made significant 
and important advances in recombinant DNA engineering, making it possible to produce 
transgenic food crops of better quality. In this biotechnological process, genetic material 
of a given crop is manipulated and modified using a technique known as recombinant 
DNA technology. This modification process is usually aimed at enhancing desired traits 
such as increased resistance to herbicides, pests, specific diseases, harsh environmental 
conditions such as cold spells, heat waves and drought, or improved shelf life or nutritional 
content. Compared to conventional plant breeding methods, GM technology is less time- 
consuming and more accurate in acquiring the desired objectives. The product obtained 
is known as a genetically modified organism (GMO) or a GM food. Great strides have 
been made in this area which have given rise to a wide range of improved food crops 
which are now increasingly being cultivated at industrial level in most developed countries 
and to a lesser extent in some developing countries. In 2006, for example, GMO crops 
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in the US were grown over an area of over 135 million acres, with the total global area 
exceeding 250 million acres. The current list of GM foods includes corn, potato, pineapple, 
cocoa bean, yellow squash, sweet pepper, sugar cane, banana, soybean, etc. In South 
Africa this technology has been used to produce transgenic maize, cotton and soybeans 
that have traits for insect resistance and herbicide tolerance.
Increasing numbers of research results on GMO are regarded as a reason for the adoption 
of GMOs in the fight against food insecurity in Africa. These milestone research results show 
the possibility of increasing crop yields, improving the storage potential of harvested crops, 
improving the protein content of starchy foods, biofortification of local foods, improving 
the functional food potential of local foods, etc. 
Contrary to the expectations of opponents of GM foods, the results of modern compre-
hensive profiling of crop composition have shown a very close similarity between GM 
foods and their conventionally bred counterparts (Catchpole et al., 2005). Reputable or-
ganisations such as the WHO and the US National Academies of Science have issued nu-
merous reports on the safety of GM foods. In June 2005, for instance, the WHO released a 
report entitled Modern Food Biotechnology, Human Health and Development, which has 
affirmed the safety of GM foods. In view of the findings, GM technology has huge potential 
for resolving the food and nutrition problems in Africa.
At present, the quality and yield of different varieties of the principal food crops grown 
and consumed in sub-Saharan Africa such as cassava, maize, yams, cocoyams, plantains, 
bananas, groundnuts, Irish potatoes, millet, beans, vegetables and tropical fruits are 
affected by several constraining factors including diseases of viral and fungal origin, poor 
soil and climatic conditions. In Cameroon, for example, several factors (Table 2.2) are 
major constraints in food production.
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Table 2.2:  Some food crop production constraints in Cameroon
No Crop Constraining factor
1 Maize Soil acidity, aluminium toxicity, striga streak, aflatoxin
2 Cassava Mosaic, root scale, cooking quality
3 Cocoyam Root rot, root scale, oxalic acid content
4 Sweet potato Weevils, virus complex
5 Irish potato Late blight, bacterial wilt, frying quality
6 Groundnut Aflatoxin, rosette, pod filling
7 Cocoa Black pod
Source: Ngeve (2006)
Based on current research trends in and successes with GM technology, these constraints 
can be eliminated. In addition, the same technology can be used to enhance the 
nutritional quality of locally grown foods such as protein, iron, zinc, vitamin A, iodine, etc. 
From a policy viewpoint, this should not be a matter of choice but compulsory for Africa 
because the successes so far in resolving food production problems on the continent have 
largely not been concerned with conventionally grown food crops but with GM crops. If 
this technology is not used to resolve Africa’s food and nutrition problems, the continent 
will be dependent on world food trade since it is virtually an island in a sea of countries 
involved in GM food production (Figure 2.5). The prospects for the economies of those 
countries that find themselves in a situation of dependency are not encouraging.
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Figure 2.5:  Major GMO-producing countries in 2007
In the light of the above, the opportunity now exists for African countries to boldly embrace 
this technology for the benefit of the huge numbers of people suffering from hunger, 
undernutrition and malnutrition. GM technology, with an appropriate quality control 
mechanism (Mbofung, 2006), can go a long way towards improving not only the yield of 
traditional African food crops but also their safety and nutritional quality.
Specifically, opportunities now exist for:
(a)  Increased food production: The main causes of reduced crop yield and availability 
are insect pests and fungal infection pre- and post-harvest. GM maize and sorghum 
resistant to these conditions can now be produced. The extension of this technology 
to root and tuber crops, as well as to other cereals commonly grown and consumed 
in Africa, would go a long way towards boosting food yields. In addition to reducing 
food crop losses due to pest and fungal attack, GM methods are currently available 
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for food crop production on otherwise infertile soil or in drought-stricken areas. A 
good part of the farming land in Africa is threatened by the changing climatic 
and soil conditions. The current success in the development of food crops that 
are drought resistant presents the opportunity for Africa to exploit land which was 
previously regarded as unsuitable for food crop production.
(b)  Minimum use of chemicals: Pest-resistant and herbicide-tolerant GM food crops 
require minimum use of chemicals against pests and weeds. This will also protect 
the environment from harmful chemicals. Fungal and insect attacks are common 
problems associated with post-harvest handling of cereals in tropical Africa. The use 
of chemicals to reduce these effects, in addition to being expensive, can be harmful 
to humans. Development of pest-resistant and herbicide-tolerant GM varieties of 
our local crops will minimise the use of toxic chemicals. On a slightly different note, 
the essential oils of some tropical plants have been advocated as alternatives to 
chemicals for the post-harvest storage of cereals because of their non-toxicity. For 
the past ten years we have been exploring the wide plant biodiversity of Cameroon 
as sources of essential oils with the potential for use against insect and fungal 
attack on grains during storage. Encouraging results have been obtained, but the 
difficulty lies with the yields of essential oils produced from the identified plants. GM 
technology could be used to overcome this difficulty.
(c)  Improvement of local food processing and storage technologies: The production 
of decaffeinated coffee entails the use of chemicals. Using GM technology, 
researchers in Japan have developed a process for the production of low-caffeine 
coffee. Cassava is a major food crop grown and consumed in Africa, but some high-
yield varieties often contain significant levels of cyanogenic glucosides (linamarin 
and lotaustralin) which on hydrolysis release toxic hydrocyanic acid (HCN) which is 
only eliminated through tedious processing. The food value of these varieties could 
be improved by developing GM versions with lower cyanogenic glucoside levels. In 
the same vein, other tropical foods such as taro (Colocassia esuculenta) and bean 
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varieties (Phaseolus vulgaris) habour natural toxicants which reduce their food value. 
GM technology could also be applied in the development of non-toxic versions of 
the same. 
(d)  Micronutrient biofortification: Some of the most disturbing cases of malnutrition in 
children in Africa are due to the low micronutrient content of the restricted diets 
they eat. GM foods with improved nutritional content could be used as a remedy 
for some of these conditions. Rice, which is a widely consumed cereal, is deficient 
in vitamin A which is important for human health. Scientists have developed a gene 
for rice crops (“golden” rice) that will contain the lacking vitamin. Other studies on 
biofortification have succeeded in producing rice with a higher iron content, which 
was shown to improve the iron deficiency of consumers (Haas et al., 2005). Given 
the high incidence of micronutrient deficiency in children and pregnant women, 
GM technology could be used to increase the level of these micronutrients in some 
commonly consumed foods.
(e)  Improvement of the protein quality and content of local foods: Some of the important 
advances made in GM technology include improvement of the nutritional content of 
GM foods. One of the major nutritional problems facing Africa is protein malnutrition. 
Improvement of the protein content of foods hitherto focused on maize, and is 
now being applied to other cereals. “Super sorghum”, which is a GMO biofortified 
version of a popular staple sorghum crop, is currently undergoing greenhouse trials 
by the Council for Scientific and Industrial Research (CSIR) in South Africa. It is a 
good example of a big step in the right direction for the alleviation of protein and 
micronutrient deficiencies in the diets of consumers. This success story is one example 
of the biofortification of several staple foods consumed in Africa but which are low in 
nutrient content.
(f)  Production of functional foods: Plant foods also contain many bioactive substances 
important to health. These bioactive substances, which are increasingly being 
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shown to be abundant in certain plant species, include carotenoids, vitamins C 
and E, pigments (beta-carotene, lycopene), polyphenols, etc. They are known to 
play a role in the prevention of malnutrition and the development of diseases such 
as cancer and cardiovascular disease, aging, etc. GM technology could be used 
to enhance the potential of the wide variety of some of our local foods to serve 
as functional foods. The production in the US of a GM Roma tomato containing 
three times more lycopene (a red pigment thought to have a role in the prevention 
of prostate cancer) is illustrative of this idea. Equally inspiring is the creation by 
researchers in Singapore of a lettuce that synthesises Resveratrol, a molecule of 
the red grape implicated in the “French paradox” concerning the positive effect 
of red wine on cholesterol metabolism. Another important research advance has 
been the creation of a strain of “golden” rice containing very high levels of beta-
carotene (pro-vitamin A) by the Swiss Federal Institute of Technology. Since rice is 
widely consumed, the availability of this strain for food will contribute to the fight 
against avitaminosis A which affects a high proportion of people in most African 
countries.
CONCLUSION
In conclusion, current advances in GMO technology present exciting opportunities to 
contribute towards the resolution of the African food and nutrition security problem. This 
of course will be possible only within the framework of a properly set out biotechnology 
policy with sufficient financing for the training of the right people, the construction of and 
equipment for the necessary laboratories and the carrying out of rigorously planned, 
results-oriented GM food research for safe and sustainable food and nutrition security. 
The need for a concerted effort cannot be overemphasised. Failure to take the bull by 
the horns in this process may leave Africa and its people at the mercy of some Western 
adventurers with respect to GM foods.
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1. Introduction
The use of genetically modified (GM) technology and its products in Africa is still in its 
infancy. South Africa, which has biosafety regulations in place, is the only country on the 
continent that is commercially producing GM crops. However, countries such as Egypt and 
Burkina Faso have recently reported growing GM crops on a commercial basis. The GM 
crops that are produced on a commercial basis have been limited to maize (Zea mays 
L.), cotton (Gossypium hirsutum L.), soybean (Glycine max L.) and oilseed rape (Brassica 
napus L.). These four crops have been transformed for the two traits of insect resistance 
and herbicide tolerance. There is a need in Africa also to develop GM crops with other 
important traits. This presentation will focus on the trait of plant disease resistance, 
specifically resistance to plant virus infection. Compared to other pathogens, such as 
bacteria and fungi, viruses have very simple structures and genomes, and for that reason 
GM crops with resistance to viral infection can easily be produced. 
2. Examples of viruses of economic importance in African 
agriculture
For a long time viruses have been known to be major limiting factors in the production 
of Africa’s major food and commercial crops. The literature abounds with examples of 
the detrimental effects of viruses on many different crops grown on the African continent 
(Figure 3.1). Maize streak virus (MSV) (Zea mays L.), discovered in 1901, is a major pathogen 
of maize (Wambugu, 1999; Bosque-Perez, 2000). The virus has rendered the production of 
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maize in some parts of Africa virtually impossible. The twin threat of cassava mosaic virus 
disease (CMD) and cassava brown streak virus disease (CBSD) has had devastating effects 
on the production of cassava (Manihot esculenta L.) in East and Central Africa (Gibson et 
al., 1996; Legg & Tresh, 2000; Hillocks et al., 2001; Tresh & Cooter, 2005). The hopelessness of 
farmers trying to eke out a living from their heavily diseased crops is a common feature in 
all production areas. In the recent past, banana bunchy top virus (BBTV) has emerged as a 
major threat to banana (Musa paradisiacal L.) production, putting at risk the food security 
of more than 70 million people in 15 countries in sub-Saharan Africa who depend on 
banana for their livelihood and food supply (FAO, 2001). Infected banana plants produce 
little or no fruit. 
Bean (Phaseolus vulgaris L.) is a major source of dietary protein for cash-poor farmers who 
constitute a large majority of people in Africa. The seed-borne viruses, bean common 
mosaic virus (BCMV) and bean common mosaic necrosis virus (BCMNV) continue to be 
serious threats to bean production on the continent (Mukeshimana et al., 2003). Potato 
virus X (PVX), potato virus Y (PVY) and potato leafroll virus (PLRV) singly or in combination, 
result in substantial yield losses in potato (Solanum tuberosum L.) production in all areas 
of production. Sweet potato (Ipomea batatas L.) is among the most important food 
staples grown in sub-Saharan Africa, particularly East Africa. Efforts to control sweet potato 
disease virus (SPDV), a result of the synergistic interaction between sweet potato feathery 
mottle virus (SPFMV) and sweet potato chlorotic stunt virus (SPCSV) which results in up to 
95% reduction in tuber yield of potato (Ipomea batatas L.) throughout Africa, are being 
pursued in earnest (Gibson et al., 2003). 
The economic impact of tomato spotted wilt virus (TSWV) is huge mainly due to its extremely 
broad host range and worldwide distribution (Rosello et al., 1996). It possesses one of the 
largest host ranges of any plant virus, with over 1 090 plant species in over 100 families 
cited (Peters, 2003). The virus infects many different vegetable crops and reduces the 
marketable value of produce. With an estimated crop loss of over US$1 million for several 
TRANSGENIC PLANTS WITH VIRUS RESISTANCE: OPPORTUNITIES 
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crops, TSWV ranks among the ten most detrimental plant viruses worldwide (Goldbach & 
Peters, 1994). Zucchini yellow mosaic virus (ZYMV) occurs wherever cucurbits are grown 
and infected plants have very poor fruit set. 
In West Africa, the production of cocoa (Theobroma cacao L.) has been under threat from 
cocoa swollen shoot virus (CSSV) for over 70 years and the search for virus-resistant cacao 
varieties is still on (Posnette & Todd, 2008). Côte d’ Ivoire, Ghana, Nigeria and Togo record 
combined loses of over 500 000 tons/year. In the citrus-producing countries, infections of 
trees with citrus tristeza virus (CTV) have resulted in millions of infected trees being felled, 
leading to severe financial losses for the affected farmers (Bar-Joseph & Marcus, 1989). 
Control of CTV continues to be a challenge. 
Figure 3.1:  (a) Maize streak virus (MSV) on maize (Zea mays L.); (b) Cassava mosaic disease 
(CMD) on cassava (Manihot esculenta L.); (c) Banana (Musa paradisiacal L.) infected with 
banana bunchy top virus (BBTV); (d) Healthy banana
a
c
b
d
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It is evident that the damage associated with viral diseases to different crops translates 
into major financial losses for the affected farmer and in most cases the losses are a real 
threat to food security. Given that the strategies that have been commonly used to 
control or manage plant viral diseases have not been very effective, there is an urgent 
need to look at alternative methods that can complement the existing strategies. To this 
end, the concept of pathogen-derived resistance (PDR) as described by Sanford and 
Johnson (1985) to produce genetically modified plants with virus resistance offers exciting 
possibilities.
2.1 Transgenic Papaya (Carica papaya L.) with Virus Resistance
One of the very few transgenic crops with virus resistance that have been commercialised 
is papaya (Carica papaya L.). Papaya with resistance to papaya ringspot virus (PRSV) is 
now grown on a commercial basis by farmers on the Hawaiian islands (Gonsalves, 1998). 
These beautiful islands have a compelling story to tell on how GM technology was used 
to save the local papaya industry from total collapse due to infection by PRSV. The Hawaii 
papaya story can be used as a model to address the many virus problems that have 
affected African farming communities for a long time.
At the height of the PRSV problem, abandoned papaya orchards were a common 
feature of the landscape in the main papaya-growing areas, and this bore testimony to 
the devastating effects the virus was having on the papaya industry. Efforts to control the 
virus using resistant papaya cultivars and cross-protection had failed dramatically. Local 
scientists looked at the concept of PDR for providing a lasting solution to the problem. To 
this end, the coat protein (CP) gene of PRSV was used in the transformation of papaya 
(Cai et al., 1990; Fitch et al., 1992). The resultant transgenic plants showed resistance to 
PRSV under greenhouse conditions (Tennant et al., 1994). 
Following a series of field tests, and having met the stringent environmental and biosafety 
requirements, transgenic papaya was eventually commercially released in 1998 (Gon-
salves, 1998). Using GM technology, the papaya industry in Hawaii was transformed from 
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the seemingly hopeless state at the height of the PRSV problem to where the industry 
today is back to its former glory (Figure 3.2). Today, transgenic Rainbow papaya is being 
exported to mainland US and Canada.
Figure 3.2:  (a) Papaya orchards before GM technology intervention; (b) Papaya orchards 
after GM technology intervention 
3 Lessons from the Hawaii papaya story
The fact that the local farmers and the scientific community in Hawaii came together to 
solve an economically important viral disease problem shows that there is no need to involve 
a multinational company in such projects. The participation of multinational companies in 
such projects always attracts the opponents of GM who use the opportunity to portray the 
technology in a negative light. The papaya story is a model of how GM technology can be 
harnessed to solve a viral disease problem and help save a whole community from total 
financial ruin. This model can be adapted to suit specific environments.
4 The way forward for Africa
PDR has been demonstrated to be very effective in controlling/managing an important 
viral disease. It is important that the use of PDR should occupy a prominent position on 
the African agricultural research agenda. There is an urgent need to initiate projects that 
a b
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address the numerous viral disease problems that African farmers are currently facing and 
have been facing for a very long time. 
4.1 Development of Transgenic Plants with Virus Resistance in Africa
It is pleasing to note that different laboratories across the continent are using GM tech-
nology to develop transgenic crops with virus resistance on a routine basis. The first all-
African produced modified plant in the form of transgenic maize with resistance to MSV 
has been developed (Shepherd et al., 2007). This maize is at present being evaluated 
under containment. Other projects underway on the continent include:
(a) Transgenic cucurbits and potato with resistance to several viruses being developed 
in Egypt.
(b) Transgenic sweet potato with resistance to SPDV being developed in Kenya, Uganda 
and South Africa.
(c) Transgenic cassava with resistance to CMD and CBSD being developed in Uganda 
and Kenya. Confined trials of cassava transformed for resistance to CMD are now 
being conducted in Uganda.
As the number of scientists with training in molecular biology, tissue culture and virology 
increase, there is likely to be a concomitant increase in the number of projects on 
developing transgenic crops with virus resistance. Against this background, the future for 
the development of GMOs in Africa looks promising.
4.2 Opportunities and Challenges
Given the many virus disease problems in Africa that need urgent research attention, 
many opportunities exist for using GM technology. However, there are many challenges 
that have to be addressed before these opportunities can be exploited. First, it is important 
for individual countries to have biosafety regulations in place so as to create environments 
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in which GMO research can take off. Second, it will also be necessary to identify centres of 
research excellence on the continent that can spearhead the research. Such centres must 
have a molecular biologist, a virologist and a tissue culture specialist to lead the research. 
Third, substantial amounts of money will be needed to fund this expensive research. The 
money will be used to buy equipment and consumables, and build facilities in which the 
research will be conducted. 
5 Conclusion
GM technology in the form of GMO plants with virus resistance could be the key to unlocking 
the potential of African agriculture by, among other things, addressing and solving the 
numerous viral disease problems that have hampered the economic production of Africa’s 
major food and commercial crops. Lessons learnt from the Hawaii transgenic papaya 
project can be used as a model to develop GMOs with virus resistance by the various 
National Agricultural Research Services (NARS) and universities across the continent. The 
long-suffering farmer will have a brighter future.
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Abstract
The human population in Africa has undergone a rapid increase in the last decade and 
this, coupled with problems such as erratic rainfall, prolonged droughts and agricultural 
pest problems, has resulted in severe food insecurity. Advanced agricultural technologies, 
including the use of genetically modified organisms (GMOs), could play a role in enhancing 
agricultural productivity in Africa. However, despite the apparent potential of GMOs to 
improve agricultural production, there is still a significant debate regarding the extent of 
the risks posed by GM crops. A number of concerns pertaining to the possible impacts 
of these crops have been raised and they include food safety, animal/human health, 
environmental, agricultural and socioeconomic issues. Even though potential impacts 
range from negative through to positive, the potential negative impacts are the most 
pronounced in the perceptions of policy-makers and the general public in Africa. Given 
the many concerns, there is a great need for accurate, credible scientific and technical 
69
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
CHALLENGES FOR GM TECHNOLOGIES: EVIDENCE-BASED 
EVALUATION OF THE POTENTIAL ENVIRONMENTAL EFFECTS OF GM CROPS 
Dr Dennis Obonyo, Ms Lilian Nfor, Dr Wendy Craig and Mr Decio Ripandelli
information, appropriate biosafety regulatory systems, policies, legal instruments, and 
decision-making processes to enable the assessment (and deployment) of GMOs in a 
rational, scientifically based manner. This paper reviews some of the concerns that have 
been expressed regarding GM crops and outlines some of the key principles of biosafety 
that are relevant to their safety assessment and sound decision-making in the context of 
their potential environmental impacts. 
1 Introduction
Population projections estimate that, during the past decade, the human population in 
Africa has increased from 820 million to over 1 billion (DESA UN, 2009). This, coupled with 
problems such as erratic rainfall, prolonged droughts and agricultural pest problems, has 
resulted in severe food insecurity (Mataruka, 2009). The total number of undernourished 
people in the world reached 963 million in 2008, nearly 15% of the world’s population 
(OECD-FAO, 2009), and it is predicted that the number of people living in hunger will soon 
surpass the 1 billion mark (FAO, 2009a). Sub-Saharan Africa is the most food-insecure region 
in the world, and many countries on the continent have seen significant increases in food 
imports while domestic food production has failed to keep pace with rising food demand 
(FAO, 2009b). 
Paarlberg (2008) attributes the high poverty and hunger levels in Africa to low levels of land 
and labour productivity: “For farmers in Africa today, productivity is low and poverty high 
because far too little science has been brought to farming. Currently, only 4% of Africa’s 
farmland is irrigated, less than 30% is planted to improved seeds, and average fertiliser 
use is only 9 kg per hectare, compared to 117 kg per hectare in the industrialised world.” 
To enhance land and labour productivity, he proposes that African farmers must utilise 
improved technologies such as improved draft animals, fertilisers and insect- and disease-
resistant crop varieties. This brings into sharp focus the role that advanced agricultural 
technologies, such as genetically modified organisms (GMOs), could play in improving 
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agriculture for socioeconomic development in Africa. Concerns pertaining to the use 
of GM technology will increasingly play a role in shaping the structure of agricultural 
production over the medium term (OECD-FAO, 2009).
The global area under GM crop cultivation is rapidly increasing. By 2008, GM crops (mostly 
herbicide-tolerant) were cultivated on up to 125 million ha worldwide (James, 2008). 
These crops have been demonstrated to enhance agricultural productivity and have the 
potential to address some of the challenges facing agricultural production in Africa. For 
example, under rain-fed irrigation, Bt maize (expressing genes that encode insecticidal 
proteins from the bacterium Bacillus thuringiensis) increased maize production in South 
Africa by 11% (James, 2008); in Burkina Faso, Bt cotton cultivation resulted in a two-thirds 
reduction in pesticide usage and 15% higher yield (Vitale et al., 2008).
Despite the apparent potential of GM crops to improve agricultural production, there 
is still significant debate regarding the risks posed by the technology. For the potential 
benefits of GM crops to be realised, it is necessary that they be assessed (and deployed) 
in a rational, science-based manner. Several African countries have therefore put in 
place policies and regulatory frameworks to support the responsible and safe use of 
biotechnology, assure public confidence, encourage local biotechnology innovation 
based on local priority needs, and help mitigate against any possible adverse effects on 
human health and the environment. This paper reviews some of the concerns that have 
been expressed regarding GM crops (drawing on examples from insect-resistant [IR] and 
herbicide-tolerant [HT] crops) and outlines some of the key principles of biosafety that are 
relevant to their safety assessment and sound decision-making with specific regard to their 
potential environmental impacts.
2 Concerns regarding GM crops
Most concerns about GM crops can be placed into four broad categories: food safety 
and animal/human health concerns, environmental concerns, agricultural concerns 
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and socioeconomic issues. Although the primary focus of this paper is on the potential 
environmental effects of GM crops, the term “environment” has a very broad definition 
in common usage and therefore a wider array of issues surrounding GM crops are also 
discussed.
Environmental concerns that have been expressed with regard to GM crops include: 
negative impact(s) on “non-target organisms”, gene flow, invasiveness, new pests and 
diseases, and unexpected variability (Kohi, 2006; Thies & Devare, 2007). For example, 
potential effects on non-target species may occur if GM crops produce novel defensive 
compounds (e.g. Bt toxin to prevent extended insect attack).
One of the agricultural concerns that have been expressed with regard to pest-resistant 
GM crops is the development of resistance by the target pest to the protective transgenic 
compound in the crops (Thies & Devare, 2007). In this case, the primary concern is the loss 
of usefulness of the control strategy, as has been frequently observed with conventional 
breeding for resistance or application of chemical pesticides (Conner et al., 2003). Strategies 
to delay the development of such resistance include the selection of transformation events 
expressing very high toxin levels, stacking different insect-resistance transgenes together 
in the same GM variety, and strategically planting nearby non-resistant crops or plants 
as refugia to allow any resistant individuals that might develop to mate with non-resistant 
individuals in order to reduce the frequency of resistance genes in the insect population 
(Bates et al., 2005).
While the aforementioned agricultural and environmental safety-related concerns are 
often presented as generic concerns when discussing biotechnology, socioeconomic 
issues also pose challenges to decision-making bodies. The issues raised include: monopoly 
control by transnational companies; profit margins being squeezed between seed cost 
and declining world prices; possible loss of existing robust crop varieties and technologies 
and challenging market dynamics, especially with the European Union (EU). Other issues 
include benefit-sharing, the transferability of biosafety assessments across the region and 
beyond, and the co-existence of organic and GM crops (Sengooba et al., 2009). 
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In addition to potential negative effects of GM crops on the environment, there are also 
potential positive effects. For example, the use of insect-resistant transgenic crops can 
lead to lower applications of conventional pesticides, and hence minimise environmental 
pollution. Potential effects of GM crops therefore run right through the continuum from 
negative to positive, as illustrated by the following examples pertaining to insect-resistant 
and herbicide-tolerant crops. Obonyo (2009) found variable effects of Bt maize plants on 
a number of non-target organisms associated with maize fields. The farm-scale field trials 
in the UK also clearly documented the fact that the impact of GM crop cultivation on 
biodiversity can be either positive or negative and always depended upon the agriculture 
system as a whole, and not on the GM crop (Firbank et al., 2003).
2.1 Insect-Resistant (IR) GM Crops
Numerous reports have documented reduced pesticide use resulting from the cultivation 
of Bt crops engineered for resistance to specific insect pests (Morse et al., 2005; Brookes 
& Barfoot, 2006; Raney, 2006; Vitale et al., 2008). Introduced genes in Bt crops encode 
crystalline (Cry) toxins, each of which acts very specifically on a narrow range of insect 
or nematode species. B. thuringiensis, either in the form of spores, bacterial suspension or 
partly purified toxin preparation, is commonly used by organic farmers as a biopesticide. 
However, the more spatially controlled toxin application via GM crops has raised concerns 
about possible effects on non-target organisms. A well-cited case by opponents of the 
technology is that of the laboratory studies on the Monarch butterfly (Losey et al., 1999), 
where the consumption of excess (and therefore unrealistic) doses of Bt expressing maize 
pollen by larvae was shown to have a deleterious effect. Follow-up studies in the breeding 
grounds of Monarch butterflies, however, demonstrated that pollen distribution patterns 
and subsequent deposits on milkweed plants (the main food source of larvae) within and 
outside the corn fields are at levels that are highly unlikely to affect caterpillars which feed 
on them (Pleasants et al., 2001; Sears et al., 2001; Stanley-Horn et al., 2001). Beneficial 
effects from the cultivation of Bt crops include the reduction of insecticide use (this also 
implies further savings on manpower, fuel consumption and less soil damage caused by 
heavy machinery), more effective pest control, and consequently higher yields (Ismael 
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et al., 2002). Indirect benefits include reduced contamination of the soil and waters by 
crop-protection chemicals and in some situations reduced mycotoxin contamination in 
the crop (Huesing & English, 2004).
2.2 Herbicide-Tolerant (HT) GM Crops
Herbicide-tolerant GM crops are those which have been transformed by genetic 
engineering such that they are unharmed when sprayed with a broad-spectrum herbicide 
while crop-infesting weeds are destroyed. However, the transfer of herbicide resistance 
genes to previously susceptible wild species may allow the recipients to proliferate in the 
presence of the herbicide (Dale, 1992). In addition, if two HT transgenes become present 
in the same host variety or varieties, the resulting plants are likely to be tolerant to both 
herbicides. This could have an impact if the host plants become volunteers in the next 
growing season. Therefore there is a need to assess the consequences of any potential 
transfer, and to consider suitable crop management strategies to minimise likely negative 
impacts. 
The selection and spread of weeds resistant to a particular broad-spectrum herbicide is 
the most frequently highlighted risk of HT crops (Sehnal & Drobnik, 2009). HT weeds could 
evolve either through (a) gene transfer to any weeds that successfully hybridise with the 
GM crop (for example, rice can cross-pollinate with wild relatives that already frequently 
appear as significant crop infestations), or (b) spontaneous mutation, followed by selection 
under herbicide pressure. This potential adverse effect aside, it is worthy of mention that 
the cultivation of HT crops has led to the use of less toxic herbicides and reduced fuel-use, 
and has facilitated the adoption of reduced-tillage or no-till production methods, hence 
helping to preserve soil quality and reducing soil erosion (Brookes & Barfoot, 2006).
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3 What does the scientific literature say?
3.1 Effects of Insect-Resistant Bt Crops on Non-Target Organisms
This section reviews some of the studies that have been carried out on impacts of Bt 
crops on non-target organisms, with significant focus on natural enemies (predators and 
parasitoids) of agricultural pests. 
A number of meta-analyses of data, collated from a wide range of non-target studies 
conducted on Bt crops, mainly from peer-reviewed journals but also from non-peer-
reviewed reports, and from industry studies conducted to gain regulatory authorisation, 
were recently published (e.g. Duan et al., 2008; Marvier et al., 2007; Wolfenbarger et 
al., 2008). These have largely shown the expected lack of effect of Bt proteins on non-
target invertebrates, regardless of whether organisms were categorised taxonomically 
(order to species) or by ecological functional guilds. However, with the exception of Duan 
and colleagues (laboratory honeybee studies), the analyses focused on field studies. In 
an extension to these analyses, Naranjo (2009) added data from 14 more studies (on Bt 
eggplant and Bt rice) to the cotton, maize and potato analyses from the original study 
by Wolfenbarger and colleagues (2008). The results from this later enlarged meta-analysis 
did not indicate any qualitative alteration to the patterns for ecological functional guilds 
previously observed. 
Collectively, the non-target studies performed to date demonstrate that Bt crops do not 
have any unexpected toxic effects on natural enemy species of agricultural pests, as 
would be predicted from knowledge of the mode of action and specificity of Bt proteins. 
Bt crops therefore effectively preserve local populations of various economically important 
biological control organisms that can be adversely impacted by broad-spectrum chemical 
insecticides. The only indirect effects on non-target organisms that have been observed 
with Bt crops are local reductions in the numbers of certain specialist parasitoids whose 
hosts are the primary targets of Bt crops. Such trophic effects will be associated with any 
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effective pest control technology, whether it be transgenic, chemical or cultural, as well 
as with natural fluctuations in host populations (Head, 2005).
3.1.1 Effects of Insect-Resistant Bt Crops on Insect Predators
Natural enemies of crop pests, and particularly generalist arthropod predators, have been 
the focus of many scientific studies due to their role in the biological control of various 
agricultural pests. Based on what is known about the limited spectrum of activity of the Bt 
proteins (Cry proteins) expressed in current Bt crops, no direct toxic effects from Bt crops 
would be expected for any of these species. As predicted, Tier 1 (“worst case scenario”) 
laboratory studies required by the regulatory process for Bt crops have not demonstrated 
any direct toxic effects of Cry1, Cry2 or Cry3 proteins against insect predators for 
concentrations at or much greater than maximum possible exposure levels under natural 
conditions (for example, see reviews in Betz et al., 2000). Obviously these tests are not 
designed to mimic natural exposure, nor do they test all possible species that could be 
exposed, but they do represent stringent tests of possible hazard characterisation using 
carefully chosen surrogate species.
Researchers interested in the fate of particular predatory species have carried out 
additional laboratory and semi-field tests of potential non-target impacts (e.g. Pilcher et 
al., 1997; Bai et al., 2005; Ahmad et al., 2006; Ludy & Lang, 2006). These tests have used 
a variety of designs, with differing degrees of realism in terms of the route and level of Bt 
exposure. Given that many predators feed on pollen at some point in their life-cycle, many 
of these studies have involved feeding predatory insect species pollen from Bt crops and 
comparable control lines. None of these studies have found any adverse impacts of Bt 
pollen on the survival or development of various insect predators. 
Even though the above studies involved direct exposure, under field conditions exposure 
can also occur through secondary pathways, with predators feeding upon herbivores that 
have fed on a Bt crop. Secondary exposure of this sort should have relatively little impact 
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on arthropod predators for the same reasons outlined above for direct exposure. However, 
one set of studies has been presented as a possible example of adverse impacts through 
secondary exposure. Hilbeck and colleagues (1998a, 1998b) performed a number of tri-
trophic laboratory studies with the predatory lacewing Chrysoperla carnea, feeding these 
larvae on prey lepidopteran larvae that had previously fed on Bt corn. They found higher 
mortality and slower development of lacewings exposed to Bt-intoxicated insects than for 
lacewings fed on comparable controls. Subsequent studies by other researchers indicate 
that these results actually reflected feeding on nutritionally poorer prey rather than any 
toxic effect of the Bt protein (Dutton et al., 2002; Romeis et al., 2004). Such a situation 
should have little relevance in the field due to the presence of other prey sources that are 
not affected by Bt crops. Furthermore, tri-trophic studies by Al-Deeb and colleagues (2001) 
with Orius insidiosus saw no effect when feeding on Bt-intoxicated prey. In this case, the 
results were confirmed with direct feeding studies on Bt corn silks and field observations.
Numerous field studies (e.g. Riddick et al., 1998; Sisterson et al., 2007; Wolfenbarger et 
al., 2008) have focused on generalist predators, particularly Coleomegilla maculata, C. 
carnea, O. insidiosus, and guilds of carabids because of their abundance in crop fields 
and their perceived importance. No adverse effects have been observed for any of 
these species or in the broader, community-level studies of Bt corn (e.g. Pilcher et al., 
1997; Lozzia, 1999; Candolfi et al., 2004; Pilcher et al., 2005) and Bt cotton (Xia et al., 1999; 
Hagerty et al., 2005). The absence of even indirect trophic effects of Bt corn and Bt cotton 
in these studies is not surprising because most of the predatory species feed on a wide 
array of prey species, the vast majority of which are not directly impacted by Bt corn, 
e.g. sucking insects such as aphids and whiteflies. In contrast, insecticidal sprays used 
in the cultivation of conventional corn have clear adverse impacts, at least transiently, 
on almost all common predators, and particularly those species foraging above ground 
(Candolfi et al., 2004). Similarly, the insecticidal sprays used in conventional cotton also 
had clear adverse impacts on almost all of the important arthropod predators studied (Xia 
et al., 1999; Hagerty et al., 2005; Wu & Guo, 2005).
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3.1.2 Effects of Insect-Resistant Bt Crops on Parasitoids
Given what is known about the spectrum of activity of the Bt proteins expressed in currently 
commercially available Bt crops (Clark et al., 2005), no direct toxic effects on any parasitoid 
species are expected. Furthermore, because the larvae of these groups feed solely on 
other arthropods, larval parasitoids will not face any direct exposure (Head, 2005). Adult 
exposure due to their occasional feeding on pollen or nectar will also be very limited. As 
with arthropod predatory species, Tier 1 laboratory studies have not found any direct toxic 
effects on parasitoids of Cry1, Cry2 or Cry3 proteins, at concentrations equivalent to or 
much greater than the maximum possible exposure level under natural conditions (see 
reviews in Betz et al., 2000). However, secondary exposure to Bt proteins may occur if the 
parasitoids feed on herbivore larvae that have fed upon Bt plant material. In addition, 
indirect effects may occur at the population level if the host species of the parasitoid(s) are 
a target of the Bt crop and are depressed in numbers. Secondary exposure studies indicate 
that parasitoids developing on hosts exposed to Bt protein may be adversely impacted. 
When reared on Bt-susceptible insects previously fed on Bt corn, the larval development 
and mortality of the parasitoid Parallorhogas pyralophagus were adversely affected, 
but the fitness of emerging adults was not impacted (Bernal et al., 2002). Obonyo (2009) 
found varying effects of Bt-intoxicated stem borer hosts on the development and fitness 
parameters of their tested parasitoids Cotesia sesamiae, C. flavipes and Xanthopimpla 
stemmator. 
A major determinant of the relative impact that Bt crops have on non-target species 
derives from the fundamental difference in their toxin delivery mechanism (in planta) as 
compared to conventional insecticides (ex planta). Non-target species must consume 
Bt plant material in order to be directly exposed, and therefore, as non-herbivores, many 
parasitoids will never be exposed. Because of their specificity, parasitoids of Bt target pest 
larvae would be expected to be rarer in fields of Bt crops than in comparable fields of non-
sprayed conventional crops. As expected, the few specialist parasitoids that parasitise 
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Ostrinia nubilalis and certain other stalk-boring Lepidoptera in corn have been found to 
be rarer in Bt corn than in conventional corn, e.g. Macrocentrus cingulum (Candolfi et al., 
2004). Similarly, the few specialist parasitoids that parasitise foliage-feeding Lepidoptera, 
such as Helicoverpa armigera, have been found to be rarer in Bt cotton than in non-Bt 
cotton (e.g. Xia et al., 1999). Of course, it is important to consider these results in the context 
of alternative practices. As mentioned earlier, the insecticidal sprays used in conventional 
corn (Candolfi et al., 2004) and cotton (Xia et al., 1999; Hagerty et al., 2005; Wu & Guo, 
2005) have clear adverse impacts, at least transiently, on these same parasitoid species. 
Furthermore, any effective pest control practice that decreases the abundance of the 
host species will have comparable effects.
3.2 Potential Environmental Effects of HT Crops
One of the most widely reported examples of studies on the potential environmental 
impacts of HT crops were the farm-scale evaluations carried out in the UK. These were a 
series of multi-year comparisons of agricultural biodiversity in conventional and transgenic 
HT maize, oilseed rape (spring- and autumn-sown) and sugar beet fields, which were 
undertaken as a response to public concerns of the effects of cultivation of transgenic HT 
crops on farmland wildlife (Firbank et al., 2003).The farm-scale evaluations tested the null 
hypothesis that “transgenic HT crops had no effect on farmland biodiversity compared 
with a conventional cropping system” (Squire et al., 2003). The results of the studies can be 
summarised as follows: in oilseed rape and sugar beet there were fewer weeds that set seed 
in the transgenic HT crop than in the conventional crop, whereas in maize there were more 
weeds in the transgenic HT crop; invertebrate numbers tended to be positively correlated 
with the abundance of weeds, although some taxa showed the opposite relationship; and 
in general, there were more decomposers in the fields of transgenic HT crops (Ammann, 
2005). See Raybould (2007) for a critical analysis of the farm-scale evaluation studies.
Sweet and colleagues (2004) observed no direct impact of the transgenes in HT winter 
oilseed rape and sugar, nor the transgenic crops themselves on crop production and 
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botanical diversity. Differences observed between treatments were attributable to the 
herbicide programmes. The GM HT crops, however, required fewer herbicide applications 
than conventional crops. Antonio and Duke (2006), in a review on the environmental 
impacts of glyphosate-tolerant (GT) crops, noted that no risks had been found with 
respect to food or feed safety nor nutritional value in products from currently available GT 
crops. They noted that GT crops have promoted the adoption of reduced or no-tillage 
agriculture in the US and Argentina, providing a substantial environmental benefit. The 
review also showed that weed species in GT crop fields have shifted to those that can more 
successfully withstand glyphosate and to those that avoid the time of its application. It also 
indicated that three weed species have evolved resistance to glyphosate in GT crops 
and that GT crops have a greater potential to become problems as volunteer crops than 
do conventional non-HT crops. They also reported that GT transgenes had unexpectedly 
been found in fields of conventional oilseed rape, indicating that the largest risk of GT crops 
may arise from transgene flow (introgression) from GT crops to their related wild species 
They concluded, however, that all of the minimal environmental risks that have been 
discussed in relation to GT crops are reversible and are in most cases not exclusive to 
transgenic crops, except for those associated with flow of transgenes to other plants (the 
same species or other species). 
A review by Kleter and colleagues (2008) of data collected from studies on a number of 
GT crops in Europe indicated that, depending on the parameters used for the prediction 
or measurement of the environmental impacts of GT crops, generally similar or less 
negative impacts were observed compared with conventional crops. They concluded 
that favourable environmental effects of the glyphosate-containing herbicide regimes 
on GT crops appear feasible, provided appropriate measures for maintaining biodiversity 
and prevention of volunteers and gene flow are applied. Graef (2009), in a review of 
the potential agro-environmental effects of cultivating GM oilseed rape, also noted the 
importance of monitoring for persistence and/or spread of feral HT oilseed rape and 
volunteers, the transfer of herbicide tolerance to wild relatives and a decline in agro-
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biodiversity, the development of herbicide tolerance in weeds, as well as any adverse 
effects on field organisms and/or soil bio-geochemical cycles. Powell and colleagues 
(2009) conducted a series of microcosm and field experiments in Ontario, Canada, that 
estimated the effects of transgenic GT crops and their management on the abundances 
of detritivorous soil biota and crop litter decomposition. Although the conventional and GT 
varieties studied differed in composition, they observed few effects of the modification for 
glyphosate-tolerance on maize and soya bean litter decomposition. Overall, the herbicide 
system associated with the GT crops reduced soya bean and corn litter decomposition, 
but responses were inconsistent across Ontario, with many trials demonstrating no effect. 
Herbicide-tolerant crops can therefore enhance agricultural productivity and, with 
appropriate measures in place, any potential risks can be kept in check.
4 Principles of biosafety and risk assessment
Biosafety worldwide is heavily influenced by the Cartagena Protocol on Biosafety 
(henceforth referred to as the Protocol), an international agreement to which many 
African countries are signatories (CBD, 2000). According to the Protocol, biosafety refers to 
“the need to protect human health and the environment from the possible adverse effects 
of the products of modern biotechnology”. The Protocol recognises that, in as much as 
modern biotechnology has a great potential for the promotion of human well-being, 
appropriate procedures have to be put in place to enhance the safety of biotechnology. 
For example, Article 16, Paragraph 1, states that “The Parties shall, taking into account 
Article 8 (g) of the Convention, establish and maintain appropriate mechanisms, measures 
and strategies to regulate, manage and control risks identified in the risk assessment 
provisions of this Protocol associated with the use, handling and transboundary movement 
of living modified organisms”. In addition, Article 2, Paragraph 2 of the Protocol states that 
“The Parties shall ensure the development, handling, transport, use, transfer and release 
of any living modified organisms are undertaken in a manner that prevents or reduces the 
risks to biological diversity, taking also into account risks to human health”. 
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Therefore in order to evaluate GM crops for safety, an acknowledgment of their potential 
benefits must be made in addition to an evaluation of the potential damage to the 
environment and human and animal health. Any biosafety evaluation of GM crops and 
their products must be based on an understanding of the technologies used in their 
development, a comparison of GM crops with the non-modified recipients or parental 
organisms, and the difference of GM crop production practices with those of current 
agricultural practices and their potential impacts. Evaluation of the benefits and risks of 
GM crops is necessary in order to set the level of acceptable risk as a basis for decision- 
making concerning the acceptance or refusal of the technology in any given situation 
(Sehnal & Drobnik, 2009). Economics may also be taken into account, in particular in any 
evaluations of the long-term use. 
A review by Hill and Sendashonga (2003) identified a number of key lessons (drawn from 
the experiences with chemical risk assessment) which have possibly served as useful 
principles to guide the risk assessment of GMOs. These include: 
a) considering multiple lines of evidence
b) assessing risks in a comparative context
c) flexibility regarding the level of detail for risk assessments
d) having iterative and adaptive risk assessments which could be re-evaluated 
whenever there have been changes that affect risk assessments
e) being able to assess cumulative effects as part of the risk assessments.
5 Risk assessment in practice
Risk may be defined as the probability of damage resulting from exposure to a hazard. 
As no activity is without risk, the risk scale does not start with zero, and only relative risk 
can be assessed by comparison with alternative human activities. Risk assessment has 
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been defined in a number of ways. For example, the European Commission (EC, 2000) 
defines risk assessment as “a process of evaluation including the identification of the 
attendant uncertainties, of the likelihood and severity of an adverse effect(s)/event(s) 
occurring to man or the environment following exposure under defined conditions to a 
risk source(s)”. According to WHO (1995), risk assessment is the “scientific evaluation of 
known or potential adverse health effects resulting from human exposure to food-borne 
hazards.” A risk assessment generally identifies the likelihood of exposure to a hazard and 
the magnitude of the consequences of the exposure on human health (Fischer et al., 2005), 
and the environment. It is often decomposed into four elements: hazard identification, 
hazard characterisation, exposure assessment and risk characterisation (EC, 2000; Codex 
Alimentarius, 2007). 
Publications and guidance documents on environmental risk assessment (USA EPA, 1998; 
EC, 2003; Suter, 2006) have outlined coherent and logical steps to progressively and 
iteratively proceed to a point where a risk is characterised and the evidence supporting the 
conclusion is clearly communicated. This process has been successfully used for chemical 
stressors and has been described in detail by the American Environmental Protection 
Agency (USA EPA, 1998). The process follows the steps of: problem formulation as the 
beginning; assessment of the exposure, including levels and likelihood of exposure; hazard 
identification and assessment that examine the potential hazard(s) using effects testing 
and the magnitude of the potential outcome; and risk characterisation that integrates the 
hazard, the magnitude of the consequences, and the likelihood of occurrence. Regulatory 
decisions regarding the acceptability of introducing a potentially harmful agent into the 
environment are based on the characterised risk (Nickson, 2008). Experimental testing is 
performed by following established procedures, e.g. feeding tests, allergy induction assays, 
in vitro digestibility tests, etc. (WTO, 2009). Since these tests are expensive, any regulatory 
decision to require testing should be taken in a responsible manner. 
In addition to the intended target effects, these studies may reveal differences between 
a GM and the comparator, but differences from standard crop cultivation practices that 
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include protective measures against insect pests, weeds, etc. should also be tested. It is 
necessary also to consider extra comparators that help to place differences between the 
GM and its counterpart in context (Perry et al., 2009). For example, comparisons should also 
be made with plots subjected to the standard agricultural practices and, if possible, cultivars 
with similar properties as the GM cultivars but obtained by other breeding methods (Sehnal 
& Drobnik, 2009). Furthermore, HT GM plants per se are unlikely to affect biodiversity, but 
the use of herbicides associated with their cultivation may have a deleterious impact. HT 
varieties developed by other breeding techniques, together with their required herbicide 
regime, should therefore be included in the studies to act as comparators.
Ideally, a risk assessment should be accompanied by a benefit assessment performed 
under the same conditions and using an identical methodology. The benefit:risk ratio is 
not only extremely useful in the identification of an acceptable level of risk, but also in 
decision-making. The potential risks and benefits from the introduction of a new GM crop 
can be assessed only by a comparison with currently grown varieties, either conventional 
non-GM or pre-existing GM, cultivated with the use of standard procedures, including 
the application of any necessary insecticides, herbicides, etc. (Sehnal & Drobnik, 2009). 
Agriculture has inevitably converted natural, diversified ecosystems to monoculture-based 
agro-ecosystems that are sometimes exploited to the point of irreversible damage. The 
evaluation of the potential environmental impacts of new technologies is dictated by the 
need to mitigate such damage for the sake of agriculture sustainability. GM crops should 
be scrutinised as is any other technology, and based upon possible significant effects on 
food safety and the agro-ecosystem. Even though new cultivars introduce a novel genetic 
set-up to the ecosystem, care should be taken to discriminate between the direct impact 
of the new plant varieties themselves with those derived from their associated agronomic 
practices, i.e. the methods of field management, applications of any chemicals, crop- 
selection and rotation, etc. The impact of new technologies can be either positive or 
negative, or even a mixture of the two (Prakash, 2001); there is no reason to classify some 
technologies a priori as negative and “risky”. 
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It is important to note, however, that the collection of large amounts of data may not 
be necessary for effective risk assessment decision-making. Craig and colleagues (2008) 
reported that “In the decade since the first authorisations for commercial release of 
GM crops, there has been an enormous increase in the amount of data generated 
by scientific studies that relates to risk assessment. If this trend continues, we run the risk 
of competent authorities being submerged by excessively large amounts of data that 
may be of questionable pertinence to verifiable safety questions.” In fact, an effective 
risk assessment should seek to minimise the amount of data required to reach a sound 
judgement because collection of superfluous data often confuses decision-making and 
diverts effort from more worthwhile activities (Raybould, 2006). Indeed, if the collection of 
additional data delays the introduction of a beneficial product, overall environmental risk 
may be increased rather than reduced (Cross, 1996). Emphasis must therefore be placed 
only on data that will facilitate the making of a sound judgement (Craig & Tepfer, 2007).
6 Conclusion
The regulation of agricultural biotechnology has both immediate and long-lasting socio-
economic consequences and can affect the sustainability of agro-ecosystems. Policy-
makers are responsible for formulating regulations, while scientists are charged to provide 
and evaluate information necessary for prudent decisions. It would be extremely useful 
for open debates if the public were familiar with the nature of various breeding methods, 
as well as those of GM technologies. Knowledgeable citizens would then be able to 
positively contribute to the discussions concerning possible safety measures and GM crop 
deployment. Scientifically unjustified bans on the deployment of GM crops may slow down 
agricultural output, and could further compound the dire food security situation in Africa. 
The socioeconomic factors affecting GM crop deployment also include pressure from 
various interest groups. All these issues are very volatile and hard to control. It is important 
that GM crops be assessed on a case-by-case basis. The evaluation of the possible risks 
arising from the deployment of a particular GM crop in the receiving environment should 
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include the results of prior research, and may or may not require the generation of new 
information.
It has been argued that GM crops should not be used, even when there may be a very 
low probability of the occurrence of an unpredictable adverse effect on the environment 
or on human health (Nuffield Council on Bioethics, 2003). This case is frequently cited in 
terms of the precautionary approach in the Protocol which emanated from Principle 15 of 
the Rio Declaration which states: “In order to protect the environment, the precautionary 
approach shall be widely applied by States according to their capabilities. Where there are 
threats of serious or irreversible damage, lack of full scientific certainty shall not be used as 
a reason for postponing cost-effective measures to prevent environmental degradation.” 
Some people have contended that irrespective of possible benefits, the precautionary 
approach argues for a delay in the use of the technology until a complete assurance of 
absence of risk is available (Nuffield Council on Bioethics, 2003). Interestingly, however, the 
text of the Protocol can also be interpreted as permitting the introduction of GM crops with 
their associated risks if they are likely to be less than the risks inherent in current practices, 
even if the full extent of the reduction is not known. The former argument could lead to 
an inappropriate embargo on the introduction of all new technology. Since an absolute 
absence of risk arising from the use of any new technology can never be guaranteed, 
the only sensible interpretation of the precautionary principle should be comparative, i.e. 
to select the course of action (or inaction) with the least overall risk (Nuffield Council on 
Bioethics, 2003). 
Scientific research has to clarify the possible environmental effects of GM crops, and 
place them in the context of real-life scenarios. This should take into account: the gene 
(or combination of genes) being inserted; the nature of the target crop; local agricultural 
practices, agro-ecological conditions, trade policies, etc. So far, it is not possible to make 
generalisations on the effects of GM technologies. Any judgement of the impact of 
GM crops should be made on a case-by-case basis using a rational, evidence-based 
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approach (FAO, 2003). It is essential to pose the question: “How does the use of a GM crop 
compare to the alternatives?” In making decisions, all possible paths of action must be 
compared, including inaction. 
Even though there is little evidence of specific harmful effects from the millions of acres of 
transgenic crops grown worldwide, the potential risks associated with the technology are 
very pronounced in the perceptions of policy-makers and the general public in Africa. 
Given this level of concern, there is a great need for accurate, credible information. 
There has been much effort to communicate issues pertinent to GM crops. While 
notable progress is being made, inadequate knowledge and misinformation about GM 
technology still prevails in the region. Efforts to address concerns include: developing 
national communication strategies, open discussions, training and supporting efficient 
communicators, developing and using effective messages and Information, Education, 
Communication (IEC) materials, and using study tours to allow key stakeholders to directly 
observe GM crops in the field. Ensuring the presence of appropriate biosafety regulatory 
systems, policies, legal instruments and decision-making processes is critical for the safe 
deployment of GM crops (Sengooba et al., 2009), as well as for meeting international 
obligations. Public policy with regard to the deployment of GM crops must be guided by 
the most accurate and objective scientific advice available.
With a large number of GM crops currently under development in Africa it is evident that 
regulatory authorities in the continent will continue receiving applications for GM trials and/
or environmental releases. In order to be able to effectively evaluate these applications, it 
is imperative that they have access to relevant information and appropriate training. For 
this to be possible, efforts have to be made to provide as much information as possible 
regarding GMOs, and training on how to evaluate them.
Acknowledgments 
Dennis Obonyo and Lilian Nfor are grateful for the support of the Academy of Science of 
South Africa who, with funding from the InterAcademy Panel, facilitated their participation 
87
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
CHALLENGES FOR GM TECHNOLOGIES: EVIDENCE-BASED 
EVALUATION OF THE POTENTIAL ENVIRONMENTAL EFFECTS OF GM CROPS 
Dr Dennis Obonyo, Ms Lilian Nfor, Dr Wendy Craig and Mr Decio Ripandelli
in the “GMOs for African Agriculture: Opportunities and Challenges” workshop. They are 
currently working as biosafety specialists in a major biosafety capacity-building project for 
sub-Saharan Africa, implemented through a partnership between the ICGEB and the Bill 
and Melinda Gates Foundation.
References
Ahmad, A., Wilde, G.E., Whitworth, R.J. & Zolnerowich, G. 2006. Effect of corn hybrids expressing the 
coleopteran-specific cry3Bb1 protein for corn rootworm control on aboveground insect predators. 
Journal of Economic Entomology, 99: 1085-1095.
Al-Deeb, M.A., Wilde, G.E. & Higgins, R.A. 2001. No effect of Bacillus thuringiensis corn and Bacillus 
thuringiensis on the predator Orius insidiosus (Hemiptera: Anthocoridae). Environmental Entomology, 
30: 625-629.
Ammann, K. 2005. Effects of biotechnology on biodiversity: herbicide-tolerant and insect-resistant crops. 
Trends in Biotechnology, 23: 388–394.
Antonio, L.C. & Duke, O.S. 2006. The current status and environmental impacts of glyphosate-resistant 
crops: A review. Journal of Environmental Quality, 35: 1633-1658.
Bai, Y.Y., Jiang, M.X. & Cheng, J. A. 2005. Effects of transgenic Cry1Ab rice pollen on fitness of Propylea 
japonica (Thunberg). Journal of Pest Science, 78, 123-128.
Bates, S.L., Zhao, J., Roush, R.T. & Shelton, A.M. 2005. Insect resistance management in GM crops: past 
present and future. Nature Biotechnology, 23: 57-62. 
Bernal, J.S., Griset, J.G. & Gillogly, P.O. 2002. Impacts of developing on Bt maize intoxicated hosts on 
fitness parameters of a stem borer parasitoid. Journal of Entomological Science, 37: 27-40.
Betz, F.S., Hammond, B.G. & Fuchs, R.L. 2000. Safety and advantages of Bacillus thuringiensis-protected 
plants to control insect pests. Regulatory Toxicology and Pharmacology, 32: 156-173.
Brookes, G. & Barfoot, P. 2006. Global impact of biotech crops: Socio-economic and environmental 
effects in the first ten years of commercial use. AgBioForum, 9: 139-151. 
Candolfi, M., Brown, K., Reber, B. & Schmidli, H. 2004. A faunistic approach to assess potential side-
effects of genetically modified Bt-corn on non-target arthropods under field conditions. Biocontrol 
Science and Technology, 14: 129-170.
CBD (The Cartagena Protocol on Biosafety). 2000. Secretariat of the Convention on Biological Diversity 
(CBD), Montreal, Canada. Available at: http://www.cbd.int/doc/legal/cartagena-protocol-en.pdf 
[Accessed 8 January 2010].
Clark, B.W., Phillips, T.A. & Coats, J.R. 2005. Environmental fate and effects of Bacillus thuringiensis (Bt) 
proteins from transgenic crops: a review. Journal of Agricultural and Food Chemistry, 53: 4643-4653.
Codex Alimentarius. 2007. Codex Alimentarius Commission: Procedural Manual. FAO-WHO, Rome, Italy. 
Available at: ftp://ftp.fao.org/docrep/fao/010/a1472e/a1472e.pdf. [Accessed 18 January 2010].
Conner, A.J., Glare, T.R. & Nap, J-P. 2003. The release of genetically modified crops in the environment, 
Part ll: Overview of ecological risk assessment. The Plant Journal, 33: 19-46.
88
WORKSHOP PROCEEDINGS REPORT
GMOs FOR AFRICAN AGRICULTURE: CHALLENGES AND OPPORTUNITIES
CHALLENGES FOR GM TECHNOLOGIES: EVIDENCE-BASED 
EVALUATION OF THE POTENTIAL ENVIRONMENTAL EFFECTS OF GM CROPS 
Dr Dennis Obonyo, Ms Lilian Nfor, Dr Wendy Craig and Mr Decio Ripandelli
Craig, W. & Tepfer, M. 2007. Introduction to the safety/risk assessment of GM crops. Journal of Agricultural 
Investment, 5: 36-42.
Craig, W., Tepfer, M., Degrassi, G. & Ripandelli, D. 2008. An overview of general features of risk assessments 
of genetically modified crops. Euphytica, 164: 853–880. 
Cross, F.B. 1996. Paradoxical perils of the precautionary principle. Washington and Lee Law Review, 53: 
851–925.
Dale, P.J. 1992. Spread of engineered genes to wild relatives. Plant Physiology, 100: 13-15.
DESA UN (Department of Economic and Social Affairs of the United Nations). 2009. World population 
prospects: the 2008 revision. New York: Population Division of the Secretariat of DESA UN. Available at: 
http://esa.un.org/unpp. [Accessed 7 January 2010].
Duan, J.J., Marvier, M., Huesing, J., Dively, G. & Huang, Z.Y. 2008. A meta-analysis of effects of Bt crops 
on honey bees (Hymenoptera: Apidae). PLoS ONE 3, e1415 (doi:10.1371/journal.pone.0001415).
Dutton, A., Klein, H., Romeis, J. & Bigler, F. 2002. Uptake of Bt-toxin by herbivores on transgenic maize and 
consequences for the predator Chrysoperla carnea. Ecological Entomology, 27: 441-447.
EC (European Commission). 2000. First report on the harmonisation of risk assessment procedures, 26–27 
October 2007. Part II. Appendices. Brussels, Belgium: EC. Available at: http://ec.europa.eu/food/fs/sc/
ssc/out84_en.pdf [Accessed 22 January 2010].
EC (European Commission). 2003. Guidance document for the risk assessment of genetically modified 
plants and derived food and feed. Brussels, Belgium: EC. Available at: http://ec.europa.eu/food/fs/sc/
ssc/out327_en.pdf [Accessed 16 January 2010]. 
FAO (Food and Agriculture Organization, United Nations). 2003. Report of the FAO expert consultation 
on environmental effects of genetically modified crops 16–18 June 2003. Rome, Italy: FAO. Available at: 
ftp://ftp.fao.org/docrep/fao/field/006/ad690e/ad690e00.pdf [Accessed: 19 January 2010].
FAO (Food and Agriculture Organization, United Nations). 2009a. 1.02 billion people hungry., Rome, 
Italy: FAO. Available at: http://www.fao.org/news/story/en/item/20568/icode/ [Accessed 23 December 
2009]. 
FAO (Food and Agriculture Organization, United Nations). 2009b. The state of food insecurity in the 
world: economic crises-impacts and lessons learned. Rome, Italy: FAO. Available at: ftp://ftp.fao.org/
docrep/fao/012/i0876e/i0876e.pdf [Accessed 31 December 2009].
Firbank, L.G., Heard, M.S., Woiwod, I.P., Hawes, C., Haughton, A.J., Champion, G.T., Scott, R.J., Hill, M.O., 
Dewar, A.M., Squire, G.R., May, M.J., Brooks, D.R., Bohan, D.A., Daniels, R.E., Osborne, J.L., Roy, D.B., 
Black, H.I.J., Rothery, P. & Perry, J.N. 2003. An introduction to the farm-scale evaluations of genetically 
modified herbicide-tolerant crops. Journal of Applied Ecology, 40: 2–16.
Fischer, R.H., de Jong, A.E.I., de Jonge, R., Frewer, L.J. & Nauta, M.J. 2005. Improving food safety in the 
domestic environment: the need for a transdisciplinary approach. Risk Analysis, 25: 503-517.
Graef, F. 2009. Agro-environmental effects due to altered cultivation practices with genetically modified 
herbicide-tolerant oilseed rape and implications for monitoring: a review. Agronomy for Sustainable 
Development, 29: 31-42.
89
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
CHALLENGES FOR GM TECHNOLOGIES: EVIDENCE-BASED 
EVALUATION OF THE POTENTIAL ENVIRONMENTAL EFFECTS OF GM CROPS 
Dr Dennis Obonyo, Ms Lilian Nfor, Dr Wendy Craig and Mr Decio Ripandelli
Hagerty, A.M., Kilpatrick, A.L., Turnipseed, S.G., Sullivan, M.J. & Bridges, W.C. 2005. Predaceous 
arthropods and lepidopteran pests on conventional, Bollgard, and Bollgard II cotton under untreated 
and disrupted conditions. Environmental Entomology, 34: 105-114.
Head, G. 2005. Assessing the effect of Bt crops on natural enemies. In: Proceedings of the Second 
International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12–16 September 
2005, Volume I. USDA Forest Service Publication FHTET-2005-08, Fort Collins, Colorado, USA. Available at: 
http://www.bugwood.org/arthropod2005/vol1/7b.pdf [Accessed 22 December 2009].
Hill, A.R. & Sendashonga, C. 2003. General principles for risk assessment of living modified organisms: 
Lessons from chemical risk assessment. Environmental Biosafety Research, 2: 81–88.
Hilbeck, A., Moar, W.J., Pusztai-Carey, M., Filippini, A. & Bigler, F. 1998a. Toxicity of Bacillus thuringiensis 
Cry1Ab toxin to the predator Chrysoperla carnea (Neuroptera: Chrysopidae). Environmental 
Entomology, 27: 1255-1263.
Hilbeck, A., Baumgartner, M., Fried, P. M. & Bigler, F. 1998b. Effects of transgenic Bacillus thuringiensis 
corn-fed prey on mortality and development time of immature Chrysoperla carnea (Neuroptera: 
Chrysopidae). Environmental Entomology, 27: 480-487.
Huesing, J. & English, L. 2004. The impact of Bt crops on the developing world. AgBioForum, 7: 84-95.
Ismael, Y., Bennet, R. & Morse, S. 2002. Benefits from Bt cotton use by smallholder farmers in South Africa. 
AgBioForum, 5: 1-5. 
James, C. 2008. Global status of commercialized biotech/GM Crops: 2008. ISAAA Brief No. 39 – 2008. 
Ithaca, New York: ISAAA (International Service for the Acquisition of Agri-biotech Applications). Available 
at: http://www.isaaa.org/resources/publications/briefs/39/executivesummary/default.html [Accessed: 
12 January 2010].
Kleter, G.A, Harris, C., Stephenson, G. & Unsworth, J. 2008. Comparison of herbicide regimes and the 
associated potential environmental effects of glyphosate-resistant crops versus what they replace in 
Europe. Pest Management Science, 64: 479–488.
Kohi, Y. (2006). Challenges in implementing biosafety systems in developing countries. Proceedings of 
a Stakeholders’ Consultative Workshop, Towards a Common Regional Policy, Regulatory and Biosafety 
Framework on Genetically Modified Organisms in East Africa, Entebbe, Uganda, 12–14 September. 
Available at: http://www.biovisioneastafrica.com/publications/EAC_Proceedings.pdf [Accessed 23 
December 2009].
Losey, J.E., Rayor, L.S. & Carter, M.E. 1999. Transgenic pollen harms monarch larvae. Nature, 399: 214.
Lozzia, G.C. 1999. Biodiversity and structure of ground beetle assemblages (Coleoptera: Carabidae) 
in Bt corn and its effects on non-target insects. Bollettino di Zoologica Agraria e di Bachicoltura, 31: 
37-58.
Ludy, C. & Lang, A. 2006. Bt maize pollen exposure and impact on the garden spider, Araneus 
diadematus. Entomologia Experimentalis et Applicata, 118: 145-156.
Marvier, M., McCreedy, C., Regetz, J. & Kareiva, P. 2007. A meta-analysis of effects of Bt cotton and 
maize on nontarget invertebrates. Science, 316: 1475-1477.
90
WORKSHOP PROCEEDINGS REPORT
GMOs FOR AFRICAN AGRICULTURE: CHALLENGES AND OPPORTUNITIES
CHALLENGES FOR GM TECHNOLOGIES: EVIDENCE-BASED 
EVALUATION OF THE POTENTIAL ENVIRONMENTAL EFFECTS OF GM CROPS 
Dr Dennis Obonyo, Ms Lilian Nfor, Dr Wendy Craig and Mr Decio Ripandelli
Mataruka, D. 2009. Role of genetically modified crops in Africa. CBI blog, Washington DC: Council 
for Biotechnology Information, USA. Available at: http://www.whybiotech.com/?p=915#more-915 
[Accessed 22 December 2009].
Morse, S., Bennett, R.M. & Ismael, Y. 2005. Genetically modified insect resistance in cotton: some farm-
level economic impacts in India. Crop Protection, 24: 433-410.
Naranjo, S. 2009. Bt crops and invertebrate non-target effects – revisited. Information Systems for 
Biotechnology News Report. Virginia Polytechnic Institute and State University. Available at: http://
www.isb.vt.edu/news/2009/Dec09.pdf.
Nickson, T.E. 2008. Planning environmental risk assessment for genetically modified crops: problem 
formulation for stress-tolerant crops. Plant Physiology, 147: 494-502.
Nuffield Council on Bioethics. 2003. The use of genetically modified crops in developing countries: a 
follow-up discussion paper. London. Available at: http://www.nuffieldbioethics.org/fileLibrary/pdf/GM_
Crops_Discussion_Paper_2004.pdf [Accessed 8 January 2010].
Obonyo, D.N. 2009. Tritrophic interactions between parasitoids, lepidopteran stem borers and Bt maize. 
PhD thesis, University of Nairobi, Kenya.
OECD-FAO (2009). Agricultural outlook 2009–2018. Organisation for Economic Co-operation and 
Development (OECD) and the Food and Agriculture Organisation (FAO) of the United Nations. Available 
at: http://www.agri-outlook.org/dataoecd/2/31/43040036.pdf [Accessed 31 December 2009].
Paarlberg, R.L. 2008. Starved for Science: How Biotechnology is Being Kept out of Africa. Cambridge, 
USA: Harvard University Press.
Perry, J.N., Ter Braak, C.J.F., Dixon, P.M., Duan, J.J., Hails, R.S. Huesken, A., Lavielle, M.C., Marvier, M., 
Scardi, M., Schmidt, K., Tothmeresz, B., Schaarschmidt, F. & Van der Voet, H. 2009. Statistical aspects of 
environmental risk assessment of GM plants for effects on non-target organisms. Environmental Biosafety 
Research, 8: 65-78. 
Pilcher, C.D., Obrycki, J.J., Rice, M.E. & Lewis, L.C. 1997. Preimaginal development, survival and field 
abundance of insect predators on transgenic Bacillus thuringiensis corn. Environmental Entomology, 
26: 446-454.
Pilcher, C.D., Rice, M.E. & Obrycki, J.J. 2005. Impact of transgenic Bacillus thuringiensis corn and crop 
phenology on five nontarget arthropods. Environmental Entomology, 34: 1302-1316.
Pleasants, J.M., Hellmich, R.L., Dively, G.P., Stanley-Horn, D.E., Mattila, H.R., Foster, J.E., Clark, P. & Jones, 
G.D. 2001. Corn pollen deposition on milkweeds in and near cornfields. Proceedings of the National 
Academy of Sciences of the USA, 98: 11919-11924.
Powell, J.R., Levy-Booth, D.J., Gulden, R.H., Asbil, W.L., Campbell, R.G., Dunfield, K.E., Hamill, A.S., Hart, 
M.M., Lerat, S., Nurse, R.E., Pauls, K.P., Sikkema, P.H., Swanton, C.J., Trevors, J.T. & Klironomos, J.N. 2009. 
Effects of genetically modified, herbicide-tolerant crops and their management on soil food web 
properties and crop litter decomposition. Journal of Applied Ecology, 46: 388-396.
Prakash, C.S. 2001. The genetically modified crop debate in the context of agricultural evolution. Plant 
Physiology, 126: 8-15.
Raney, T. 2006. Economic impact of transgenic crops in developing countries. Current Opinion in 
Biotechnology, 17: 174-178.
91
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
CHALLENGES FOR GM TECHNOLOGIES: EVIDENCE-BASED 
EVALUATION OF THE POTENTIAL ENVIRONMENTAL EFFECTS OF GM CROPS 
Dr Dennis Obonyo, Ms Lilian Nfor, Dr Wendy Craig and Mr Decio Ripandelli
Raybould, A. 2006. Problem formulation and hypothesis testing for environmental risk assessments of 
genetically modified crops. Environmental Biosafety Research, 5: 119-125.
Raybould, A. 2007. Ecological versus ecotoxicological methods for assessing the environmental risks of 
transgenic crops. Plant Science, 173: 589-602.
Riddick, E.W., Dively, G. & Barbosa, P. 1998. Effect of a seed-mix deployment of Cry3A transgenic and 
nontransgenic potato on the abundance of Lebia grandis (Coleoptera: Carabidae) and Coleomegilla 
maculata (Coleoptera: Coccinellidae). Annals of the Entomological Society of America, 91: 647-653.
Romeis, J., Dutton, A. & Bigler, F. 2004. Bacillus thuringiensis toxin (Cry1Ab) has no direct effect on larvae 
of the green lacewing Chrysoperla carnea (Stephens) (Neuroptera: Chrysopidae). Journal of Insect 
Physiology, 50: 175-183.
Sears, M.K., Stanley-Horn, D.E., Oberhauser, K.S., Pleasants, J.M., Mattila, H.R., Siegfried, B.D. & Dively, 
G.P. 2001. Impact of Bt corn pollen on monarch butterfly populations: A risk assessment. Proceedings of 
the National Academy of Sciences of the USA, 98: 11937-11942.
Sehnal, F. & Drobnik, J. (Eds). 2009. White book. Genetically modified crops. EU regulations and research 
experience from the Czech republic. Biology Centre of the Academy of Sciences of the Czech Republic, 
Ceské Budejovice, Czech Republic. Available at: http://forskarbloggen.typepad.com/files/white-book-
on-gmo.pdf [Accessed 30 November 2009].
Sengooba, T., Grumet, R., Hancock, J., Zawedde, B., Kitandu, L., Weebadde, C., Karembu, M., Kenya, 
E., Meredia, K., Nampala, P., Ochanda, J.O., Quemada, H. & Rubindamayugi, M. 2009. Biosafety 
education relevant to genetically engineered crops for academic and non-academic stakeholders 
in East Africa. Electronic Journal of Biotechnology 12. Available at: http://www.ejbiotechnology.cl/
content/vol12/issue1/full/6/index.html [Accessed 23 December 2009].
Sisterson, M.S., Biggs, R.W., Manahrdt, N.M., Carriere, Y., Dennehy, T.J. & Tabashnik, B.E. 2007. Effects 
of transgenic Bt cotton on insecticide use and abundance of two generalist predators. Entomologia 
Experimentalis et Applicata, 124: 305-311.
Squire, G.R., Brooks, D.R., Bohan, D.A., Champion, G.T., Daniels, R.E., Haughton, A.J., Hawes, C., Heard, 
M.S., Hill, M.O., May, M.J., Osborne, J.L., Perry, J.N., Roy, D.B., Woiwod, I.P. & Firbank, L.G. 2003. On the 
rationale and interpretation of the farm-scale evaluations of genetically modified herbicide-tolerant 
crops. Philosophical Transactions of the Royal Society of London - Biological Sciences, 358: 1779–1799.
Stanley-Horn, D.E,. Dively, G.P., Hellmich, R.L., Mattila, H.R., Sears, M.K., Rose, R., Jesse, L.C. H., Losey, 
J.E., Obrycki, J.J. & Lewis L. 2001. Assessing the impact of Cry1Ab-expressing corn pollen on monarch 
butterfly larvae in field studies. Proceedings of the National Academy of Sciences of the USA, 98: 11931–
11936.
Suter II, G.W. 2006. Ecological Risk Assessment, 2nd volume. Boca Raton, FL, USA: CRC Press.
Sweet, J., Simpson, E., Law, J. Lutman, P., Berry, K. Payne, R., Champion, G.M., May, G.M., Walker, 
K., Wightman P. & Lainsbury, M. 2004. Botanical and rotational implications of genetically modified 
herbicide tolerance in winter oilseed rape and sugar beet (BRIGHT Project). Project Report No. 353. 
Agriculture and Horticulture Development Board, Kenilworth, UK. Available at: http://www.hgca.com/
document.aspx?fn=load&media_id=1454&publicationId=1805 [Accessed 8 January 2010].
Thies, J.E. & Devare, M.H. 2007. An ecological assessment of transgenic crops. Journal of Development 
Studies, 43: 97-129.
92
WORKSHOP PROCEEDINGS REPORT
GMOs FOR AFRICAN AGRICULTURE: CHALLENGES AND OPPORTUNITIES
USA EPA (U.S. Environmental Protection Agency). 1998. Guidelines for ecological risk assessment. 
Risk Assessment Forum, Washington, DC: EPA. Available at: http://oaspub.epa.gov/eims/eimsapi.
dispdetail?deid=12460 [Accessed 8 January 2010].
Vitale, J., Harvey, G., Greenplate, J., Abdennadher, M. & Traoré, O. 2008. Second-generation Bt cotton 
field trials in Burkina Faso: analyzing the potential benefits to West African farmers. Crop Science, 48: 
1958-1966.
WHO (Word Health Organisation). 1995. Application of risk analysis to food standards issues. Report of 
the Joint FAO/WHO Expert Consultation, Geneva, Switzerland, 13-17 March 1995. Available at: http://
www.fao.org/docrep/008/ae922e/ae922e00.htm [Accessed 22 January 2010]. 
Wolfenbarger, L.L., Naranjo, S.E., Lundgren. J.G., Bitzer, R.J. & Watrud. L.S. 2008. Bt crop effects on 
functional guilds of non-target arthropods: a meta-analysis. PLoS ONE, 3(5): e2118. doi:10.1371/journal.
pone.0002118.
WTO (World Trade Organisation). 2009. Risk assessment in the international food safety policy arena: 
can the multilateral institutions encourage unbiased outcomes? Staff Working Paper ERSD-2009-01, 
Economic Research and Statistics Division, WTO, Geneva, Switzerland. Available at: http://www.wto.
org/english/res_e/reser_e/ersd200901_e.pdf [Accessed 18 January 2009].
Wu, K.M. & Guo, Y.Y. (2005). The evolution of cotton pest management practices in China. Annual 
Review of Entomology, 50: 31-52.
Xia, J.Y., Cui-Jin, J., Ma, L.H., Dong, S.L. & Cui, X.F. 1999. The role of transgenic Bt cotton in integrated 
insect pest management. Acta Gossypii Sinica, 11: 57-64.
5
Systems Biology Approach to 
the Evaluation of  
GM Plants – a Case Study 
Dr Eugenia Barros
94
WORKSHOP PROCEEDINGS REPORT
GMOs FOR AFRICAN AGRICULTURE: CHALLENGES AND OPPORTUNITIES
SYSTEMS BIOLOGY APPROACH TO THE EVALUATION 
OF GM PLANTS – A CASE STUDY DR EUGENIA BARROS 
Council for Scientific and Industrial Research (CSIR), Biosciences, Meiring Naudé Road, 
Brummeria, Pretoria, 0001, South Africa
Abstract
A common element in the assessment of food safety of transgenic crops is centred on 
a comparative analytical evaluation with the conventionally bred crop plant assuming 
that these products have a history of safe use. This complies with the Organisation for 
Economic Co-operation and Development (OECD) principle of substantial equivalence. 
Non-targeted analytical approaches of gene, transcript, protein and metabolite levels 
are, however, the methods of choice to investigate the physiology of genetically modified 
(GM) plants as comprehensively as possible, thus increasing the chances of detecting 
unintended effects. In South Africa, the use of non-targeted analytical approaches to 
validate the concept of substantial equivalence in GMO plants is being investigated. 
While the results of the first study have been submitted for a scientific publication, this 
report summarises some of the outcomes of a specific data set. This case study evaluated 
the effect of genetic modification and environmental variation of one Bt maize cultivar 
grown in one location over three years (seasons) with its non-GM maize counterpart. Four 
non-targeted methods were used. The study showed that the variation observed in the 
two maize lines was mainly due to environmental factors.
1 Introduction
In the early stages of production and commercialisation of foods derived from GM plants, 
international consensus was reached regarding the principles of food-safety evaluation. 
The concept of substantial equivalence became the starting point of the safety evaluation 
framework based on the idea that existing foods can serve as a basis to compare the 
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properties of GM foods with the appropriate counterpart (Kuiper et al., 2001). However, 
the controversy regarding GM plants and their potential impact on human health and 
the environment have led to the development of additional methods for risk assessment. 
Risk assessment focuses on potential adverse effects which could result from unintended 
effects of genetic modifications. Unintended effects can also occur in conventional 
breeding. The best way to detect unintended effects is through non-targeted analysis 
by using profiling techniques. These techniques allow screening of potential changes 
in the physiology of the modified host plant at different cellular integration levels that 
include the genome level, during gene expression and protein translation and at the 
metabolic pathway level (Rischer & Oksman-Caldentey, 2006). Other factors, such as 
genetic characteristics (cultivar, isogenic lines), agronomic factors (soil, fertilisers) and 
environmental influences (location, weather, stress), also need to be considered during 
GM versus non-GM evaluations because they could contribute to some alteration that is 
not necessarily due to the genetic modification. There is therefore a need to use some of 
these profiling techniques to evaluate a GM plant versus a non-GM plant under different 
conditions to be able to determine their application in future risk assessment evaluations 
as more complex genetic traits are introduced into plants. 
2 Targeted versus non-targeted approach to detect 
unintended effects
The evaluation of GM plants using targeted analysis looks at the compositional variation 
in the GM plant compared to the non-GM counterpart using a selection of analytes of 
interest. These key compounds have been determined by international standards to form 
the basis of substantial equivalence. The substantial equivalence approach was adopted 
by regulatory bodies to ensure that GM plants and foods are as safe and nutritious as their 
conventional counterparts (Kuiper and Kleter, 2003). The analytes or key compounds that 
are included in the baseline analysis of targeted studies include proteins, carbohydrates, 
fats, vitamins and other nutritional/anti-nutritional compounds that may affect the nutritional 
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value and safety of the crop (Kuiper et al., 2001). The selection of compounds may be 
limited to a restricted number representing essential biochemical/physiological pathways 
in the plant. The targeted approach has many limitations with respect to unknown anti-
nutrients and natural toxins. Furthermore, any unforeseen, unintended effects of the 
genetic modification may escape detection using the targeted approach. Thus analyses 
using non-targeted profiling technologies have been developed that allow the screening 
of potential changes in the physiology of the plant at different cellular integration levels 
that include gene expression, protein translation and at the metabolic pathway level. 
These system biology technologies are also known as “omics” technologies, which refer 
to the comprehensive analysis of biological systems. In this case study four profiling 
technologies were used to evaluate one GM maize (Bt) and its non-GM counterpart. The 
effect of genetic modification and the environmental variation were included in the study 
by growing the two maize cultivars in one location over three growing seasons.
3 Data analysis
Profiling techniques generate a large amount of data even when a limited number of 
samples are used. To obtain a meaningful analysis of the profiles from the GM maize and its 
non-GM counterpart, the first stage of data analysis took into account all the compounds 
at once to give an overall view of the data. The multivariate analysis used in this study 
to identify the main sources of variation in the data set was the Principal Component 
Analysis (PCA). This technique reduces multidimensional data sets to smaller numbers of 
new variables called components that still retain most of the variation in the data. Once 
the major sources of variation are identified the next step is to examine each component 
individually using Analysis of Variance (ANOVA), taking into account all the relevant 
features of the experimental design (Davies, 2009). Compounds are then listed in order of 
significant level.
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3.1 Transcriptomics
The microarray technology is the most common approach for gene expression profiling. 
cDNA microarrays have been used to investigate changes in gene expression during 
maize kernel development. One drawback of cDNA microarrays is the false discovery rate 
that results from cross-hybridisation among family members of the plant being studied. 
By contrast, oligo arrays can achieve hybridisation patterns of transcript levels relatively 
accurately and there are a few that are commercially available. The microarray used in this 
study was obtained from the Maize Oligonucleotide Array Project (US). In total 3 541 spots 
were included in the data analysis and PCA results showed a separation of the samples 
according to season and genotype. When the drivers of variation were investigated using 
ANOVA, the largest variation was due to year, whereas a much lower variation was due to 
genotype. This suggests that the variation found between GM and non-GM maize at the 
gene expression level was not significant. 
3.2 Proteomics
The main approach currently used in protein profiling studies is two-dimensional (2-D) gel 
electrophoresis. This technology allows the comparative analyses of protein patterns, 
changes in protein concentrations or post-translational modifications triggered by 
environmental factors or genetic modification. There are, at present, two major short-
comings with this technology: the first is that only highly expressed proteins can be detected 
in a complex protein mixture and the second is that there is not sufficient protein sequence 
data for identification purposes. The protein profiles generated by 2-D electrophoresis of 
the two maize cultivars showed that 714 proteins were included in data analysis, and PCA 
results showed that the samples could be separated according to season and genotype. 
The ANOVA tests showed that the effect of year was stronger than the effect of genotype. 
There was a very slight separation between genotypes which suggests that no significant 
variation was observed between GM and non-GM maize at the protein level. 
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3.3 Metabolomics
The analysis of plant metabolites is generally complicated due to their highly complex 
nature and vast chemical diversity. There is a range of technologies that can be used to 
identify individual compounds that could represent alterations in the content of cellular 
compounds such as sugars, fats, acids and other metabolites. These include Nuclear 
Magnetic Resonance (NMR), Gas Chromatography–Mass Spectrometry (GC-MS), Liquid 
Chromatography–Mass Spectrometry and Fourier-transform (near) infrared spectroscopy. 
Both 1H-NMR and GC-MS were the metabolite profiling techniques used in this case study.
1H-NMR fingerprinting plays a central role in dissecting the relationship between sequence 
and biological function. Although there is incomplete coverage of the plant metabolome, 
1H-NMR was sensitive enough to produce metabolic profiles of the two maize cultivars 
(15 500 complex data points were examined). Thirty-six compounds were identified for 
data analysis and the results showed a separation among the three seasons but no visible 
separation between the genotypes (GM and non-GM).
GC-MS metabolite profiling provides valuable information on the structural identity of 
compounds, but limitations of this technology include its restriction to low molecular weight 
constituents and the range of detectable analytes that is dependent on the choice of 
solvents used in metabolite extraction. Using GC-MS, 120 compounds were included in the 
data analysis and a separation was observed for seasons and for genotypes. The effect of 
season was greater than that of genotype.
4 CONCLUSION
The application of systems biology as a multidisciplinary approach to validate the concept 
of substantial equivalence as part of the safety assessment of GM plants can provide 
relevant information regarding changes in gene expression and associated protein and 
metabolite derivatives as a result of genetic modification. The non-selective comparison of 
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GM maize with its non-GM counterpart offers unlimited possibilities for the identification of 
unintended effects. In this “case study” non-targeted molecular profiling technologies were 
used to provide insight into the extent of variation in the maize transcriptome, proteome 
and metabolome by analysing two maize genotypes grown in the same location in three 
different years. The results showed that the variation observed was mainly caused by 
growing season and the associated environmental factors and was not due to genotype. 
Although the environment was the dominant source of variation, no common drivers of 
variation could be identified in this dataset. The differences that were observed between 
the Bt maize and the non-GM counterpart using the four technologies were not statistically 
significant. Since only two maize lines were used the possibility of identifying differences 
due to natural variation was not part of the scope of this study. 
This study also highlighted the possibilities, as well as the challenges, of profiling analysis for 
food-safety evaluation. A big challenge of the “omics” technologies is the vast amount 
of data that they generate, making it extremely complex to evaluate individual GM lines 
and making a meaningful interpretation difficult. Other challenges include the many 
gaps related to the number of genes for which a function has been identified and the 
limited coverage of the proteome and metabolome. These technologies still need to be 
validated before they can be used for routine safety assessment. They are not intended 
to replace existing analyses but to confirm and supplement current targeted analytical 
approaches. 
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1 Why we did the project
The potato tuber moth (PTM), Phthorimaea operculella (Zeller), is a serious insect pest of 
potatoes in South Africa (Visser et al., 2003; Visser, 2007) and has become an increasingly 
important pest on tobacco and tomato as well (Van Vuuren et al., 1998; Gilboa & Podoler, 
1994). Damage has also been reported on eggplant and other solanaceous crops and 
weeds (Rahalkar et al., 1985). It is an introduced pest, originating from South America (Visser, 
2005), and is therefore not a native component of the South African ecosystem. The larvae 
attack potato plants and tubers under the soil and in stores, and are responsible for losses 
of up to R40 million per annum to the South African potato industry (Visser & Schoeman, 
2004). Commercial producers rely on insecticide application for PTM, generally applied 
at weekly intervals. Applications start when the first moths appear and the insecticide is 
applied eight to twelve times per season. Control is not always satisfactory and damage 
levels vary between seasons and years, depending largely on the survival of over-
wintering moths and their re-infestation of newly planted fields (Visser, 2004). No insecticide 
is registered against the PTM in South Africa under storage conditions. This includes Bt 
sprays, none of which are registered for use against PTM either on foliage or tubers (Nel et 
al., 2002). The only control strategy that gives consistently good control against the PTM 
is the use of genetically modified (GM) insect-resistant potatoes containing the Cry1Ia1 
gene (Visser, 2004). Because PTM in South Africa occurs outside of its natural distribution 
range (Visser, 2005), has demonstrated potential to feed on and therefore threaten 
other species (potatoes, other solanaceous crops, and other wild solanaceous species), 
and causes economic harm (Visser & Schoeman, 2004), this pest fits the definition of an 
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invasive species. Therefore attempts to control this pest are consistent not only with good 
agricultural practice, but also with the objectives of the Biodiversity Act. 
Another reason for the project is to demonstrate the feasibility of efforts led by the public 
sector and developing country institutions to make biotechnology products available in 
Africa. The PTM-resistant potato could be one of the first public sector-developed products 
to be approved and deployed in a developing country. Largely due to the high cost 
of developing a transgenic crop, only the large multinational companies have had the 
financial resources to pursue the commercial development of GM crops. Many laboratories 
at universities and other research organisations have produced GMOs. However, to put 
the GMO through all the regulatory hoops and produce a regulatory dossier with all the 
evidence to demonstrate that the GMO is not harmful is a costly affair. Therefore many of 
these products will never be commercially released. Proper commercial development of 
this product will benefit all potato farmers in South Africa. The technology is in the tuber, 
and the benefit is not scale-dependent. 
A further aim is to demonstrate the value of developing country involvement in generating 
safety assessment data, namely the scientific contribution and at a reduced cost. This 
would result in the building of capacity of public sector institutions in commercialising GM 
crops.
2 What was done?
The following product commercialisation approach was followed.
2.1 Technology and Product Development
First field tests had to be conducted under normal agricultural conditions to demonstrate 
the proof of concept. Multi-location field trials in the major growing regions were conducted 
over a number of growing seasons to select the ideal clone and for the bulking-up of 
material. 
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2.2 Regulatory File Development
Food-safety analysis was performed and environmental studies done. 
Intellectual property ownership of product components had to be assessed and “freedom- 
to-operate” and licensing of the potato had to be done. In the case of this potato some of 
these licensing issues still have to finalised.
2.3 Marketing and Distribution
A delivery strategy had to be developed that would fit into the existing potato industry in 
South Africa. Discussions were held with seed producers who had historically supplied small-
scale farmers (emerging farmers) with seed potatoes. They were quite keen to distribute 
the GM potatoes. Initially, due to the small amounts of seed, farmer participatory trials with 
small-scale producers were planned. 
Extension will have to be done to assist farmers to use the technology safely and according 
to permit regulations. Standard farming extension will also have to be included in this 
package.
A stewardship and liability strategy was developed.
2.4 Outreach and Communication
Public communication of the benefits and impacts of the potato was started. However, 
due to budget constraints this part of the project was scaled down. It was also decided 
that it would perhaps be more beneficial if the potatoes were in the pipeline before more 
substantial communication efforts were undertaken. Creating expectations of a product 
that may never be commercialised can also have a negative impact on the consumer. 
On the whole the retail industry was not opposed to the new potato, but there were fears 
that organisations would mobilise customers to boycott the product or their stores, thus 
affecting profits.
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2.5 Documentation of Socioeconomic Assessments
The Spunta G2 potatoes offer farmers an alternative to the use of pesticides for controlling 
potato tuber moth in the field and in storage. The Spunta G2 potatoes can be safely stored 
without any chemical treatment for tuber moth, even under heavy moth infestations. 
Socioeconomic studies have shown that smallholder farmers lose a considerable amount 
of their stored potatoes to the potato tuber moth and that chemical treatments are used in 
attempts to prevent these loses. Furthermore, some of these chemicals are not approved 
for use on potatoes. A study was undertaken with commercial farmers as well as five small-
scale farmer communities. A few commercial farmers were against the technology as 
they believed it would interfere with their exports. Some welcomed the potato and others 
did not see that it would be beneficial to them. The small-scale farmers’ major concerns 
revolved around more basic issues, such as land availability and other input constraints. 
3 Summary of data needed for the regulatory dossier
3.1 Agronomic Performance
We had to demonstrate that the GM Spunta G2 potato performed as well as the standard 
Spunta under various farming conditions. The potato was tested in six potato-growing 
regions for a number of seasons. Resistance to tuber moth under diffused light store 
conditions was also examined and found to be excellent. The GM potato performed as 
well as the standard potato and gave 100% protection against PTM.
3.2 Molecular Data
We demonstrated that we had a single copy gene insert in Spunta G2 without any vector 
backbone or other additional DNA fragments. The inserted gene, as well as about 1 Kb on 
either side of the inserted gene, was sequenced to demonstrate that the gene itself was 
intact and that no new reading frames were generated. The levels of expression of the Bt 
protein were also determined in the leaves and tubers. 
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3.3 Food and Feed Safety
Both the transformed and non-transformed Spunta potatoes were analysed for nutrient 
composition and it was found that they were identical. Solanine levels in the tubers were 
also determined to see if there were any increases in levels. Toxicity tests were performed 
by feeding mice a large single dose of the Bt protein, but no ill effects were seen. A whole 
food-feeding study with rats was conducted over 90 days and a number of parameters 
were measured (e.g. growth, organ weight, blood chemistry) and no differences could be 
determined in the various test groups. 
3.4 Environmental Safety
A study in three of the trial locations was conducted over a number of years on the 
arthropod populations that inhabit the potato plots. Arthropods found above the canopy, 
within the canopy and on the ground were collected and assessed. Tens of thousands of 
arthropods were collected during the study and no negative impacts were found. The 
predation on PTM larvae and eggs was also studied, and no negative results were found. 
Studies were also conducted on the soil microflora to determine whether the Bt protein 
produced in the plant affects these populations. Once again, no negative impact could 
be determined. 
3.5 Socioeconomic Impact Data
Two surveys were conducted to attempt to shed light on the socioeconomic impact of 
the Bt potato. It is important to note that although this information is requested by the 
Executive Council, there are no guidelines on what kind of information is needed. We 
were subsequently informed that even a “desktop” study may have been sufficient. These 
studies are very expensive and the Executive Council should provide proper guidelines of 
what they require.
The two studies that were conducted were for smallholder and commercial producers 
were: “Smallholder potato production activities in South Africa: a socioeconomic and 
107
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
COMMERCIALISATION OF A GM POTATO (A CASE STUDY – LESSONS LEARNED) 
Mr Gurling Bothma
technical assessment of five cases in three provinces” and “Potential economic benefits 
of a genetically modified (GM) tuber moth resistant-potato variety in South Africa: an ex-
ante socioeconomic evaluation for commercial producers”.
Smallholder farmers indicated a range of problems, many of which might be simply and 
cost-effectively reduced by means of adapting existing technology to local conditions 
and practices. Engaging in a process of participatory and adaptive research with farmers 
will enable them to help optimise their potato production within their specific environment. 
This can be achieved by encouraging farmers, research institutions and community workers 
(NGOs and PDA) to work together in close collaboration. Adapting current technologies to 
local conditions tends to be more cost-effective than developing new technologies which, 
due to their generic nature, are not adapted to local conditions and might not be adopted 
as a result. Optimising production and storage practices within a low-input situation could 
help to address many pest and disease problems experienced by subsistence farmers, as 
many of the problems faced are management problems, exacerbated by lack of access 
to sufficient resources.
It appears that commercial farmers in general would agree to introduce GM potatoes 
into their production planning on condition that the new technology significantly increases 
their profits. The GM potato with PTM-resistant genes might not have the expected rapid 
adoption rate among farmers, since most farmers have PTM infestation under control at a 
reasonable cost.
3.6 Post-Approval Stewardship Plan
An 80-page post-approval stewardship plan was developed that could be implemented 
if approval were granted. 
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4 Where are we now?
The Regulatory Dossier was compiled and submitted with an application for general 
release to the office of the Registrar of the GMO Act in 2008. The Executive Council 
assessed the application and decided not to grant a general release permit in July 2009. 
The Executive Council cited 11 points for this rejection. The Agricultural Research Council 
(ARC), with support from their partners, decided to appeal this decision on the grounds 
that the reasons provided did not warrant a rejection. This process is still in progress at 
the time of writing, but it is hoped that the appeal process will have been completed by 
mid-2010. The project has therefore been on hold since 2008. If the appeal is successful, 
planting material for the farmer participatory trials will only be available at the end of 2011. 
The project is at a point where it is unable to continue unless we manage to get permission 
to do “farmer participatory trials”.
5 What have we learned?
South Africa has the expertise to assess GM products. However, there are still gaps in this 
expertise. Many of the tests that were to be performed in South Africa, e.g. testing for 
the solanine content in potato tubers, soil microbiological work, protein production and 
antibody production, could not be done here. Either it had not been done before and/
or no-one could be found who was willing to develop the methodology or perform the 
tests. At times the fees that laboratories wanted to charge to develop tests were far higher 
than those charged in the US. One possible reason for the lack of testing facilities is that 
there is no demand for these tests and therefore the expertise has not been developed. 
However, the fieldwork, animal-feeding studies, molecular analysis and food nutritional 
analysis, for example, could be done at a reasonable cost. Although there is in general a 
large scientific pool of expertise in South Africa that would be able to be involved in GMO 
evaluation, research institutions and groups are not necessarily set up to perform these 
tests.
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Stakeholder buy-in from the early stages is essential for success. Stakeholders should be part 
of the team from start to finish. However, stakeholders can have a change of heart during 
the project, which can have a severe negative impact on the project. Every attempt 
should be made to keep communication lines open and to keep all the stakeholders on 
board. Stakeholders who have inside information about the project can become major 
liabilities if they decide to withdraw from the project.
Adequate funding is essential. The process of developing and bringing a GM crop to the 
market can be expensive and can take a very long time. Therefore funders must make 
long-term commitments as the project can stagnate for years while regulatory authorities 
make decisions that impact on the project. Unexpected or unplanned expenses may arise 
during the project which can have severe implications if no additional funding can be 
sourced. 
Intellectual property issues should be addressed before the project begins or as soon as 
possible after the project has started. Years of work can be wasted if the IP-holders decide 
not to allow their property to be used for commercial purposes.
Post-release stewardship is a very difficult but important aspect of such a project. 
Research organisations typically do not have the resources and mechanisms to implement 
stewardship programmes. Therefore it is essential to have industry or trade partners with the 
resources and skills to implement the stewardship campaign. These partners should be part 
of the team from the early stages of the project.
6 Final comments
Before embarking on the long journey of developing and commercialising a GM product, 
one must ask the following questions:
Is it only an academic exercise• ?
Is it worth the time and effort• ?
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Is there real benefit to anyone• ?
Is it a case of “we have an answer, let us find a problem”• ?
Is the government serious about using GM technology and will they create an • 
enabling environment?
Can public organisations really compete with large multinationals• ?
I suspect that few research organisations are totally truthful about the answers they 
will give to the above questions. Financial pressures and the push for publications may 
encourage research groups to develop GM crops that will have “great benefit” for certain 
communities, but will ultimately end up as academic exercises. 
It is important that all serious role-players should evaluate what they want to achieve, 
assessing the chances of success and, if successful, how will the product be rolled out for 
the beneficiaries. Only the larger multi-institutional and multidisciplinary groups stand any 
chance of success. Expertise and resources must be pooled and directed to a few “good” 
projects. The South African authorities appear to be becoming more conservative and less 
keen on granting permits. If this is the case, it may make it more difficult for other African 
countries to embrace this potentially beneficial technology.
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1 Techniques available to produce GMOs
1.1 Recombinant DNA Technology
A genetically modified organism (GMO) is an organism whose genetic material has been 
altered. Recombinant DNA technology makes use of DNA molecules from different sources 
which are transferred into the genome of an organism giving it modified or new genes. In 
general, GMOs are produced to endow them with new useful traits.
However, when no gene, or genes, can be found in the available gene pool to introduce 
the desired trait into a particular plant, plant breeders have no obvious alternative but to 
attempt mutation induction.
Mutation can be induced artificially in two principal ways:
1) by the use of chemical agents
2) by radiation techniques.
As these methods work in entirely different ways, they are really complementary.
1.2 Chemical Methods
Chemicals, such as sodium azide and ethyl methyl sulphonate, are used to induce mutations 
in plants. However, some plant genes are more easily mutated by radiation.
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1.3 Nuclear Techniques
Artificial induction of mutation by ionising radiation dates back to the late 1920s. Initial 
attempts used X-rays, subsequently replaced by gamma and neutron radiation. Currently, 
gamma radiation is most widely used.
The irradiation of seeds speeds up the natural process of evolution of the plant’s DNA. 
Thus new varieties of crops can be produced with characteristics tailored to a particular 
need.
The seeds are normally subjected to a range of radiation doses to produce genetic 
variation. The plant with the desired trait is selected following field trials. The development 
of plant cell and tissue culture over the past decades has made it possible to transfer part 
of the breeding work from the field to the laboratory.
2 The importance of breeding new plant varieties
Food security is one of the most challenging problems facing poor countries. The production 
of improved varieties of food crops can contribute significantly towards alleviating 
malnutrition in these countries.
Important desirable properties which can be achieved through plant breeding include:
(a) Increased disease resistance: This is very important, as many crops are ruined by 
diseases. The use of chemicals for protection may be limited by cost or concern for 
the environment.
(b) Improved lodging resistance: Lodging is a serious problem, affecting cereal crops 
such as barley and durum wheat in particular. The desired properties are a reduction 
in plant height and a stiffer stem with at least an equal or an improved yield.
(c) Earlier or later maturing time: The “earliness’’ of many important crop plants, such 
as bread wheat, rice and barley, can be improved by five to ten days, thus making 
THE USE OF NUCLEAR TECHNIQUES TO PRODUCE IMPROVED VARIETIES 
OF FOOD CROPS IN AFRICA Dr Yousuf Maudarbocus
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room in the field for other crops. Altering the maturing time may also allow some 
crops to escape drought, frost or pests.
(d) Improved seed characteristics: These concern the improvement of nutritional value 
(protein or oil content), baking qualities, reduction of cooking time and taste.
(e) Improved agronomic characteristics: These are, for example, greater heat tolerance 
and better adaptability to adverse soil conditions (barren or high-salinity land).
(f) Increased yields: These techniques have resulted in an increase in yield of up to 45% 
for certain crops.
3 Mutation breeding in African countries
3.1 New Wheat Varieties in Kenya
In Kenya and other African countries wheat crops are plagued by a virulent new strain of 
fungus called “wheat rust’’.
Using radiation-based techniques to modify crop characteristics and traits, scientists and 
crop researchers at the Kenya Agricultural Research Institute (KARI), working closely with 
the International Atomic Energy Agency (IAEA), developed new wheat seeds over the 
past decade. The first mutant wheat variety, called Njoro-BW1, was released in 2001. It 
is tolerant to drought and uses limited rainfall efficiently. Moreover, it exhibits moderate 
resistance to wheat rust, has high yields and the flour is of good baking quality.
Today, Njoro-BWI is cultivated on more than 10 000 ha in Kenya. It has become so popular 
among Kenyan wheat farmers that KARI’s seed unit can hardly keep up with demand.
Another high-yielding mutant, codenamed DH4, is due to be released soon.
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3.2 New Sorghum and Rice Varieties in Mali
Mali’s native sorghum has traits that give it some resistance to drought, but it still needs 
substantial rainfall for a good harvest. As sorghum production has not kept up with 
population growth, Malian scientists, especially at the Institut Polytechnique Rural, initiated 
a programme to improve the production of sorghum while conserving their essential 
traits. With the assistance of the IAEA, traditional varieties of sorghum were irradiated with 
gamma rays according to prescribed procedures. Initial field tests show increases of more 
than 10% in productivity.
It is worth noting that other traits of sorghum in Mali have also been altered using different 
gamma irradiation doses, as shown in Table 7.1.
Table 7.1:  Altered traits of sorghum
Dose Year Traits
300 Gy 1992 Increased lodging resistance
250 Gy 1998 Earliness
100 Gy 1998
Increased panicle size, increased yield and change in 
grain colour
Rice has been grown in the flood plains of the Niger River for several centuries. Following 
irradiation of the local variety, new mutants have been developed with white colour 
characteristics and higher yields (> 15%). White rice in Africa fetches double the price of 
red; so for farmers, the colour alone means a substantial increase in income.
3.3 Sesame in Egypt
In Egypt, three mutant varieties of high-yielding, disease and insect-resistant sesame are 
bringing higher economic returns than standard varieties.
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3.4 Cassava in Ghana
Ghana’s cassava variety “Tek Bankye’’, with improved cooking quality, was released 
recently. Trials are underway to produce higher-yielding, disease-resistant cassava, with 
improved starch content.
3.5 Other New Radiation-Induced Varieties
Several other radiation-induced varieties of crops with improved traits, higher yield and 
better nutrition value, which are adaptable to harsh environments have been released. 
These include, among many others, finger millet and cotton in Zambia and banana in 
Sudan.
3.6 Ongoing Activities
Numerous research and development (R&D) activities are being carried out in African 
countries to develop improved varieties of various crops through the use of nuclear 
technology. These include the development of:
a) A better lodging and higher-yield variety of tef in Ethiopia.
b) An improved variety of rice at the Sokoine University of Agriculture, Morogoro, 
Tanzania.
c) A disease-resistant variety of cocoa at the Cocoa Research Institute of Ghana 
(CRIG), Tafo, Ghana.
The cocoa swollen shoot virus (CSSV) is a major disease which has destroyed more than 
40% of the cocoa production in Ghana. In fact, during the last 50 years, about 200 million 
cocoa trees have been destroyed in Ghana as a result of CSSV.
Buds of cocoa plants are subjected to gamma radiation at the Ghana Atomic Energy 
Commission (GAEC) with a view to producing new plant strains with disease-resistant 
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properties. Some of these new strains are being field-tested; if successful, the economic 
benefit to Ghana would be immense.
4 Conclusion
Nuclear techniques can help to address the issues of food security in Africa. These 
techniques are highly competitive in relation to non-nuclear technologies and can be 
used to achieve better solutions to new challenges in Africa.
Other regions have already derived huge economic benefits through the use of radiation-
induced mutations.
In China, up to 2005, a total of 638 mutant varieties of 42 plant species have been released, 
covering 9 million ha of planting area. The economic benefit derived from increased 
cereal production alone is estimated to be about US$420 million a year.
In Pakistan, a mutant producing better quality and higher-yielding crops quadrupled 
cotton production within ten years of release (1983–1992) and now accounts for 70% of 
all cotton grown in the Punjab region, resulting in an economic benefit of US$20 million a 
year. 
In Peru’s high Andes, stronger and healthier varieties of barley, grown at altitudes of up 
to 5 000 m, produce about 1 200 kg per hectare, that is, an increase of 50% in relation to 
previous varieties. This translates to an economic benefit of about US$9 million a year.
There is no doubt that the use of nuclear techniques to produce improved varieties of food 
crops in Africa could contribute significantly towards alleviating the food crisis and bring 
about considerable economic benefits.
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Abstract
Agricultural sustainability usually refers to agronomic sustainability, including aspects 
such as agronomical practices, productivity and ecological diversity – all factors that 
should be considered during the risk assessment of a genetically modified (GM) crop 
before it is released commercially. Most GM crops that have been commercialised to 
date were developed primarily for large-scale farming systems and would, arguably, 
not impart the same scale of benefit to small-scale and subsistence farmers, typical of 
developing countries. Therefore, to allow developing countries to derive the full potential 
benefits of biotech crops, we propose that, in addition to the traditional biosafety aspects 
mentioned above, technology developers should also more carefully consider factors such 
as the relevance and accessibility of a particular technology to ensure sustainability. Risk 
assessment and risk management play a critical role in the successful commercialisation 
of GM crops and should therefore be considered as an integral part of any GM research 
and development programme. This paper will develop these concepts and present a 
risk analysis framework which can be used in an R&D programme to identify, assess and 
mitigate potential biosafety and other deployment risks. 
1 Introduction
In a discussion on the sustainability of genetically modified organisms (GMOs), it usually 
revolves around their sustainable use in agricultural systems, focusing predominantly on 
food/feed and environmental safety. Sustainability is therefore often equated to the 
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post-release safety of the GMO, an aspect that is regulated in all systems and is therefore 
carefully considered during the development and risk assessment processes. Potential 
socioeconomic impacts, by contrast, are currently either not regulated in many countries 
or are only considered at a very late stage of product development. The facts that most 
of the current commercial GMO crops were designed around the needs of specific 
markets that differ considerably from those in the developing world, and that they were 
not developed based on locally established priorities and competencies, resulted in GMO 
products that are unable to deliver positive socioeconomic impacts to many farmers in 
developing countries. 
The sustainable adoption and use of GM technology also depend on many socioeconomic 
and practical constraints, which should be considered proactively in ex ante sustainability 
analyses. By integrating sustainability analyses, including biosafety and socioeconomic 
assessments, into a GMO research and development pipeline, the development of both 
safe and economically sustainable products could be ensured. Such an approach should 
also improve the overall efficiency of the innovation system because it will help to ensure 
the development of safe, relevant and accessible products that are truly sustainable.
2 Why focus on sustainable GM technologies?
Obvious answers to this question will revolve around the post-release endurance, safety, 
diversity and productivity aspects of the GM crop and its receiving environment, but it also 
has an important developmental or strategic aspect. To successfully unlock the potential 
of GM technology, it is important to realise that the technology in itself is not a product. GM 
technology should be packaged into a final product that, in addition to the sustainability 
aspects listed above, is also relevant and accessible to ensure adoption and continued 
use. Defining sustainability in this holistic way and integrating these considerations from 
an early stage into a GM research and development programme will not only help with 
the development of safe, sustainable products, but will also improve the efficiency of the 
innovation process because flawed products can be discarded at an early stage.
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3 Defining the sustainability of GMOs
Sustainability implies safety and the safety of GMOs is defined in terms of their food/
feed and environmental safety, issues that should be proactively considered from the 
very start of a GM research and development project to ensure regulatory compliance. 
These safety aspects of sustainability are not disputed and are similar for all markets, but 
GM crop sustainability also includes a socioeconomic aspect that can vary dramatically 
between different markets. It should therefore come as no surprise that the socioeconomic 
sustainability and benefit of the currently available GM crops have been questioned in 
many developing countries. Even in countries where the potential socioeconomic impact 
of GMOs is considered before general release, this is only done as part of regulatory 
compliance with the aim of limiting undesired ex post impacts and is not intended to be 
a comprehensive feasibility analysis. To ensure the sustainable adoption and use of GMOs 
in a particular environment, these aspects should be considered proactively during the 
development process of the specific product. The integrated, proactive assessment of 
both the biosafety and socioeconomic aspects, i.e. a continuous sustainability assessment, 
of a new GMO is therefore critical to ensure the development of sustainable products 
for African agriculture that will impart a real benefit to the adopters of the technology 
(Figure 8.1).
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Figure 8.1:  Integrating sustainability assessments into a GMO crop R,D&C programme
To be sustainable, GMOs for African agriculture have to be safe, relevant and accessible. 
The best way to ensure this is to develop these crops locally, based on local knowledge, 
priorities, capacities and constraints. 
4 Sustainability assessment of GMOs
Sustainability was previously defined on the basis of its three contributing aspects, i.e. food/
feed safety, environmental safety and socioeconomic feasibility. However, when using it 
as an integrated tool for decision-making in a GMO R,D&C programme, it is more relevant 
to define it chronologically. I will therefore briefly discuss the seven sequential sustainability 
assessment clusters as indicated in Figure 8.1 and illustrate the principle of integrated 
sustainability assessment by way of a few examples in each cluster.
(a) Biosafety assessment – at molecular level: Even before the first construct is developed 
for a transformation programme, the possible implications of the individual genetic 
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components and interventions should be considered. This early-stage, strategic 
assessment could help to ensure that the final product will be safe and viable. 
Possible impacts of the molecular biology interventions/protocols and tools that are 
used during the transformation programme include the following:
The choice of a particular transformation system can impact on transgene copy • 
number and the presence of partial vector sequences. 
Using tissue-specific promoter sequences could reduce the possible environmental • 
impact of the transgene. 
Certain selectable markers such as antibiotic resistance genes might be prohibited • 
in certain regulatory territories. 
Under the current South African legislation the use of a human gene will have • 
specific labelling implications while analogues from different sources will not.
(b) Biosafety assessment – at organism level: Both the selection of a particular organism/
crop and the GM trait(s) of the resulting organism should be considered at an early 
stage. Possible risks associated with different organisms will obviously vary – targeting 
a particular crop disease via the causative agent, its possible vectors or the crop 
itself will, for example, have very different possible impacts. 
Modifying food crops to sustain industrial applications could also have significant • 
socioeconomic impacts. 
The availability of biological containment measures could play a significant role in • 
risk management strategies. 
The introduction of a GM crop into its geographical centre of origin or where sexually • 
compatible wild relatives are present would imply vertical gene flow, which could 
limit the type of GM traits that could be transferred to that particular crop.
(c) Biosafety assessment – comprehensive regulatory overview: The regulatory overview 
or development of the regulatory dossier for a GMO constitutes the compre-
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hensive characterisation of the final transgenic line that has been earmarked for 
commercialisation, i.e. the GM product. At this stage, all the aspects of biosafety, i.e. 
food/feed safety and environmental safety, and where appropriate, the potential 
socioeconomic impacts of the GMO are considered. 
As part of the food/feed safety assessment, possible toxic components, allergens, • 
nutrients and their interactions will be investigated, with the frame of reference for 
many of these studies being substantial equivalence. 
Possible environmental impacts will be considered with reference to the new GM trait • 
and where relevant, e.g. the transgene’s possible impact on the competitiveness of 
the organism, the potential for gene flow and its likely impact, non-target organisms 
and resistance development. 
Currently, no clear guidelines exist for evaluating the possible socioeconomic impacts • 
of GMOs, but it is probably fair to say that current evaluations focus on ensuring that 
the impacted industry and the majority of its stakeholders will not be disadvantaged 
by the release of the GMO. Possible changes in agricultural practices and potential 
gains and losses in agricultural inputs, yields and markets are also considered. 
(d) Biosafety assessment – monitoring: In most countries the release of GMOs is 
conditional on post-release monitoring to gauge possible long-term effects and 
to ensure the employment of prescribed management practices, e.g. the use of 
refugia as part of a resistance management programme. One strategic aspect to 
assess here is the identification of measurable endpoints, e.g. exactly how will non-
target impacts be evaluated over time?
(e) Socioeconomic assessment – relevance: When considering the use of GM tech-
nology, its relevance to a particular targeted community should be carefully 
considered. As stated earlier, the focus should be on the intended product and its 
potential benefits and not on the technology. The potential benefit for the specific 
target market/community under their particular circumstances should be clearly 
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described. The benefit should be a priority for the targeted community. Other 
technologies that could deliver the same benefit and the acceptability of GM 
technology should also be considered. 
(f) Socioeconomic assessment - accessibility: Many technical and practical aspects sur-
rounding the deployment of a GMO can impact on its accessibility in a developing 
country. 
The potential costs or legal obligations associated with intellectual property rights • 
could impact on many of the technology packages that have been used during 
the development of a GMO. Also, technology deployment should never be at the 
expense of freedom to choose.
Management practises associated with particular GM traits could make them • 
non-viable on a small scale or in an informal environment, e.g. seed-saving and 
associated introgression could contribute to resistance development. 
Cultural practices and preferences could impact on the acceptability of a particular • 
trait, e.g. yellow maize as a result of high ß-carotene levels for human consumption, 
or the presence of an inconspicuous trait in an unacceptable variety. 
(g) Socioeconomic assessment – integration: Integrating GM technology effectively 
and seamlessly into current local agricultural systems is crucial for the sustainable 
use of the technology. If the deployment of GM technology remains dependent 
on sophisticated distribution, implementation and management programmes, the 
distribution of its benefits will be severely limited in the developing world. Again, the 
sustainable solution is to focus more widely on issues such as institutional development 
than just on the technology. 
5 Conclusion
A final strategic aspect of sustainability that deserves brief mention is the public accept-
ance of GM technology. Other applications of GM technology, such as that in the medi-
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cal industry have not initiated as many negative perceptions, most probably because 
the potential benefit/risk ratio is perceived to be much more favourable in these applica-
tions. The nature of the debate on GM foods will therefore probably change significantly 
when more products are developed that deliver a tangible benefit to the end consumer. 
Developing such products specifically for application in the developing world and ensur-
ing that they are supported with credible biosafety and sustainability data and under-
pinning principles as described above, will help to ensure that the true potential of GM 
technology can be unlocked for African agriculture. 
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1 Introduction
Africa is home to over 900 million people representing 14% of the world’s population. It is 
the only continent where food production per capita is decreasing and where hunger 
and malnutrition afflict at least one in three people (James, 2008). Africa is recognised 
as the continent that represents by far the biggest challenge in terms of adoption and 
acceptance of new technologies.
Present agricultural practices in Africa are not producing adequate amounts of food for its 
growing population (Blancfield et al., 2008). For this reason farmers are putting additional 
pressure on the environment in their quest to feed more and more people.
Success in meeting these challenges will depend on the unearthing of new information 
and knowledge, and the development and use of new technologies. If these are 
combined with the broader adaptation of existing technologies, it will allow increased 
crop production on the continent.
Africa is yet to fulfil its food production potential and it is especially vulnerable in terms 
of food security (Brink et al., 1998). To meet Africa’s food requirements, it is therefore 
necessary to increase the efficiency of food production. Several key factors including 
plant biotechnology are required for improved crop production.
New technologies need to be assessed to determine the role they can play in improving 
crop yield, controlling diseases and pests and improving nutritional content. Africa is very 
poor and challenges to the development and effective use of biotechnology exist not 
only in financial constraints but also in policy, national capacities, information access and 
the regulatory environment.
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2 Agricultural biotechnology
Agricultural biotechnology has been around for centuries. Mankind has been manipulating 
living organisms for thousands of years. Three thousand years ago civilisations were using 
yeast to make bread, beer and wine and using bacteria to extract minerals from ore; for 
the past 500 years we have been selectively breeding crops and since 1920 we have been 
able to increase crop yields six-fold (Evansa & Fischerb, 1999). 
Agricultural biotechnology is vital for addressing the chronic food shortages in sub-Saharan 
Africa. Despite the Green Revolution, crop yields in sub-Saharan Africa have hardly 
changed over the past 40 years and cereal production per capita is steadily declining. 
It has been estimated that with current yields the projected shortfall of cereals will be 
88.7 million tons by 2025 (Thompson, 2002). 
3 The role of biotechnology in Africa
Biotechnology offers considerable opportunity for addressing many of Africa’s pressing 
challenges. Ongoing biotechnology research in Africa focuses largely on attempting to 
solve local problems associated with food production, health and the environment.
Biotechnology can play a role in increased global crop productivity to improve food, feed 
and fibre security in sustainable crop production systems that also conserve biodiversity. It 
can contribute to the alleviation of poverty and hunger, augmentation of traditional plant 
breeding, reduce the environmental footprint of agriculture, mitigate climate change and 
reduce greenhouse gases and contribute to the cost-effective production of biofuel.
4 The status of biotechnology in Africa
Genetic modification technology is being employed only in a very few African countries, 
namely South Africa, Zimbabwe, Egypt, Kenya, Burkina Faso, Uganda and Malawi, and 
to a lesser extent in Mauritius. Of all these countries, only South Africa, Egypt and Burkina 
Faso have reached the commercialisation stage. The remaining countries have either 
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only recently approved contained trials of crops such as cotton and maize (e.g. Kenya, 
Uganda, Zimbabwe and Malawi), or do not as yet have any regulatory or scientific 
capacity to conduct such trials. 
Most countries in Africa have ratified the Cartagena Protocol on Biosafety (CPB) and have 
received  United Nations Environment Programme – Global Environment Facility (UNEP-GEF) 
assistance to formulate their biosafety frameworks. Only a few have functioning biosafety 
legislation that allows field trials of GM products (South Africa, Zimbabwe, Malawi, Kenya, 
Uganda, Tanzania, Burkina Faso, Ghana, Nigeria, Egypt, Tunisia, Morocco, Mauritania). 
5 Challenges
A third of the African population suffers from chronic hunger. • 
There is a volatile political environment in most African countries.• 
Lack of biosafety regulation is the biggest limitation to biotech growth in Africa. • 
Changing regulatory regimes or lack of them have serious implications for the 
development of biotechnology in Africa. Biosafety regulations and legislation are 
in place only in a few countries in Africa, and such a limitation is a serious constraint 
that impairs the use, evaluation and release of GMOs. 
Extension services are virtually non-existent.• 
The media and anti-biotechnology groups: three countries in Africa have commer-• 
cialised biotechnology crops and a few are conducting or are on the verge of 
conducting confined or field trials. Anti-biotech campaigners will increasingly target 
these countries. 
Public awareness and acceptance – biotechnology regulation is essential to • 
promote public interest and ensure safety. Consumer acceptance will increase 
when there is confidence in the checks and balances that biosafety regulations 
offer.
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6 Opportunities
There is political will for biotech in Africa. The lack of priority setting in agricultural research 
is evident in many African countries, which is reflected in a lack of awareness and 
commitment by the national governments. Continuous technical and financial support 
will assist Africa to create an enabling environment for biotechnology to thrive.
Over 90% of sub-Saharan Africa relies on rain-fed agriculture. Severe drought occurs 
approximately every eight years. Drought-tolerance technology could help farmers to 
maximise their inputs and management practices and protect their investments in times of 
water shortages. Without Africa-focused R&D, capacity building and policies that enable 
the safe and beneficial use of biotechnology, African farmers may be denied access to 
drought-tolerance technology. 
Biotechnology products in the pipeline that will revolutionise agriculture in Africa for the 
poor are drought-tolerant, nitrogen-efficient and biofortified crops. South Africa has the 
capacity, expertise, experience, enabling legislations and resources to lead the continent 
in R&D, innovations and expanding crop acre. South Africa’s experience and vast capacity 
should be shared with the rest of Africa. 
The Millennium Development Goals (MDGs), launched in 2000 (MDG Africa Steering 
Group, 2008), consist of eight key objectives, one of which is the eradication of poverty 
and hunger in Africa by 2015. The G8 nations have, however, been lagging behind in their 
commitments to boost aid to Africa. With rising food prices, hunger and poverty the G8 
leaders are under immense pressure to do something.
We need to ensure the renewal of the G8’s commitments by developing an initiative to 
tap into the G8’s resources and those of other organisations, such as the World Bank and 
the FAO, which would help Africa to realise some key MDGs.
Networking and training opportunities in Africa should be continued. Linkages between 
African countries as well as with the developed world should be stimulated through existing 
networks and joint projects.
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7 The South African experience 
South Africa became the first country in Africa to adopt GM crops when it approved its 
first transgenic crops for commercial use in 1997. To date the commercial release of insect-
resistant (Bt) cotton and maize as well as herbicide-tolerant (RR) soya beans, cotton and 
maize have been approved in South Africa. In October 2005, stacked-gene cotton (Bt & 
RR) was approved and in March 2007 the stacked-gene maize (Bt & RR) was approved. 
The present national GM crop percentages are: cotton 90%, white maize 56%, yellow 
maize 72% and soya 80% (James, 2008).
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Figure 9.1:  Adoption of GM crops in South Africa (James, 2008)
For the first 12 years of commercialisation of biotech crops from 1996 to 2007, South Africa 
was the only country on the African continent to benefit from commercialising biotech 
crops. In 2008, Burkina Faso grew 8 500 ha of Bt cotton for seed multiplication and initial 
commercialisation, and Egypt grew 700 ha of Bt maize for the first time (James, 2008).
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Table 9.1:  Total area of GM crops planted in South Africa in 2008 (James, 2008)
Crop Total area Area GM % GM Remarks
Maize
White maize 1 600 000 ha 891 000 ha* 56% * Bt/HT  164 000 ha (83%)
 HT       148 000 ha (9%)
 Bt       576 000 ha (8%)
Yellow maize 1 000 000 ha 720 000 ha* 72% * Bt/HT  138 000 ha (83%)
 HT       131 000 ha (9%)
 Bt       455 000 ha (72%)
Soybeans 230 000 ha 184 000 ha* 80% * HT soybeans
Cotton 13 000 ha 12 000 ha* 92% * Bt/HT  10 000 ha (83%)
 HT       1 000 ha (9%)
 Bt        950 ha (8%)
8 Socioeconomic benefits of GM crops in South Africa
In South Africa a study published in 2005 involving 368 small and resource-poor farmers and 
33 commercial farmers, the latter divided into irrigated and dry-land maize production 
systems. The data indicated that under irrigated conditions, Bt maize resulted in an 11% 
higher yield (from 10.9 MT to 12.1 MT/ha), a cost savings in insecticides of US$18/ha 
equivalent to a 60% cost reduction, and an increased income of US$117/ha. Under rain-
fed conditions, Bt maize resulted in an 11% higher yield (from 3.1 to 3.4 MT/ha), a cost 
saving on insecticides of US$7/ha equivalent to a 60% cost reduction, and an increased 
income of US$35/ha (Gouse et al., 2005). Farmers are paying premium prices for the use 
of the technology because of increased productivity and efficiency gains (Brookes & 
Barfoot, 2008).
South Africa is estimated to have increased farming income from biotech maize, soybean 
and cotton by US$383 million in the period between 1998 and 2007, with benefits for 2007 
alone estimated at US$227 million (Brookes & Barfoot, 2009).
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9 Conclusion
With the commercialisation of biotechnology products in other parts of Africa, South Africa 
is no longer the sole producer of biotechnology products in Africa. However, the country 
remains the pioneer of the technology and is a role model for the rest of Africa. 
South Africa is seen as the hub of agricultural biotechnology for Africa as it is one of the 
few countries in Africa that has a well-developed regulatory system and the expertise 
to manage the technology. However, South Africa seems to be moving towards stricter 
legislation which is not based on scientific fact. 
There is therefore a need in South Africa to ensure that decision-makers who develop 
policies, amend and enforce the existing legislation and regulations are continuously 
educated and well informed on biosafety and biotechnology.
GM crops can contribute to improved food security and poverty alleviation in Africa. 
Developing farmers in Africa have shown that they are able to access the benefits of GM 
crops, but they need good governance, financial support, skills training, market access, 
the support of competent extension services and an adequate rural infrastructure. 
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REGULATION OF GMO ACTIVITIES IN SOUTH AFRICA: 
EXPERIENCE FROM A TECHNOLOGY DEVELOPER  
MS MICHELLE VOSGES
Monsanto, Johannesburg, South Africa
1 Introduction 
As a technology developer, one experiences various challenges as a result of the regulatory 
frameworks in particular countries. This also applies to the biosafety framework in operation 
in South Africa. These challenges are discussed below, with some recommendations. 
2 Discussion 
Challenges are experienced at various levels: design of the legislative framework, opera-
tional procedures and authorisations granted. These levels are discussed below. 
2.1 Legislative Framework 
A functional, practical and operational biosafety framework in a country is essential for 
a technology developer to invest in that country. More importantly though, protection of 
the technology and rights of the developer should be provided for in such legislation. The 
provisions of the legislation must be conducive for an application to be made and activities 
to be conducted in that country. Assessments should be science-based and reviews 
conducted in a transparent manner with clear communication on the requirements, 
review process and reasons for decisions taken. 
In many countries a lack of knowledge, third party influences and political pressure can 
lead to “over-regulation” of the technology. This very often results in the requirements and 
restrictions imposed on activities being so strict that the developer is unable to meet the 
requirements and restrictions, which means that the developer does not invest in that 
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particular country, thus preventing access to the technology and the eventual “killing” of 
the technology in that country. 
Biotechnology products have been used safely in many countries for many years. This 
implies that a country that does not have experience in the regulation of this technology 
can obtain not only guidance in the safety assessments of biotechnology products, but also 
information and data from reviews already conducted by other regulatory authorities. 
Although it is still a relatively new technology, the developments in this field are tremendous. 
From planting single events in the beginning, we are now moving towards commercialising 
products containing four or more traits in a single product. This, however, provides challenges 
to the regulators as to how they will assess these new stacked products, as the approach 
followed for assessments for single events would not be practical for stacked products. 
2.2 Operational Procedures 
2.2.1 Applications 
The process of applying for authorisation and the review process must be practical and 
reasonable. Application forms must be easy to understand with clear directions on which 
application is applicable to which activity. As the technology develops and experience 
is gained by regulators, it is obvious that application requirements and forms will change 
from time to time. It is, however, important that any change be communicated to the 
developers in a transparent and efficient way to enable a smooth transition from one set 
of requirements/forms to another. 
Several committees and experts are involved during review of an application, requiring the 
need for several copies of the application to be submitted to the authorities. It is recognised 
that it may not always be possible and may be a challenge in some developing countries, 
but the replacement of hard copies with electronic copies could save time and costs for 
the regulators and developers. 
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As indicated before, this technology is moving fast and stacked products will be prominent 
in the future. It is therefore unavoidable that activities containing more than one transgenic 
product will be present in single activities such as confined field releases. It is therefore 
important that the regulatory process be structured in such a manner that applications 
that enable such activities are possible. 
2.2.2 Review process 
Time is always of the essence for developers, hence the review process must be conducted 
in such a manner that any additional information/clarity required from the applicant is 
requested in a coordinated manner. Requesting additional information/data from an 
applicant at various intervals during the review process not only frustrates the regulatory 
system, but also delays the time in which an application is processed. 
Certain information is definitely required to enable an informed decision on the safety 
of a product or proposed activity. However, regulators should refrain from requesting 
information or data from the developer that are not relevant to the safety assessment 
(“nice-to-know” data). These requirements often result in unnecessary costs and time 
delays, without adding substance to the decision on safety. 
The developer aims to provide enough information and data to enable a scientific safety 
assessment of a product. In the event that additional information or data is requested, the 
developer would aim to address the outstanding issues as quickly as possible, as it means 
that the review process can be continued sooner. However, it is very difficult to respond 
with the correct information or data if the requests from the regulators are not clear. It is 
therefore important that the requests be clearly defined. Furthermore, in many instances, 
concerns could be addressed through direct communication between the individuals/
committees assessing the application and the applicant. Opportunities where there could 
be some sort of direct communication between the review committees and the applicant 
could ease the review process and again reduce cost and time, without impacting 
negatively on the quality of the assessment or integrity of the review bodies. 
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Although transparency is important, it is well known that there are some institutions that 
would take certain actions in an attempt to prevent or delay an assessment or activity. It is 
important that the regulators should therefore manage third parties who participate in the 
review process through public consultation processes. 
2.2.3 Authorisations 
Applications are submitted with the intention of conducting the activity in a particular 
growing season, regardless of the type of activity. The timely issue of permits/authorisations 
to enable execution in the planned growing season is therefore of crucial importance to 
developers. Activities with regulated transgenic events are normally subject to specific 
conditions. These conditions are not only important during the activity per se, but are used 
as a reference by developers when planning future activities. This is especially important 
during confined field trial activities, when trial sites for activities in the follow-up growing 
season are selected based on the ability to meet the isolation conditions that were 
applicable to the same activity in the previous growing season. Although permit conditions 
are designed on the basis of the specific conditions and product, some conditions would 
remain constant for similar conditions. Changing conditions, and especially isolation 
conditions, a few months or weeks prior to a growing season could have serious impacts 
on the ability of developers to continue with authorised trials, as the trial locations may no 
longer meet the new isolation conditions. 
Conditions should further be practical and in line with current agricultural practices. It 
serves no purpose to institute conditions that cannot or are very difficult to implement in 
the field. 
As experience is gained by the regulators, permit conditions will be amended. This is very 
important for adapting to the different requirements applicable during different activities. 
There should also be a procedure in place whereby developers are able to request 
amendments and regulators can review proposed amendments and make decisions 
within a short time period, as there are normally not weeks available in which to deliberate 
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on whether a proposed condition should be approved or not, and the amendment 
authorisation be granted. 
3 Conclusions 
Legislative frameworks must be functional, practical and operational, while providing 
protection of the developer’s investment in terms of intellectual property. Application 
forms should be activity-specific, easily accessible and science-based. 
Assessment of applications by regulators should be timely, transparent and focused on 
information that will assist in determining the safety of the proposed activity and product. 
Concerns, decisions and reasons for decisions should be communicated in a timely fashion 
and be clearly stated. 
Conditions should be activity-specific, based on agricultural practice and remain consistent 
to enable implementation, unless supported by scientific evidence that would necessitate 
any amendment to the conditions. 
Applications should be processed within the time periods described in legislative frame- 
works.
Appendix 1:
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Committee Members
Dr HENNIE GROENEWALD (Chairperson) is the Executive Manager of Biosafety South Africa, a 
national biosafety platform initiated by the national Department of Science and Technology 
(DST). Biosafety South Africa supports innovation in biotechnology through the delivery of 
value-adding services and investment in biosafety research to help ensure the safety and 
sustainability of biotechnological products. He has a PhD in plant biotechnology and has 
20 years of experience in research and development, teaching, project management, 
entrepreneurship and business development. His research career focused on aspects of 
plant molecular physiology, biosafety, tissue culture, molecular biology and biochemistry, 
and he has authored several peer-reviewed papers and patents on these subjects. Prior 
to joining Biosafety South Africa, he worked at Stellenbosch University and still holds an 
Extraordinary Senior Lecturer position at that institution. He has previously also worked at 
the South African Sugarcane Research Institute and has been a visiting researcher at the 
Texas Agricultural & Medical University, Weslaco, US, the Max Planck Institut für Molekuläre 
Pflanzenphysiologie, Golm, Germany, and the Commonwealth Scientific and Industrial 
Research Organisation (CSIRO), Plant Industry, Brisbane, Australia.
Dr ANTONIO LLOBELL is the Chief Executive Officer of PlantBio Trust, which he joined in 
April 2004. He has played an integral role in building the PlantBio team and growing the 
portfolio of projects funded by the Trust. He has been instrumental in establishing a wide 
base of strategic initiatives, both locally and internationally. With more than 12 years of 
senior management experience in research in the plant and microbial biotechnology 
field, he was Professor of Plant Biotechnology at the African Centre for Crop Improvement, 
University of KwaZulu-Natal, Pietermaritzburg, before joining PlantBio. He has also been 
Professor Titular at the Department of Biochemistry and Molecular Biology and Institute 
of Plant Biochemistry and Photosynthesis, University of Seville and the Spanish National 
Research Council, CSIC (Consejo Superior de Investigaciones Científicas). He has a 
149
A
c
a
d
e
m
y o
f Sc
ie
nc
e
 o
f So
uth A
fric
a
strong entrepreneurial background and was co-founder and scientific consultant in 
Newbiotechnic S.A. (NBT) in Spain, a biotech company specialising in the development of 
applications for the agri-food and industrial sectors, and in NBT Diagen, S.A., also in Spain, 
a biotech company commercialising molecular diagnosis services for the medical sector. 
He has published more than 60 scientific articles in books and first-rated, peer-reviewed 
international journals and more than 100 communications to national and international 
congresses. He has also been referee for a number of international journals and is the 
inventor of six Spanish patent applications and four international patent applications on 
antifungal genes and proteins, gene expression systems and biocontrol formulations.
Prof. PATRICK RUBAIHAYO is Professor of Crop Science at Makerere University (Uganda). 
He has expertise in plant breeding, genetics, plant tissue and cell culture, and genomics. 
He has worked with a number of crops including grain legumes, bananas, tomatoes, 
potatoes, maize and sorghum. He moved up through the ranks from Special Lecturer to 
Associate Professor and was appointed Professor in 1995. Prior to joining Makerere University 
he was a member of the Ugandan parliament and minister of state for agriculture and 
forestry where he was in charge of the Coffee Rehabilitation Programme, the Agriculture 
Rehabilitation Project, and agricultural research among other duties. He coordinated the 
National Banana-Based Cropping Systems Research Programme, the National Pigeon Pea 
Improvement Programme and the Tomato Improvement Programme. He is a member of 
the Ugandan National Academy of Sciences. 
Prof. EDWARD RYBICKI is a Professor in Microbiology at the University of Cape Town (UCT). He 
is also a Founder Member of the Institute of Infectious Disease and Molecular Medicine 
(IIDMM) based in the Health Sciences Faculty (UCT). His main research interests are in 
making human and animal vaccine candidates in plants and insect cells, these include 
vaccines for mucosal human papillomaviruses (HPV) and human immunodeficiency virus 
type 1 (HIV-1) subtype C. He also works on the characterisation and molecular biology 
of the parrot beak and feather disease virus and the possibility of making vaccines and 
therapeutics for this viral disease. He also has an interest in the diversity of southern African 
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Mastreviruses (family Geminiviridae), the molecular determinants of pathogenicity and 
host range in these viruses, and especially in maize streak virus, the use of geminiviruses as 
vectors of foreign genes in plants, and in the engineering of viral resistance, especially in 
maize. He has authored or co-authored some 90 articles in peer-reviewed journals, and 
approximately 20 book chapters, as well as a number of popular or opinion articles and 
report-backs in journals. He has deposited a significant number of virus-related nucleic 
acid sequences in GenBank. He is a Member of the Academy of Science of South Africa. 
Speakers
Mrs REMI AKANBI is at present the Director for Project and Operations at AfricaBio, a 
biotechnology stakeholder association working in South Africa and the SADC region. Since 
joining AfricaBio, she has headed and participated in research on consumer perceptions 
and public awareness of biotechnology in South Africa and other southern African 
countries under various project activities. She has also been involved in demonstrating 
the impact of agricultural biotechnology on small-scale farmers in South Africa. She has 
participated in numerous international conventions and conferences and has also made 
numerous presentations at workshops, to community groups, consumers and farmers. The 
focus of her current research is the socioeconomic impact of biotechnology on farming 
communities in South Africa. She has a Master of Science Degree in microbiology from the 
University of Pretoria. 
Dr EUGENIA BARROS is a Research Fellow at the CSIR in the Bio/Chemtek business unit 
and is the business area manager of the crop genomics group. She studied genetics, 
biochemistry and microbiology at the University of the Witwatersrand and obtained a 
PhD in molecular biology at the University of Cape Town. She has more than ten years’ 
experience in molecular marker technology in cereal crops and eucalyptus. She also 
works closely with the tree improvement group on biotechnology projects. She has worked 
in research projects involving gene cloning and gene expression of bacteria for industrial 
applications and in projects involving the development of molecular markers using various 
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molecular marker technologies for DNA profiling, genetic purity evaluation and marker-
assisted selection (MAS) of cereal crops, legumes, trees and fungi. She has also worked 
on detection methods for genetically modified (GM) plants using protein (ELISA) and DNA 
methods (normal PCR and real-time PCR). Her research interests are the development 
of molecular markers linked to genes coding for important traits using cDNA-based 
marker technologies. It includes the generation of ESTs for both MAS and identification of 
candidate genes, the generation of diversity arrays, and the integration of bioinformatics 
with marker-assisted selection. She is involved in DNA fingerprinting of cereal crops, trees, 
fungi and other plants for identity preservation, parentage analysis, molecular marker 
development for MAS and for gene identification.
Mr GURLING BOTHMA has recently joined CSIR, and prior to this he was a scientist at the 
ARC-Roodeplaat Vegetable and Ornamental Plant Institute, South Africa.
Dr AUGUSTINE GUBBA is a Senior Lecturer in Plant Pathology at the University of KwaZulu-
Natal (School of Agricultural Sciences and Agribusiness). He holds a BSc. Agric (Hons) 
degree from the University of Zimbabwe, an MSc in applied plant sciences from Wye 
College (University of London) and a PhD in plant pathology from Cornell University (USA). 
His area of expertise is plant virology focusing on the identification and characterisation 
of viruses, developing sustainable control strategies for plant viral diseases and plant 
transformation for transgenic virus resistance. He has worked in both agricultural extension 
and research in Zimbabwe. His research interests are on developing transgenic vegetables 
with broad resistance to virus infection. He is currently investigating the development of 
sweet potato plants with multiple resistance to different viruses that infect the crop under 
field conditions. In 2005, he spent a six-month sabbatical attached to the USDA in Hilo, 
Hawaii studying the transgenic papaya that has been commercialised. He intends to play 
an active role in current efforts to  use biotechnology to address some of the agricultural 
challenges facing Africa. 
Prof. HANS-WALTER HELDT is Emeritus Professor at the University of Göttingen in the Plant 
Biochemistry Section of the Albrecht von Haller Institute for Plant Sciences. He studied 
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chemistry at the Universities of Innsbruck (Austria), Marburg (Germany) and Edinburgh 
(Scotland), and obtained his D.Phil. from the University of Marburg, where he also served 
as Scientific Assistant at the Institute for Physiological Chemistry. He has worked in the 
sabbaticals in the Department of Plant Industry, CSIRO, in Canberra, Australia, and was 
Director of the Albrecht von Haller Institute for Plant Sciences at Göttingen. From 2000 to 
2006 he served as representative of the Union of German Academies of Science in the 
InterAcademy Panel. Prof. Heldt’s interests are metabolite transport across cellular and 
subcellular membranes of plants, photosynthesis metabolism and gene technology. He 
is the author of the textbook Plant Biochemistry, which is in its 4th German edition – there 
are also US, Japanese, Chinese and Indian editions of the book, with a Russian edition in 
preparation.
Dr YOUSUF MAUDARBOCUS is a physicist with broad experience in project management 
and is a lecturer at the University of Mauritius. As Regional Programme Manager for Africa 
with the Department of Technical Cooperation of the International Atomic Energy Agency 
(IAEA), Vienna, Austria, he evaluated, designed and formulated technical co-operation 
projects for African member states. He managed several projects in the fields of human 
health (radiotherapy, nuclear medicine, radiation protection), food and agriculture (pest 
eradication, food preservation, crop improvement, animal disease monitoring), water 
resources management (especially ground water assessment), pollution monitoring 
(mainly the marine environment) and industrialisation (non-destructive testing and tracer 
techniques, strengthening of materials through irradiation). He also led multi-disciplinary 
team missions and conducted programming and project monitoring missions in various 
African member states. He is an ex-IAEA member and he is currently a member of the 
Mauritius Academy of Science & Technology. He has a PhD in physics from the University 
of London.
Prof. CARL MBOFUNG is the Director and Lecturer for the National Advanced School of 
Agro-Industrial Sciences (ENSAIC) at the University of Ngaoundere in Cameroon. He is also 
a member of the Cameroon Academy of Science.
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Dr DENNIS OBONYO is a Biosafety Specialist in a major biosafety capacity-building project 
for sub-Saharan Africa, implemented through a partnership between the International 
Centre for Genetic Engineering and Biotechnology (ICGEB) and the Bill and Melinda 
Gates Foundation. He is based at the Cape Town component of the ICGEB. Prior to joining 
the ICGEB he worked as KARI Deputy Co-ordinator of the BiosafeTrain Project (a DANIDA-
funded programme involved in building capacity for biosafety and ecological impact 
assessment of transgenic plants in East Africa [DANIDA; Danish International Development 
Agency: KARI; Kenya Agricultural Research Institute]) in Nairobi, Kenya. He was also the 
theme leader of the Environmental Impacts Assessment group (responsible for conducting 
studies on the potential impacts of Bt maize on non-target arthropods in Kenya) of the 
Insect-Resistant Management for Africa (IRMA) project (a Syngenta Foundation funded 
joint KARI-CIMMYT programme)(CIMMYT; International Maize and Wheat Improvement 
Centre). He has a PhD in entomology from the University of Nairobi.
Dr GOSPEL OMANYA is the Seed Systems Manager at the African Agricultural Technology 
Foundation (AATF). He is an accomplished plant breeder and geneticist with a PhD in plant 
genetics and breeding from the University of Hohenheim in Germany. He has worked for the 
International Crops Research Institute for the Semi-Arid Tropics (ICRISAT), Sahelian Centre 
in Niamey (Niger) as a Special Project Scientist responsible for pearl millet improvement 
for West and Central Africa, where he facilitated the development of farmer-managed 
seed production and distribution systems. At the AATF he oversees the formulation and 
implementation of technology deployment policies and strategies, including stewardship, 
products demonstration and delivery to target users in Africa. His biography was also in the 
Marquis Who’s Who in Science and Engineering (2008–2009).
Ms MICHELLE VOSGES is currently responsible for matters pertaining to regulatory affairs at 
Monsanto South Africa. Prior to joining Monsanto she worked at the Biosafety Directorate of 
the Department of Agriculture. After eight years at the Department and as Registrar for the 
Genetically Modified Organisms Act, 1997, she joined Syngenta South Africa as Regulatory 
Affairs Manager for Biotechnology. She has a Masters’ degree in plant physiology from the 
University of Pretoria.
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Staff Members
Prof. ROSEANNE DIAB is the full- time Executive Officer of ASSAf and Emeritus Professor in 
the School of Environmental Sciences, University of KwaZulu-Natal. She is a Member of 
ASSAf and is recognised for her research contributions in the field of atmospheric sciences, 
particularly air quality, and more generally environmental management. She is a Fellow 
of the University of KwaZulu-Natal and of the South African Geographical Society. She has 
been a Fulbright senior research scholar, is a member of a number of international bodies 
such as the International Ozone Commission (IOC) and the Commission on Atmospheric 
Chemistry and Global Pollution (CACGP), and serves on the editorial board of the journal 
Atmospheric Environment.
Dr NTHABISENG TAOLE is a Project Manager at ASSAf. Her primary responsibility is to lead 
and manage the implementation of the ASSAf’s approved projects. She was also a study 
director for the consensus study entitled A Strategic Approach to Scholarly Publishing 
in Books and Book Chapters in South Africa. She serves on the ASSAf task team on “A 
Possible Scholarly Publishing Platform”. She also serves on the ASSAf peer-review panel on 
Agriculture and Related Basic Life Sciences. Before joining ASSAf she worked as systems 
manager at the National University of Lesotho Library and as ICT Advocacy Manager at 
the Southern African NGO Network (SANGONeT). She holds a PhD in information science 
from the University of Pretoria.
Ms PHAKAMILE MNGADI is a Project Officer at ASSAf. She is responsible for all administrative 
aspects of the GMOs Forum project. She is also responsible for the “Consensus Study on 
Clinical Research in South Africa”, the “Consensus Study on Long-term Strategy on the 
Burden of HIV/AIDS” and a “Forum Study on Improving Maternal, Newborn and Child 
Health in Africa”. Prior to joining ASSAf, she worked for the Medical Research Council as a 
project leader for a microbiocide clinical trial. She has a Masters degree in biotechnology 
from the Durban University of Technology. 
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WORKSHOP AGENDA/PROGRAMME
GMOs FOR AFRICAN AGRICULTURE: OPPORTUNITIES AND CHALLENGES
DATE: 17-18 September 2009
VENUE: ASSAf Offices [Persequor Park, Lynnwood, Pretoria SOUTH AFRICA]
DAY 1 (17 September 2009): Chaired by DR HENNIE GROENEWALD 
09:30-10:00
10:00-10:10
TEA/ARRIVALS
Opening/Welcoming Remarks 
PROF. ROSEANNE DIAB [ASSAf Executive Officer]
10:10-10:20 Overview/Introductions 
PROF. ROSEANNE DIAB [ASSAf Executive Officer]
10:20-10:45 Introduction and problem statement
DR GOSPEL OMANYA – African Agricultural Technology Foundation 
(AATF) [Kenya]
10:45-12:30 Presentations [20-25 minutes each] 
 
The situation concerning GM crop plants in Germany
PROF. HANS-WALTER HELDT – Union of German Academies of 
Sciences and Humanities [Germany] 
The role of GMOs in Africa: Food and nutrition security 
PROF. CARL MBOFUNG – University of Ngaoundere [Cameroon]
Transgenic plants with virus resistance: opportunities and challenges 
for Africa
DR AUGUSTINE GUBBA – University of KwaZulu-Natal [South Africa]
12:30-13:00 DISCUSSION
13:00-13:45 LUNCH 
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13:45–15:00 Presentations [20-25 minutes each] 
1. Challenges of GM technologies [with a focus on potential risks, how 
these risks are addressed through policy, legal and administrative 
frameworks including risk assessment]
 MR ABISAI MAFA – National Biotechnology Authority [Zimbabwe]
2. Challenges of regulating agricultural biotechnology in Africa
 PROF. DIRAN MAKINDE – West African Bioscience Network (WABNet) 
[Senegal]
3. Challenges for GM technologies: Evidence-based evaluation of 
the potential environmental impacts of GM crops
 DR DENNIS NDOLO OBONYO – International Centre for Genetic 
Engineering and Biotechnology (ICGEB) [South Africa (base)]
15:00-15:30 DISCUSSION
15:30-15:50 TEA BREAK
15:50-16:30 Group discussion and closure for the day
DAY 2 (18 September 2009): Chaired by PROF. PATRICK RUBAIHAYO
09:30-09:45 Re-cap from DAY 1 and Outline for DAY 2
09:45-10:45 Presentations [20-25 minutes each] 
Systems biology approach1.  to the evaluation of GM plants: a case study 
DR EUGENIA BARROS – Council for Scientific and Industrial Research 
(CSIR) [South Africa]
Commercialisation of a GM potato for South Africa developed by 2. 
publicly funded research organisations – lessons learned: a case study 
MR GURLING BOTHMA – Agricultural Research Council (ARC) 
[South Africa]
10:45-11:10 DISCUSSION
11:10-11:30 TEA BREAK
APPENDIX 2
11:30-13:00 Presentations [20-25 minutes each] 
3.    The use of nuclear techniques to produce improved varieties 
of food crops in Africa
        DR YOUSUF MAUDARBOCUS – Mauritius Academy of Science & 
Technology [Mauritius]
4.     Challenges in effective implementation of biosafety legislative 
frameworks in Africa
         MS LILLIAN NFOR - International Centre for Genetic Engineering 
and Biotechnology (ICGEB) [South Africa (base)]
5.     Sustainable GM technologies for African Agriculture
        DR JAN-HENDRIK GROENEWALD – Biosafety [South Africa]
13:00-13:30 DISCUSSION
13:30-14:15 LUNCH
14:15-15:15 Presentations [20-25 minutes each] 
6.    Agricultural biotechnology: Does it work in Africa?
       MRS REMI AKANBI – AfricaBio [South Africa]
7.    Regulation of GMO activities in South Africa: Experience from 
a technology developer
        MS MICHELLE VOSGES – Monsanto [South Africa] 
15:15-15:40 DISCUSSION
15:40 Way forward and closure
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